CA2562047A1 - Cosmetic formulations comprising zno nanoparticles - Google Patents
Cosmetic formulations comprising zno nanoparticles Download PDFInfo
- Publication number
- CA2562047A1 CA2562047A1 CA002562047A CA2562047A CA2562047A1 CA 2562047 A1 CA2562047 A1 CA 2562047A1 CA 002562047 A CA002562047 A CA 002562047A CA 2562047 A CA2562047 A CA 2562047A CA 2562047 A1 CA2562047 A1 CA 2562047A1
- Authority
- CA
- Canada
- Prior art keywords
- phase
- zinc oxide
- particles
- surface treated
- monomers
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 167
- 238000009472 formulation Methods 0.000 title claims abstract description 89
- 239000002537 cosmetic Substances 0.000 title claims abstract description 31
- 239000002105 nanoparticle Substances 0.000 title claims abstract description 31
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 claims abstract description 157
- 239000002245 particle Substances 0.000 claims abstract description 105
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 claims abstract description 78
- 239000011787 zinc oxide Substances 0.000 claims abstract description 76
- 229920000578 graft copolymer Polymers 0.000 claims abstract description 34
- 238000004381 surface treatment Methods 0.000 claims description 57
- 238000000034 method Methods 0.000 claims description 47
- 239000000178 monomer Substances 0.000 claims description 37
- NMEPHPOFYLLFTK-UHFFFAOYSA-N trimethoxy(octyl)silane Chemical compound CCCCCCCC[Si](OC)(OC)OC NMEPHPOFYLLFTK-UHFFFAOYSA-N 0.000 claims description 17
- MSRJTTSHWYDFIU-UHFFFAOYSA-N octyltriethoxysilane Chemical compound CCCCCCCC[Si](OCC)(OCC)OCC MSRJTTSHWYDFIU-UHFFFAOYSA-N 0.000 claims description 14
- 239000003446 ligand Substances 0.000 claims description 12
- ZNOCGWVLWPVKAO-UHFFFAOYSA-N trimethoxy(phenyl)silane Chemical compound CO[Si](OC)(OC)C1=CC=CC=C1 ZNOCGWVLWPVKAO-UHFFFAOYSA-N 0.000 claims description 12
- AHUXYBVKTIBBJW-UHFFFAOYSA-N dimethoxy(diphenyl)silane Chemical compound C=1C=CC=CC=1[Si](OC)(OC)C1=CC=CC=C1 AHUXYBVKTIBBJW-UHFFFAOYSA-N 0.000 claims description 10
- ZZNQQQWFKKTOSD-UHFFFAOYSA-N diethoxy(diphenyl)silane Chemical compound C=1C=CC=CC=1[Si](OCC)(OCC)C1=CC=CC=C1 ZZNQQQWFKKTOSD-UHFFFAOYSA-N 0.000 claims description 7
- 230000000475 sunscreen effect Effects 0.000 claims description 7
- 239000000516 sunscreening agent Substances 0.000 claims description 7
- NRAYZPGATNMOSB-UHFFFAOYSA-N dichloro(dihexyl)silane Chemical compound CCCCCC[Si](Cl)(Cl)CCCCCC NRAYZPGATNMOSB-UHFFFAOYSA-N 0.000 claims description 6
- KKRMHVJQWMXYBZ-UHFFFAOYSA-N dichloro-hexyl-methylsilane Chemical compound CCCCCC[Si](C)(Cl)Cl KKRMHVJQWMXYBZ-UHFFFAOYSA-N 0.000 claims description 6
- ZVMRWPHIZSSUKP-UHFFFAOYSA-N dicyclohexyl(dimethoxy)silane Chemical compound C1CCCCC1[Si](OC)(OC)C1CCCCC1 ZVMRWPHIZSSUKP-UHFFFAOYSA-N 0.000 claims description 6
- ZMAPKOCENOWQRE-UHFFFAOYSA-N diethoxy(diethyl)silane Chemical compound CCO[Si](CC)(CC)OCC ZMAPKOCENOWQRE-UHFFFAOYSA-N 0.000 claims description 6
- JJQZDUKDJDQPMQ-UHFFFAOYSA-N dimethoxy(dimethyl)silane Chemical compound CO[Si](C)(C)OC JJQZDUKDJDQPMQ-UHFFFAOYSA-N 0.000 claims description 6
- GOIPELYWYGMEFQ-UHFFFAOYSA-N dimethoxy-methyl-octylsilane Chemical compound CCCCCCCC[Si](C)(OC)OC GOIPELYWYGMEFQ-UHFFFAOYSA-N 0.000 claims description 6
- LIKFHECYJZWXFJ-UHFFFAOYSA-N dimethyldichlorosilane Chemical compound C[Si](C)(Cl)Cl LIKFHECYJZWXFJ-UHFFFAOYSA-N 0.000 claims description 6
- YYLGKUPAFFKGRQ-UHFFFAOYSA-N dimethyldiethoxysilane Chemical compound CCO[Si](C)(C)OCC YYLGKUPAFFKGRQ-UHFFFAOYSA-N 0.000 claims description 6
- AILBOMWJRYLVFG-UHFFFAOYSA-N dodecyl-diethoxy-methylsilane Chemical compound CCCCCCCCCCCC[Si](C)(OCC)OCC AILBOMWJRYLVFG-UHFFFAOYSA-N 0.000 claims description 6
- CZWLNMOIEMTDJY-UHFFFAOYSA-N hexyl(trimethoxy)silane Chemical compound CCCCCC[Si](OC)(OC)OC CZWLNMOIEMTDJY-UHFFFAOYSA-N 0.000 claims description 6
- BFXIKLCIZHOAAZ-UHFFFAOYSA-N methyltrimethoxysilane Chemical compound CO[Si](C)(OC)OC BFXIKLCIZHOAAZ-UHFFFAOYSA-N 0.000 claims description 6
- SLYCYWCVSGPDFR-UHFFFAOYSA-N octadecyltrimethoxysilane Chemical compound CCCCCCCCCCCCCCCCCC[Si](OC)(OC)OC SLYCYWCVSGPDFR-UHFFFAOYSA-N 0.000 claims description 6
- 230000005855 radiation Effects 0.000 claims description 6
- JCVQKRGIASEUKR-UHFFFAOYSA-N triethoxy(phenyl)silane Chemical compound CCO[Si](OCC)(OCC)C1=CC=CC=C1 JCVQKRGIASEUKR-UHFFFAOYSA-N 0.000 claims description 6
- XYJRNCYWTVGEEG-UHFFFAOYSA-N trimethoxy(2-methylpropyl)silane Chemical compound CO[Si](OC)(OC)CC(C)C XYJRNCYWTVGEEG-UHFFFAOYSA-N 0.000 claims description 6
- HQYALQRYBUJWDH-UHFFFAOYSA-N trimethoxy(propyl)silane Chemical compound CCC[Si](OC)(OC)OC HQYALQRYBUJWDH-UHFFFAOYSA-N 0.000 claims description 6
- 150000001875 compounds Chemical class 0.000 claims description 5
- 239000004408 titanium dioxide Substances 0.000 claims description 5
- 239000000825 pharmaceutical preparation Substances 0.000 claims description 4
- 229920001688 coating polymer Polymers 0.000 claims description 2
- 238000000576 coating method Methods 0.000 abstract description 19
- 239000011248 coating agent Substances 0.000 abstract description 12
- KPUWHANPEXNPJT-UHFFFAOYSA-N disiloxane Chemical class [SiH3]O[SiH3] KPUWHANPEXNPJT-UHFFFAOYSA-N 0.000 abstract description 6
- 230000015572 biosynthetic process Effects 0.000 abstract description 3
- 230000003993 interaction Effects 0.000 abstract description 2
- 239000012071 phase Substances 0.000 description 218
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 39
- 239000004615 ingredient Substances 0.000 description 31
- 238000002156 mixing Methods 0.000 description 31
- 239000003921 oil Substances 0.000 description 29
- 235000019198 oils Nutrition 0.000 description 28
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 28
- -1 siloxane backbone Chemical group 0.000 description 26
- 229920000642 polymer Polymers 0.000 description 22
- 239000002243 precursor Substances 0.000 description 22
- 238000003756 stirring Methods 0.000 description 22
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 20
- 235000011187 glycerol Nutrition 0.000 description 18
- 239000008367 deionised water Substances 0.000 description 17
- 229910021641 deionized water Inorganic materials 0.000 description 17
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 16
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 16
- 238000002360 preparation method Methods 0.000 description 16
- 210000003491 skin Anatomy 0.000 description 16
- OSCJHTSDLYVCQC-UHFFFAOYSA-N 2-ethylhexyl 4-[[4-[4-(tert-butylcarbamoyl)anilino]-6-[4-(2-ethylhexoxycarbonyl)anilino]-1,3,5-triazin-2-yl]amino]benzoate Chemical compound C1=CC(C(=O)OCC(CC)CCCC)=CC=C1NC1=NC(NC=2C=CC(=CC=2)C(=O)NC(C)(C)C)=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=N1 OSCJHTSDLYVCQC-UHFFFAOYSA-N 0.000 description 15
- 229920001577 copolymer Polymers 0.000 description 15
- 229960004418 trolamine Drugs 0.000 description 15
- QFOHBWFCKVYLES-UHFFFAOYSA-N Butylparaben Chemical compound CCCCOC(=O)C1=CC=C(O)C=C1 QFOHBWFCKVYLES-UHFFFAOYSA-N 0.000 description 14
- 229940081733 cetearyl alcohol Drugs 0.000 description 14
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 13
- YBGZDTIWKVFICR-JLHYYAGUSA-N Octyl 4-methoxycinnamic acid Chemical compound CCCCC(CC)COC(=O)\C=C\C1=CC=C(OC)C=C1 YBGZDTIWKVFICR-JLHYYAGUSA-N 0.000 description 13
- 239000011734 sodium Substances 0.000 description 13
- 229910052708 sodium Inorganic materials 0.000 description 13
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 13
- 239000000126 substance Substances 0.000 description 13
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 12
- 239000003109 Disodium ethylene diamine tetraacetate Substances 0.000 description 11
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 11
- 230000003750 conditioning effect Effects 0.000 description 11
- 235000019301 disodium ethylene diamine tetraacetate Nutrition 0.000 description 11
- 150000002148 esters Chemical class 0.000 description 11
- 229960001679 octinoxate Drugs 0.000 description 11
- 239000000047 product Substances 0.000 description 11
- 235000014113 dietary fatty acids Nutrition 0.000 description 10
- 239000000194 fatty acid Substances 0.000 description 10
- 229930195729 fatty acid Natural products 0.000 description 10
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 10
- ICIDSZQHPUZUHC-UHFFFAOYSA-N 2-octadecoxyethanol Chemical compound CCCCCCCCCCCCCCCCCCOCCO ICIDSZQHPUZUHC-UHFFFAOYSA-N 0.000 description 9
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 9
- 239000002253 acid Substances 0.000 description 9
- 239000003963 antioxidant agent Substances 0.000 description 9
- 235000006708 antioxidants Nutrition 0.000 description 9
- 229960005323 phenoxyethanol Drugs 0.000 description 9
- 229940100458 steareth-21 Drugs 0.000 description 9
- 239000001993 wax Substances 0.000 description 9
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 8
- 150000001252 acrylic acid derivatives Chemical class 0.000 description 8
- 239000004480 active ingredient Substances 0.000 description 8
- 125000005250 alkyl acrylate group Chemical group 0.000 description 8
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 8
- 229960001617 ethyl hydroxybenzoate Drugs 0.000 description 8
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 description 8
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 description 8
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 description 8
- 239000000499 gel Substances 0.000 description 8
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 8
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 8
- 229960002216 methylparaben Drugs 0.000 description 8
- VAMFXQBUQXONLZ-UHFFFAOYSA-N n-alpha-eicosene Natural products CCCCCCCCCCCCCCCCCCC=C VAMFXQBUQXONLZ-UHFFFAOYSA-N 0.000 description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 7
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 7
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 7
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 7
- 235000013871 bee wax Nutrition 0.000 description 7
- 229940092738 beeswax Drugs 0.000 description 7
- 239000012166 beeswax Substances 0.000 description 7
- 229940067596 butylparaben Drugs 0.000 description 7
- 238000006243 chemical reaction Methods 0.000 description 7
- RMGVATURDVPNOZ-UHFFFAOYSA-M potassium;hexadecyl hydrogen phosphate Chemical compound [K+].CCCCCCCCCCCCCCCCOP(O)([O-])=O RMGVATURDVPNOZ-UHFFFAOYSA-M 0.000 description 7
- 229910052710 silicon Inorganic materials 0.000 description 7
- 239000010703 silicon Substances 0.000 description 7
- OMIGHNLMNHATMP-UHFFFAOYSA-N 2-hydroxyethyl prop-2-enoate Chemical compound OCCOC(=O)C=C OMIGHNLMNHATMP-UHFFFAOYSA-N 0.000 description 6
- BANXPJUEBPWEOT-UHFFFAOYSA-N 2-methyl-Pentadecane Chemical compound CCCCCCCCCCCCCC(C)C BANXPJUEBPWEOT-UHFFFAOYSA-N 0.000 description 6
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical class OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 6
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 6
- 229920002125 Sokalan® Polymers 0.000 description 6
- 150000001298 alcohols Chemical class 0.000 description 6
- 150000004665 fatty acids Chemical class 0.000 description 6
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 6
- 150000003839 salts Chemical class 0.000 description 6
- 229920002545 silicone oil Polymers 0.000 description 6
- 229940032094 squalane Drugs 0.000 description 6
- 239000002562 thickening agent Substances 0.000 description 6
- XTJFFFGAUHQWII-UHFFFAOYSA-N Dibutyl adipate Chemical compound CCCCOC(=O)CCCCC(=O)OCCCC XTJFFFGAUHQWII-UHFFFAOYSA-N 0.000 description 5
- 229920001214 Polysorbate 60 Polymers 0.000 description 5
- 229960001631 carbomer Drugs 0.000 description 5
- 229920006037 cross link polymer Polymers 0.000 description 5
- 229940100539 dibutyl adipate Drugs 0.000 description 5
- FDATWRLUYRHCJE-UHFFFAOYSA-N diethylamino hydroxybenzoyl hexyl benzoate Chemical compound CCCCCCOC(=O)C1=CC=CC=C1C(=O)C1=CC=C(N(CC)CC)C=C1O FDATWRLUYRHCJE-UHFFFAOYSA-N 0.000 description 5
- 239000006185 dispersion Substances 0.000 description 5
- 239000000839 emulsion Substances 0.000 description 5
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 5
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 5
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 5
- 229940113124 polysorbate 60 Drugs 0.000 description 5
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 5
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 5
- 235000013772 propylene glycol Nutrition 0.000 description 5
- 229960003415 propylparaben Drugs 0.000 description 5
- 229920006395 saturated elastomer Polymers 0.000 description 5
- WAYINTBTZWQNSN-UHFFFAOYSA-N 11-methyldodecyl 3,5,5-trimethylhexanoate Chemical compound CC(C)CCCCCCCCCCOC(=O)CC(C)CC(C)(C)C WAYINTBTZWQNSN-UHFFFAOYSA-N 0.000 description 4
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 4
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 4
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 4
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 4
- 239000000443 aerosol Substances 0.000 description 4
- 229960000458 allantoin Drugs 0.000 description 4
- 239000008346 aqueous phase Substances 0.000 description 4
- 238000010923 batch production Methods 0.000 description 4
- 229910052799 carbon Inorganic materials 0.000 description 4
- 125000004432 carbon atom Chemical group C* 0.000 description 4
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 4
- 229960001630 diethylamino hydroxybenzoyl hexyl benzoate Drugs 0.000 description 4
- WSDISUOETYTPRL-UHFFFAOYSA-N dmdm hydantoin Chemical compound CC1(C)N(CO)C(=O)N(CO)C1=O WSDISUOETYTPRL-UHFFFAOYSA-N 0.000 description 4
- 239000000975 dye Substances 0.000 description 4
- 239000012530 fluid Substances 0.000 description 4
- 229930195733 hydrocarbon Natural products 0.000 description 4
- 150000002430 hydrocarbons Chemical class 0.000 description 4
- PYIDGJJWBIBVIA-UYTYNIKBSA-N lauryl glucoside Chemical compound CCCCCCCCCCCCO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O PYIDGJJWBIBVIA-UYTYNIKBSA-N 0.000 description 4
- 229940048848 lauryl glucoside Drugs 0.000 description 4
- QAOJADINKLMTRR-UHFFFAOYSA-N octan-3-yl 16-methylheptadecanoate Chemical compound CCCCCC(CC)OC(=O)CCCCCCCCCCCCCCC(C)C QAOJADINKLMTRR-UHFFFAOYSA-N 0.000 description 4
- 229920001223 polyethylene glycol Polymers 0.000 description 4
- 230000002265 prevention Effects 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 150000003722 vitamin derivatives Chemical class 0.000 description 4
- 229940043268 2,2,4,4,6,8,8-heptamethylnonane Drugs 0.000 description 3
- ILCOCZBHMDEIAI-UHFFFAOYSA-N 2-(2-octadecoxyethoxy)ethanol Chemical compound CCCCCCCCCCCCCCCCCCOCCOCCO ILCOCZBHMDEIAI-UHFFFAOYSA-N 0.000 description 3
- KKJKXQYVUVWWJP-UHFFFAOYSA-N 4-[(4,7,7-trimethyl-3-oxo-2-bicyclo[2.2.1]heptanylidene)methyl]benzenesulfonic acid Chemical compound CC1(C)C2CCC1(C)C(=O)C2=CC1=CC=C(S(O)(=O)=O)C=C1 KKJKXQYVUVWWJP-UHFFFAOYSA-N 0.000 description 3
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 3
- 229920001661 Chitosan Polymers 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000004904 UV filter Substances 0.000 description 3
- 150000007513 acids Chemical class 0.000 description 3
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 3
- 229910052782 aluminium Inorganic materials 0.000 description 3
- XNEFYCZVKIDDMS-UHFFFAOYSA-N avobenzone Chemical compound C1=CC(OC)=CC=C1C(=O)CC(=O)C1=CC=C(C(C)(C)C)C=C1 XNEFYCZVKIDDMS-UHFFFAOYSA-N 0.000 description 3
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 3
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 3
- 239000006227 byproduct Substances 0.000 description 3
- 239000004359 castor oil Substances 0.000 description 3
- 235000019438 castor oil Nutrition 0.000 description 3
- 229940073639 ceteareth-6 Drugs 0.000 description 3
- 229940093528 cetearyl ethylhexanoate Drugs 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000000470 constituent Substances 0.000 description 3
- 239000006071 cream Substances 0.000 description 3
- 229940086555 cyclomethicone Drugs 0.000 description 3
- 150000002170 ethers Chemical class 0.000 description 3
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 3
- 239000003925 fat Substances 0.000 description 3
- 235000019197 fats Nutrition 0.000 description 3
- 150000002191 fatty alcohols Chemical class 0.000 description 3
- FOYKKGHVWRFIBD-UHFFFAOYSA-N gamma-tocopherol acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 FOYKKGHVWRFIBD-UHFFFAOYSA-N 0.000 description 3
- 239000007789 gas Substances 0.000 description 3
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 3
- 239000011261 inert gas Substances 0.000 description 3
- KUVMKLCGXIYSNH-UHFFFAOYSA-N isopentadecane Natural products CCCCCCCCCCCCC(C)C KUVMKLCGXIYSNH-UHFFFAOYSA-N 0.000 description 3
- 150000002632 lipids Chemical class 0.000 description 3
- 239000006210 lotion Substances 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 3
- 229960003493 octyltriethoxysilane Drugs 0.000 description 3
- 239000012188 paraffin wax Substances 0.000 description 3
- 239000011591 potassium Substances 0.000 description 3
- 229910052700 potassium Inorganic materials 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 108090000765 processed proteins & peptides Proteins 0.000 description 3
- 102000004196 processed proteins & peptides Human genes 0.000 description 3
- 239000003380 propellant Substances 0.000 description 3
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 3
- 239000011814 protection agent Substances 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 229940098760 steareth-2 Drugs 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- 239000000230 xanthan gum Substances 0.000 description 3
- 235000010493 xanthan gum Nutrition 0.000 description 3
- 229920001285 xanthan gum Polymers 0.000 description 3
- 229940082509 xanthan gum Drugs 0.000 description 3
- HEOCBCNFKCOKBX-RELGSGGGSA-N (1s,2e,4r)-4,7,7-trimethyl-2-[(4-methylphenyl)methylidene]bicyclo[2.2.1]heptan-3-one Chemical compound C1=CC(C)=CC=C1\C=C/1C(=O)[C@]2(C)CC[C@H]\1C2(C)C HEOCBCNFKCOKBX-RELGSGGGSA-N 0.000 description 2
- DSEKYWAQQVUQTP-XEWMWGOFSA-N (2r,4r,4as,6as,6as,6br,8ar,12ar,14as,14bs)-2-hydroxy-4,4a,6a,6b,8a,11,11,14a-octamethyl-2,4,5,6,6a,7,8,9,10,12,12a,13,14,14b-tetradecahydro-1h-picen-3-one Chemical compound C([C@H]1[C@]2(C)CC[C@@]34C)C(C)(C)CC[C@]1(C)CC[C@]2(C)[C@H]4CC[C@@]1(C)[C@H]3C[C@@H](O)C(=O)[C@@H]1C DSEKYWAQQVUQTP-XEWMWGOFSA-N 0.000 description 2
- AALXZHPCKJILAZ-UHFFFAOYSA-N (4-propan-2-ylphenyl)methyl 2-hydroxybenzoate Chemical compound C1=CC(C(C)C)=CC=C1COC(=O)C1=CC=CC=C1O AALXZHPCKJILAZ-UHFFFAOYSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- DURPTKYDGMDSBL-UHFFFAOYSA-N 1-butoxybutane Chemical compound CCCCOCCCC DURPTKYDGMDSBL-UHFFFAOYSA-N 0.000 description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 2
- MEZZCSHVIGVWFI-UHFFFAOYSA-N 2,2'-Dihydroxy-4-methoxybenzophenone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1O MEZZCSHVIGVWFI-UHFFFAOYSA-N 0.000 description 2
- WHQOKFZWSDOTQP-UHFFFAOYSA-N 2,3-dihydroxypropyl 4-aminobenzoate Chemical compound NC1=CC=C(C(=O)OCC(O)CO)C=C1 WHQOKFZWSDOTQP-UHFFFAOYSA-N 0.000 description 2
- ZXDDPOHVAMWLBH-UHFFFAOYSA-N 2,4-Dihydroxybenzophenone Chemical compound OC1=CC(O)=CC=C1C(=O)C1=CC=CC=C1 ZXDDPOHVAMWLBH-UHFFFAOYSA-N 0.000 description 2
- CZVOIAOPRGNENY-UHFFFAOYSA-N 2-butyloctyl 2-hydroxybenzoate Chemical compound CCCCCCC(CCCC)COC(=O)C1=CC=CC=C1O CZVOIAOPRGNENY-UHFFFAOYSA-N 0.000 description 2
- SFAAOBGYWOUHLU-UHFFFAOYSA-N 2-ethylhexyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(CC)CCCC SFAAOBGYWOUHLU-UHFFFAOYSA-N 0.000 description 2
- WSSJONWNBBTCMG-UHFFFAOYSA-N 2-hydroxybenzoic acid (3,3,5-trimethylcyclohexyl) ester Chemical compound C1C(C)(C)CC(C)CC1OC(=O)C1=CC=CC=C1O WSSJONWNBBTCMG-UHFFFAOYSA-N 0.000 description 2
- 229940100555 2-methyl-4-isothiazolin-3-one Drugs 0.000 description 2
- LEEDMQGKBNGPDN-UHFFFAOYSA-N 2-methylnonadecane Chemical compound CCCCCCCCCCCCCCCCCC(C)C LEEDMQGKBNGPDN-UHFFFAOYSA-N 0.000 description 2
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 2
- 229940100484 5-chloro-2-methyl-4-isothiazolin-3-one Drugs 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 description 2
- KAKZBPTYRLMSJV-UHFFFAOYSA-N Butadiene Chemical compound C=CC=C KAKZBPTYRLMSJV-UHFFFAOYSA-N 0.000 description 2
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- FPVVYTCTZKCSOJ-UHFFFAOYSA-N Ethylene glycol distearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCOC(=O)CCCCCCCCCCCCCCCCC FPVVYTCTZKCSOJ-UHFFFAOYSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 2
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- XPJVKCRENWUEJH-UHFFFAOYSA-N Isobutylparaben Chemical compound CC(C)COC(=O)C1=CC=C(O)C=C1 XPJVKCRENWUEJH-UHFFFAOYSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- CQOVPNPJLQNMDC-UHFFFAOYSA-N N-beta-alanyl-L-histidine Natural products NCCC(=O)NC(C(O)=O)CC1=CN=CN1 CQOVPNPJLQNMDC-UHFFFAOYSA-N 0.000 description 2
- WYWZRNAHINYAEF-UHFFFAOYSA-N Padimate O Chemical compound CCCCC(CC)COC(=O)C1=CC=C(N(C)C)C=C1 WYWZRNAHINYAEF-UHFFFAOYSA-N 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 2
- 244000044822 Simmondsia californica Species 0.000 description 2
- 235000004433 Simmondsia californica Nutrition 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 230000002776 aggregation Effects 0.000 description 2
- 238000004220 aggregation Methods 0.000 description 2
- 230000001476 alcoholic effect Effects 0.000 description 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical class [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 2
- MTHSVFCYNBDYFN-UHFFFAOYSA-N anhydrous diethylene glycol Natural products OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 230000000035 biogenic effect Effects 0.000 description 2
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 2
- 235000021466 carotenoid Nutrition 0.000 description 2
- 150000001747 carotenoids Chemical class 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 235000010980 cellulose Nutrition 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- DHNRXBZYEKSXIM-UHFFFAOYSA-N chloromethylisothiazolinone Chemical compound CN1SC(Cl)=CC1=O DHNRXBZYEKSXIM-UHFFFAOYSA-N 0.000 description 2
- 239000007957 coemulsifier Substances 0.000 description 2
- GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 2
- 239000004205 dimethyl polysiloxane Substances 0.000 description 2
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 2
- 238000012674 dispersion polymerization Methods 0.000 description 2
- DLAHAXOYRFRPFQ-UHFFFAOYSA-N dodecyl benzoate Chemical compound CCCCCCCCCCCCOC(=O)C1=CC=CC=C1 DLAHAXOYRFRPFQ-UHFFFAOYSA-N 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- IAJNXBNRYMEYAZ-UHFFFAOYSA-N ethyl 2-cyano-3,3-diphenylprop-2-enoate Chemical compound C=1C=CC=CC=1C(=C(C#N)C(=O)OCC)C1=CC=CC=C1 IAJNXBNRYMEYAZ-UHFFFAOYSA-N 0.000 description 2
- 239000006260 foam Substances 0.000 description 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
- 125000005456 glyceride group Chemical group 0.000 description 2
- 229940075529 glyceryl stearate Drugs 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 2
- 239000001023 inorganic pigment Substances 0.000 description 2
- 238000005342 ion exchange Methods 0.000 description 2
- NNPPMTNAJDCUHE-UHFFFAOYSA-N isobutane Chemical compound CC(C)C NNPPMTNAJDCUHE-UHFFFAOYSA-N 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000011777 magnesium Chemical class 0.000 description 2
- 229940049920 malate Drugs 0.000 description 2
- SOXAGEOHPCXXIO-UHFFFAOYSA-N meradimate Chemical compound CC(C)C1CCC(C)CC1OC(=O)C1=CC=CC=C1N SOXAGEOHPCXXIO-UHFFFAOYSA-N 0.000 description 2
- 229910044991 metal oxide Inorganic materials 0.000 description 2
- BEGLCMHJXHIJLR-UHFFFAOYSA-N methylisothiazolinone Chemical compound CN1SC=CC1=O BEGLCMHJXHIJLR-UHFFFAOYSA-N 0.000 description 2
- MJVGBKJNTFCUJM-UHFFFAOYSA-N mexenone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=C(C)C=C1 MJVGBKJNTFCUJM-UHFFFAOYSA-N 0.000 description 2
- 239000004200 microcrystalline wax Substances 0.000 description 2
- 235000019808 microcrystalline wax Nutrition 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 239000002777 nucleoside Substances 0.000 description 2
- 125000003835 nucleoside group Chemical group 0.000 description 2
- 239000002773 nucleotide Substances 0.000 description 2
- 125000003729 nucleotide group Chemical group 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 229940101267 panthenol Drugs 0.000 description 2
- 239000011619 pantothenol Substances 0.000 description 2
- 235000020957 pantothenol Nutrition 0.000 description 2
- 239000006072 paste Substances 0.000 description 2
- 235000019271 petrolatum Nutrition 0.000 description 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 2
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 2
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- NPCOQXAVBJJZBQ-UHFFFAOYSA-N reduced coenzyme Q9 Natural products COC1=C(O)C(C)=C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)C(O)=C1OC NPCOQXAVBJJZBQ-UHFFFAOYSA-N 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 238000001179 sorption measurement Methods 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 239000003381 stabilizer Substances 0.000 description 2
- CXVGEDCSTKKODG-UHFFFAOYSA-N sulisobenzone Chemical compound C1=C(S(O)(=O)=O)C(OC)=CC(O)=C1C(=O)C1=CC=CC=C1 CXVGEDCSTKKODG-UHFFFAOYSA-N 0.000 description 2
- LOIYMIARKYCTBW-OWOJBTEDSA-N trans-urocanic acid Chemical compound OC(=O)\C=C\C1=CNC=N1 LOIYMIARKYCTBW-OWOJBTEDSA-N 0.000 description 2
- LADGBHLMCUINGV-UHFFFAOYSA-N tricaprin Chemical compound CCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCC)COC(=O)CCCCCCCCC LADGBHLMCUINGV-UHFFFAOYSA-N 0.000 description 2
- 238000010977 unit operation Methods 0.000 description 2
- WTVHAMTYZJGJLJ-UHFFFAOYSA-N (+)-(4S,8R)-8-epi-beta-bisabolol Natural products CC(C)=CCCC(C)C1(O)CCC(C)=CC1 WTVHAMTYZJGJLJ-UHFFFAOYSA-N 0.000 description 1
- RGZSQWQPBWRIAQ-CABCVRRESA-N (-)-alpha-Bisabolol Chemical compound CC(C)=CCC[C@](C)(O)[C@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-CABCVRRESA-N 0.000 description 1
- FEVZXFSZKJUNGA-UHFFFAOYSA-N (2-hydroxy-4-methoxyphenyl)-phenylmethanone 2-phenyl-3H-benzimidazole-5-sulfonic acid Chemical compound COc1ccc(C(=O)c2ccccc2)c(O)c1.OS(=O)(=O)c1ccc2[nH]c(nc2c1)-c1ccccc1 FEVZXFSZKJUNGA-UHFFFAOYSA-N 0.000 description 1
- OIQXFRANQVWXJF-ACCUITESSA-N (2e)-2-benzylidene-4,7,7-trimethylbicyclo[2.2.1]heptan-3-one Chemical compound CC1(C)C2CCC1(C)C(=O)\C2=C\C1=CC=CC=C1 OIQXFRANQVWXJF-ACCUITESSA-N 0.000 description 1
- DBSABEYSGXPBTA-RXSVEWSESA-N (2r)-2-[(1s)-1,2-dihydroxyethyl]-3,4-dihydroxy-2h-furan-5-one;phosphoric acid Chemical compound OP(O)(O)=O.OC[C@H](O)[C@H]1OC(=O)C(O)=C1O DBSABEYSGXPBTA-RXSVEWSESA-N 0.000 description 1
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical class OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- PDHSAQOQVUXZGQ-JKSUJKDBSA-N (2r,3s)-2-(3,4-dihydroxyphenyl)-3-methoxy-3,4-dihydro-2h-chromene-5,7-diol Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2OC)=CC=C(O)C(O)=C1 PDHSAQOQVUXZGQ-JKSUJKDBSA-N 0.000 description 1
- HSINOMROUCMIEA-FGVHQWLLSA-N (2s,4r)-4-[(3r,5s,6r,7r,8s,9s,10s,13r,14s,17r)-6-ethyl-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]-2-methylpentanoic acid Chemical compound C([C@@]12C)C[C@@H](O)C[C@H]1[C@@H](CC)[C@@H](O)[C@@H]1[C@@H]2CC[C@]2(C)[C@@H]([C@H](C)C[C@H](C)C(O)=O)CC[C@H]21 HSINOMROUCMIEA-FGVHQWLLSA-N 0.000 description 1
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-M (E)-Ferulic acid Natural products COC1=CC(\C=C\C([O-])=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-M 0.000 description 1
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 1
- IZFHEQBZOYJLPK-SSDOTTSWSA-N (R)-dihydrolipoic acid Chemical compound OC(=O)CCCC[C@@H](S)CCS IZFHEQBZOYJLPK-SSDOTTSWSA-N 0.000 description 1
- NKJOXAZJBOMXID-UHFFFAOYSA-N 1,1'-Oxybisoctane Chemical compound CCCCCCCCOCCCCCCCC NKJOXAZJBOMXID-UHFFFAOYSA-N 0.000 description 1
- JYEUMXHLPRZUAT-UHFFFAOYSA-N 1,2,3-triazine Chemical compound C1=CN=NN=C1 JYEUMXHLPRZUAT-UHFFFAOYSA-N 0.000 description 1
- KBKGPMDADJLBEM-UHFFFAOYSA-N 1-(4-pentylphenyl)ethanone Chemical compound CCCCCC1=CC=C(C(C)=O)C=C1 KBKGPMDADJLBEM-UHFFFAOYSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- OVYMWJFNQQOJBU-UHFFFAOYSA-N 1-octanoyloxypropan-2-yl octanoate Chemical compound CCCCCCCC(=O)OCC(C)OC(=O)CCCCCCC OVYMWJFNQQOJBU-UHFFFAOYSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- RKJGFHYCZPZJPE-UHFFFAOYSA-N 2,2-bis(16-methylheptadecanoyloxymethyl)butyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(CC)(COC(=O)CCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCCCC(C)C RKJGFHYCZPZJPE-UHFFFAOYSA-N 0.000 description 1
- KAWVQDRRFHLAPC-UHFFFAOYSA-N 2-(2,3-dimethoxyphenyl)-2-oxoacetic acid Chemical compound COC1=CC=CC(C(=O)C(O)=O)=C1OC KAWVQDRRFHLAPC-UHFFFAOYSA-N 0.000 description 1
- FLPJVCMIKUWSDR-UHFFFAOYSA-N 2-(4-formylphenoxy)acetamide Chemical compound NC(=O)COC1=CC=C(C=O)C=C1 FLPJVCMIKUWSDR-UHFFFAOYSA-N 0.000 description 1
- ZGGHMDBVRJATBC-UHFFFAOYSA-N 2-butyloctyl benzoate Chemical compound CCCCCCC(CCCC)COC(=O)C1=CC=CC=C1 ZGGHMDBVRJATBC-UHFFFAOYSA-N 0.000 description 1
- LFPRPWSOCDKNRE-UHFFFAOYSA-N 2-cyano-3-(2-ethyl-3-hexylphenyl)-3-phenylprop-2-enoic acid Chemical compound CCCCCCC1=CC=CC(C(=C(C#N)C(O)=O)C=2C=CC=CC=2)=C1CC LFPRPWSOCDKNRE-UHFFFAOYSA-N 0.000 description 1
- NFIHXTUNNGIYRF-UHFFFAOYSA-N 2-decanoyloxypropyl decanoate Chemical compound CCCCCCCCCC(=O)OCC(C)OC(=O)CCCCCCCCC NFIHXTUNNGIYRF-UHFFFAOYSA-N 0.000 description 1
- JGUMTYWKIBJSTN-UHFFFAOYSA-N 2-ethylhexyl 4-[[4,6-bis[4-(2-ethylhexoxycarbonyl)anilino]-1,3,5-triazin-2-yl]amino]benzoate Chemical compound C1=CC(C(=O)OCC(CC)CCCC)=CC=C1NC1=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=N1 JGUMTYWKIBJSTN-UHFFFAOYSA-N 0.000 description 1
- LWLRMRFJCCMNML-UHFFFAOYSA-N 2-ethylhexyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCC(CC)CCCC LWLRMRFJCCMNML-UHFFFAOYSA-N 0.000 description 1
- MWKPHOIHTLQZIY-UHFFFAOYSA-N 2-hexyldecyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(CCCCCC)CCCCCCCC MWKPHOIHTLQZIY-UHFFFAOYSA-N 0.000 description 1
- RFVNOJDQRGSOEL-UHFFFAOYSA-N 2-hydroxyethyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCO RFVNOJDQRGSOEL-UHFFFAOYSA-N 0.000 description 1
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 description 1
- RUDXBXPTJPNTSO-UHFFFAOYSA-N 2-octyldodecyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(CCCCCCCC)CCCCCCCCCC RUDXBXPTJPNTSO-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- ODJQKYXPKWQWNK-UHFFFAOYSA-N 3,3'-Thiobispropanoic acid Chemical compound OC(=O)CCSCCC(O)=O ODJQKYXPKWQWNK-UHFFFAOYSA-N 0.000 description 1
- UIVPNOBLHXUKDX-UHFFFAOYSA-N 3,5,5-trimethylhexyl 3,5,5-trimethylhexanoate Chemical compound CC(C)(C)CC(C)CCOC(=O)CC(C)CC(C)(C)C UIVPNOBLHXUKDX-UHFFFAOYSA-N 0.000 description 1
- AGNTUZCMJBTHOG-UHFFFAOYSA-N 3-[3-(2,3-dihydroxypropoxy)-2-hydroxypropoxy]propane-1,2-diol Chemical class OCC(O)COCC(O)COCC(O)CO AGNTUZCMJBTHOG-UHFFFAOYSA-N 0.000 description 1
- FPINZPXUZLJTAF-UHFFFAOYSA-N 3-[4-methoxy-2-(3-methylbutyl)phenyl]prop-2-enoic acid Chemical compound COC1=CC=C(C=CC(O)=O)C(CCC(C)C)=C1 FPINZPXUZLJTAF-UHFFFAOYSA-N 0.000 description 1
- QJZYHAIUNVAGQP-UHFFFAOYSA-N 3-nitrobicyclo[2.2.1]hept-5-ene-2,3-dicarboxylic acid Chemical compound C1C2C=CC1C(C(=O)O)C2(C(O)=O)[N+]([O-])=O QJZYHAIUNVAGQP-UHFFFAOYSA-N 0.000 description 1
- GWXXFGWOWOJEEX-UHFFFAOYSA-N 4,4,4-trihydroxy-1-phenylbutan-1-one Chemical compound OC(CCC(=O)C1=CC=CC=C1)(O)O GWXXFGWOWOJEEX-UHFFFAOYSA-N 0.000 description 1
- 229940086681 4-aminobenzoate Drugs 0.000 description 1
- HBTAOSGHCXUEKI-UHFFFAOYSA-N 4-chloro-n,n-dimethyl-3-nitrobenzenesulfonamide Chemical compound CN(C)S(=O)(=O)C1=CC=C(Cl)C([N+]([O-])=O)=C1 HBTAOSGHCXUEKI-UHFFFAOYSA-N 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-M 4-hydroxybenzoate Chemical compound OC1=CC=C(C([O-])=O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-M 0.000 description 1
- VVZCFQPOPYXQBM-UHFFFAOYSA-N 6-amino-3-methyl-6-propan-2-ylcyclohexa-2,4-diene-1-carboxylic acid Chemical compound CC(C)C1(N)C=CC(C)=CC1C(O)=O VVZCFQPOPYXQBM-UHFFFAOYSA-N 0.000 description 1
- XUVVLJKRLAXOKZ-UHFFFAOYSA-N 7-methyloctyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCCCCCC(C)C XUVVLJKRLAXOKZ-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 235000019489 Almond oil Nutrition 0.000 description 1
- 108010085443 Anserine Proteins 0.000 description 1
- XHVAWZZCDCWGBK-WYRLRVFGSA-M Aurothioglucose Chemical compound OC[C@H]1O[C@H](S[Au])[C@H](O)[C@@H](O)[C@@H]1O XHVAWZZCDCWGBK-WYRLRVFGSA-M 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- GWZYPXHJIZCRAJ-UHFFFAOYSA-N Biliverdin Natural products CC1=C(C=C)C(=C/C2=NC(=Cc3[nH]c(C=C/4NC(=O)C(=C4C)C=C)c(C)c3CCC(=O)O)C(=C2C)CCC(=O)O)NC1=O GWZYPXHJIZCRAJ-UHFFFAOYSA-N 0.000 description 1
- RCNSAJSGRJSBKK-NSQVQWHSSA-N Biliverdin IX Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(\C=C/2C(=C(C)C(=C/C=3C(=C(C=C)C(=O)N=3)C)/N\2)CCC(O)=O)N1 RCNSAJSGRJSBKK-NSQVQWHSSA-N 0.000 description 1
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 1
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 1
- 239000005632 Capric acid (CAS 334-48-5) Substances 0.000 description 1
- 239000005635 Caprylic acid (CAS 124-07-2) Substances 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 108010087806 Carnosine Proteins 0.000 description 1
- 229910052684 Cerium Inorganic materials 0.000 description 1
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 description 1
- LAAPRQODJPXAHC-UHFFFAOYSA-N Coniferyl benzoate Natural products C1=C(O)C(OC)=CC(C=CCOC(=O)C=2C=CC=CC=2)=C1 LAAPRQODJPXAHC-UHFFFAOYSA-N 0.000 description 1
- 244000303965 Cyamopsis psoralioides Species 0.000 description 1
- LEVWYRKDKASIDU-QWWZWVQMSA-N D-cystine Chemical compound OC(=O)[C@H](N)CSSC[C@@H](N)C(O)=O LEVWYRKDKASIDU-QWWZWVQMSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- GHKOFFNLGXMVNJ-UHFFFAOYSA-N Didodecyl thiobispropanoate Chemical compound CCCCCCCCCCCCOC(=O)CCSCCC(=O)OCCCCCCCCCCCC GHKOFFNLGXMVNJ-UHFFFAOYSA-N 0.000 description 1
- 239000003508 Dilauryl thiodipropionate Substances 0.000 description 1
- 239000002656 Distearyl thiodipropionate Substances 0.000 description 1
- IUMSDRXLFWAGNT-UHFFFAOYSA-N Dodecamethylcyclohexasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 IUMSDRXLFWAGNT-UHFFFAOYSA-N 0.000 description 1
- CTKXFMQHOOWWEB-UHFFFAOYSA-N Ethylene oxide/propylene oxide copolymer Chemical compound CCCOC(C)COCCO CTKXFMQHOOWWEB-UHFFFAOYSA-N 0.000 description 1
- FMRHJJZUHUTGKE-UHFFFAOYSA-N Ethylhexyl salicylate Chemical compound CCCCC(CC)COC(=O)C1=CC=CC=C1O FMRHJJZUHUTGKE-UHFFFAOYSA-N 0.000 description 1
- 244000165918 Eucalyptus papuana Species 0.000 description 1
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 1
- 241000206672 Gelidium Species 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- CMBYOWLFQAFZCP-UHFFFAOYSA-N Hexyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCCCCCC CMBYOWLFQAFZCP-UHFFFAOYSA-N 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- IMQLKJBTEOYOSI-GPIVLXJGSA-N Inositol-hexakisphosphate Chemical compound OP(O)(=O)O[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O IMQLKJBTEOYOSI-GPIVLXJGSA-N 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- SLRNWACWRVGMKD-UHFFFAOYSA-N L-anserine Natural products CN1C=NC(CC(NC(=O)CCN)C(O)=O)=C1 SLRNWACWRVGMKD-UHFFFAOYSA-N 0.000 description 1
- QAQJMLQRFWZOBN-LAUBAEHRSA-N L-ascorbyl-6-palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O QAQJMLQRFWZOBN-LAUBAEHRSA-N 0.000 description 1
- 239000011786 L-ascorbyl-6-palmitate Substances 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- 125000000174 L-prolyl group Chemical group [H]N1C([H])([H])C([H])([H])C([H])([H])[C@@]1([H])C(*)=O 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- 102000010445 Lactoferrin Human genes 0.000 description 1
- 108010063045 Lactoferrin Proteins 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical class [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 235000017011 Mandorlo dulce Nutrition 0.000 description 1
- 244000076313 Mandorlo dulce Species 0.000 description 1
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 1
- 125000003047 N-acetyl group Chemical group 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- OQILCOQZDHPEAZ-UHFFFAOYSA-N Palmitinsaeure-octylester Natural products CCCCCCCCCCCCCCCC(=O)OCCCCCCCC OQILCOQZDHPEAZ-UHFFFAOYSA-N 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- IMQLKJBTEOYOSI-UHFFFAOYSA-N Phytic acid Natural products OP(O)(=O)OC1C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C1OP(O)(O)=O IMQLKJBTEOYOSI-UHFFFAOYSA-N 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 229920002651 Polysorbate 85 Polymers 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 241000210053 Potentilla elegans Species 0.000 description 1
- KNAHARQHSZJURB-UHFFFAOYSA-N Propylthiouracile Chemical compound CCCC1=CC(=O)NC(=S)N1 KNAHARQHSZJURB-UHFFFAOYSA-N 0.000 description 1
- 235000019484 Rapeseed oil Nutrition 0.000 description 1
- ARCJQKUWGAZPFX-KBPBESRZSA-N S-trans-stilbene oxide Chemical compound C1([C@H]2[C@@H](O2)C=2C=CC=CC=2)=CC=CC=C1 ARCJQKUWGAZPFX-KBPBESRZSA-N 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- RJFAYQIBOAGBLC-BYPYZUCNSA-N Selenium-L-methionine Chemical compound C[Se]CC[C@H](N)C(O)=O RJFAYQIBOAGBLC-BYPYZUCNSA-N 0.000 description 1
- RJFAYQIBOAGBLC-UHFFFAOYSA-N Selenomethionine Natural products C[Se]CCC(N)C(O)=O RJFAYQIBOAGBLC-UHFFFAOYSA-N 0.000 description 1
- PJANXHGTPQOBST-VAWYXSNFSA-N Stilbene Natural products C=1C=CC=CC=1/C=C/C1=CC=CC=C1 PJANXHGTPQOBST-VAWYXSNFSA-N 0.000 description 1
- 235000019486 Sunflower oil Nutrition 0.000 description 1
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 1
- 239000003490 Thiodipropionic acid Substances 0.000 description 1
- 102000002933 Thioredoxin Human genes 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- 241000384110 Tylos Species 0.000 description 1
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 1
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- PTFCDOFLOPIGGS-UHFFFAOYSA-N Zinc dication Chemical compound [Zn+2] PTFCDOFLOPIGGS-UHFFFAOYSA-N 0.000 description 1
- QCWXUUIWCKQGHC-UHFFFAOYSA-N Zirconium Chemical compound [Zr] QCWXUUIWCKQGHC-UHFFFAOYSA-N 0.000 description 1
- BZUVPTAFNJMPEZ-CLFAGFIQSA-N [(z)-docos-13-enyl] (z)-docos-13-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCCCCCCOC(=O)CCCCCCCCCCC\C=C/CCCCCCCC BZUVPTAFNJMPEZ-CLFAGFIQSA-N 0.000 description 1
- TXZRBCSUYLEATA-GALHSAGASA-N [(z)-docos-13-enyl] (z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC TXZRBCSUYLEATA-GALHSAGASA-N 0.000 description 1
- SZAMSYKZCSDVBH-CLFAGFIQSA-N [(z)-octadec-9-enyl] (z)-docos-13-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCCCCCC(=O)OCCCCCCCC\C=C/CCCCCCCC SZAMSYKZCSDVBH-CLFAGFIQSA-N 0.000 description 1
- YKTSYUJCYHOUJP-UHFFFAOYSA-N [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] Chemical compound [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] YKTSYUJCYHOUJP-UHFFFAOYSA-N 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- ZOZIGIGSKMAFFZ-UHFFFAOYSA-N acetic acid;2-aminopropanoic acid Chemical compound CC(O)=O.CC(O)=O.CC(N)C(O)=O ZOZIGIGSKMAFFZ-UHFFFAOYSA-N 0.000 description 1
- 229920006322 acrylamide copolymer Polymers 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 238000007792 addition Methods 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 235000010419 agar Nutrition 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 1
- 239000008168 almond oil Substances 0.000 description 1
- RGZSQWQPBWRIAQ-LSDHHAIUSA-N alpha-Bisabolol Natural products CC(C)=CCC[C@@](C)(O)[C@@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-LSDHHAIUSA-N 0.000 description 1
- 229940063655 aluminum stearate Drugs 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229960004050 aminobenzoic acid Drugs 0.000 description 1
- MYYIAHXIVFADCU-QMMMGPOBSA-N anserine Chemical compound CN1C=NC=C1C[C@H](NC(=O)CC[NH3+])C([O-])=O MYYIAHXIVFADCU-QMMMGPOBSA-N 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- BTFJIXJJCSYFAL-UHFFFAOYSA-N arachidyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 description 1
- 235000010385 ascorbyl palmitate Nutrition 0.000 description 1
- 229940071097 ascorbyl phosphate Drugs 0.000 description 1
- 229960001799 aurothioglucose Drugs 0.000 description 1
- 229960005193 avobenzone Drugs 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- OGBUMNBNEWYMNJ-UHFFFAOYSA-N batilol Chemical class CCCCCCCCCCCCCCCCCCOCC(O)CO OGBUMNBNEWYMNJ-UHFFFAOYSA-N 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 235000012216 bentonite Nutrition 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- ISAOCJYIOMOJEB-UHFFFAOYSA-N benzoin Chemical compound C=1C=CC=CC=1C(O)C(=O)C1=CC=CC=C1 ISAOCJYIOMOJEB-UHFFFAOYSA-N 0.000 description 1
- 238000011956 best available technology Methods 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 239000003613 bile acid Substances 0.000 description 1
- QBUVFDKTZJNUPP-UHFFFAOYSA-N biliverdin-IXalpha Natural products N1C(=O)C(C)=C(C=C)C1=CC1=C(C)C(CCC(O)=O)=C(C=C2C(=C(C)C(C=C3C(=C(C=C)C(=O)N3)C)=N2)CCC(O)=O)N1 QBUVFDKTZJNUPP-UHFFFAOYSA-N 0.000 description 1
- WXNRYSGJLQFHBR-UHFFFAOYSA-N bis(2,4-dihydroxyphenyl)methanone Chemical compound OC1=CC(O)=CC=C1C(=O)C1=CC=C(O)C=C1O WXNRYSGJLQFHBR-UHFFFAOYSA-N 0.000 description 1
- UFVWHIGSVGIZRQ-UHFFFAOYSA-N bis(2-ethylhexyl) naphthalene-2,6-dicarboxylate Chemical compound C1=C(C(=O)OCC(CC)CCCC)C=CC2=CC(C(=O)OCC(CC)CCCC)=CC=C21 UFVWHIGSVGIZRQ-UHFFFAOYSA-N 0.000 description 1
- 229940036350 bisabolol Drugs 0.000 description 1
- HHGZABIIYIWLGA-UHFFFAOYSA-N bisabolol Natural products CC1CCC(C(C)(O)CCC=C(C)C)CC1 HHGZABIIYIWLGA-UHFFFAOYSA-N 0.000 description 1
- FQUNFJULCYSSOP-UHFFFAOYSA-N bisoctrizole Chemical compound N1=C2C=CC=CC2=NN1C1=CC(C(C)(C)CC(C)(C)C)=CC(CC=2C(=C(C=C(C=2)C(C)(C)CC(C)(C)C)N2N=C3C=CC=CC3=N2)O)=C1O FQUNFJULCYSSOP-UHFFFAOYSA-N 0.000 description 1
- 239000001273 butane Substances 0.000 description 1
- ULBTUVJTXULMLP-UHFFFAOYSA-N butyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCCC ULBTUVJTXULMLP-UHFFFAOYSA-N 0.000 description 1
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 description 1
- 229940110975 butyloctyl benzoate Drugs 0.000 description 1
- 239000004204 candelilla wax Substances 0.000 description 1
- 235000013868 candelilla wax Nutrition 0.000 description 1
- 229940073532 candelilla wax Drugs 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 235000013869 carnauba wax Nutrition 0.000 description 1
- 229940044199 carnosine Drugs 0.000 description 1
- CQOVPNPJLQNMDC-ZETCQYMHSA-N carnosine Chemical compound [NH3+]CCC(=O)N[C@H](C([O-])=O)CC1=CNC=N1 CQOVPNPJLQNMDC-ZETCQYMHSA-N 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- 150000001765 catechin Chemical class 0.000 description 1
- 235000005487 catechin Nutrition 0.000 description 1
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 1
- 239000012185 ceresin wax Substances 0.000 description 1
- GWXLDORMOJMVQZ-UHFFFAOYSA-N cerium Chemical compound [Ce] GWXLDORMOJMVQZ-UHFFFAOYSA-N 0.000 description 1
- 229940074979 cetyl palmitate Drugs 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol group Chemical group [C@@H]1(CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)[C@H](C)CCCC(C)C HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 229940071160 cocoate Drugs 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 description 1
- 235000017471 coenzyme Q10 Nutrition 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 239000013065 commercial product Substances 0.000 description 1
- LAAPRQODJPXAHC-AATRIKPKSA-N coniferyl benzoate Chemical compound C1=C(O)C(OC)=CC(\C=C\COC(=O)C=2C=CC=CC=2)=C1 LAAPRQODJPXAHC-AATRIKPKSA-N 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000013256 coordination polymer Substances 0.000 description 1
- 239000000973 cosmetic coloring agent Substances 0.000 description 1
- 239000008406 cosmetic ingredient Substances 0.000 description 1
- 239000007822 coupling agent Substances 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- OOTFVKOQINZBBF-UHFFFAOYSA-N cystamine Chemical compound CCSSCCN OOTFVKOQINZBBF-UHFFFAOYSA-N 0.000 description 1
- 229940099500 cystamine Drugs 0.000 description 1
- 229960002433 cysteine Drugs 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- 229960003067 cystine Drugs 0.000 description 1
- SASYSVUEVMOWPL-NXVVXOECSA-N decyl oleate Chemical compound CCCCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC SASYSVUEVMOWPL-NXVVXOECSA-N 0.000 description 1
- 230000001877 deodorizing effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 150000001983 dialkylethers Chemical class 0.000 description 1
- WQQOKAKJKDTIBY-UHFFFAOYSA-N diethyl 2-[(4-ethoxyanilino)methylidene]propanedioate Chemical compound CCOC(=O)C(C(=O)OCC)=CNC1=CC=C(OCC)C=C1 WQQOKAKJKDTIBY-UHFFFAOYSA-N 0.000 description 1
- 229940031578 diisopropyl adipate Drugs 0.000 description 1
- 235000019304 dilauryl thiodipropionate Nutrition 0.000 description 1
- 239000000539 dimer Substances 0.000 description 1
- 229940008099 dimethicone Drugs 0.000 description 1
- 150000002009 diols Chemical class 0.000 description 1
- 229960004960 dioxybenzone Drugs 0.000 description 1
- 125000001303 disiloxanyl group Chemical group [H][Si]([*])([H])O[Si]([H])([H])[H] 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- PWWSSIYVTQUJQQ-UHFFFAOYSA-N distearyl thiodipropionate Chemical compound CCCCCCCCCCCCCCCCCCOC(=O)CCSCCC(=O)OCCCCCCCCCCCCCCCCCC PWWSSIYVTQUJQQ-UHFFFAOYSA-N 0.000 description 1
- 235000019305 distearyl thiodipropionate Nutrition 0.000 description 1
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 239000002019 doping agent Substances 0.000 description 1
- HUVYTMDMDZRHBN-UHFFFAOYSA-N drometrizole trisiloxane Chemical compound C[Si](C)(C)O[Si](C)(O[Si](C)(C)C)CC(C)CC1=CC(C)=CC(N2N=C3C=CC=CC3=N2)=C1O HUVYTMDMDZRHBN-UHFFFAOYSA-N 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 239000010696 ester oil Substances 0.000 description 1
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
- DEFVIWRASFVYLL-UHFFFAOYSA-N ethylene glycol bis(2-aminoethyl)tetraacetic acid Chemical compound OC(=O)CN(CC(O)=O)CCOCCOCCN(CC(O)=O)CC(O)=O DEFVIWRASFVYLL-UHFFFAOYSA-N 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-N ferulic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 description 1
- 229940114124 ferulic acid Drugs 0.000 description 1
- KSEBMYQBYZTDHS-UHFFFAOYSA-N ferulic acid Natural products COC1=CC(C=CC(O)=O)=CC=C1O KSEBMYQBYZTDHS-UHFFFAOYSA-N 0.000 description 1
- 235000001785 ferulic acid Nutrition 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 229940020356 folic acid and derivative as antianemic Drugs 0.000 description 1
- 239000008098 formaldehyde solution Substances 0.000 description 1
- 239000013022 formulation composition Substances 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- VZCCETWTMQHEPK-QNEBEIHSSA-N gamma-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCC(O)=O VZCCETWTMQHEPK-QNEBEIHSSA-N 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 125000005908 glyceryl ester group Chemical group 0.000 description 1
- 229940100608 glycol distearate Drugs 0.000 description 1
- 229940100242 glycol stearate Drugs 0.000 description 1
- 125000003147 glycosyl group Chemical group 0.000 description 1
- 239000003722 gum benzoin Substances 0.000 description 1
- 239000008266 hair spray Substances 0.000 description 1
- 230000009931 harmful effect Effects 0.000 description 1
- IUJAMGNYPWYUPM-UHFFFAOYSA-N hentriacontane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC IUJAMGNYPWYUPM-UHFFFAOYSA-N 0.000 description 1
- PXDJXZJSCPSGGI-UHFFFAOYSA-N hexadecanoic acid hexadecyl ester Natural products CCCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCC PXDJXZJSCPSGGI-UHFFFAOYSA-N 0.000 description 1
- RAMRROOXFMYSNA-UHFFFAOYSA-N hexadecyl benzoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)C1=CC=CC=C1 RAMRROOXFMYSNA-UHFFFAOYSA-N 0.000 description 1
- HTDJPCNNEPUOOQ-UHFFFAOYSA-N hexamethylcyclotrisiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O1 HTDJPCNNEPUOOQ-UHFFFAOYSA-N 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 229960004881 homosalate Drugs 0.000 description 1
- 239000004021 humic acid Substances 0.000 description 1
- 239000000416 hydrocolloid Substances 0.000 description 1
- 239000008309 hydrophilic cream Substances 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 229920003063 hydroxymethyl cellulose Polymers 0.000 description 1
- 229940031574 hydroxymethyl cellulose Drugs 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 150000002460 imidazoles Chemical class 0.000 description 1
- 239000010954 inorganic particle Substances 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N iron oxide Inorganic materials [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 1
- 235000013980 iron oxide Nutrition 0.000 description 1
- 235000010213 iron oxides and hydroxides Nutrition 0.000 description 1
- 239000004407 iron oxides and hydroxides Substances 0.000 description 1
- VBMVTYDPPZVILR-UHFFFAOYSA-N iron(2+);oxygen(2-) Chemical class [O-2].[Fe+2] VBMVTYDPPZVILR-UHFFFAOYSA-N 0.000 description 1
- 239000001282 iso-butane Substances 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 229940078546 isoeicosane Drugs 0.000 description 1
- 229940100554 isononyl isononanoate Drugs 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 1
- 229940089456 isopropyl stearate Drugs 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- CSSYQJWUGATIHM-IKGCZBKSSA-N l-phenylalanyl-l-lysyl-l-cysteinyl-l-arginyl-l-arginyl-l-tryptophyl-l-glutaminyl-l-tryptophyl-l-arginyl-l-methionyl-l-lysyl-l-lysyl-l-leucylglycyl-l-alanyl-l-prolyl-l-seryl-l-isoleucyl-l-threonyl-l-cysteinyl-l-valyl-l-arginyl-l-arginyl-l-alanyl-l-phenylal Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CSSYQJWUGATIHM-IKGCZBKSSA-N 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 229940078795 lactoferrin Drugs 0.000 description 1
- 235000021242 lactoferrin Nutrition 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- AGBQKNBQESQNJD-UHFFFAOYSA-N lipoic acid Chemical compound OC(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-N 0.000 description 1
- 239000008308 lipophilic cream Substances 0.000 description 1
- 235000012661 lycopene Nutrition 0.000 description 1
- 229960004999 lycopene Drugs 0.000 description 1
- 239000001751 lycopene Substances 0.000 description 1
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N malic acid Chemical compound OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 229910052748 manganese Inorganic materials 0.000 description 1
- 239000011572 manganese Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 238000010297 mechanical methods and process Methods 0.000 description 1
- 230000005226 mechanical processes and functions Effects 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 150000002736 metal compounds Chemical class 0.000 description 1
- 150000004706 metal oxides Chemical class 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 229940098779 methanesulfonic acid Drugs 0.000 description 1
- AFVFQIVMOAPDHO-UHFFFAOYSA-N methanesulfonic acid Substances CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- JZMJDSHXVKJFKW-UHFFFAOYSA-M methyl sulfate(1-) Chemical compound COS([O-])(=O)=O JZMJDSHXVKJFKW-UHFFFAOYSA-M 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 229950000999 mexenone Drugs 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 229940042472 mineral oil Drugs 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- IJDNQMDRQITEOD-UHFFFAOYSA-N n-butane Chemical compound CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 description 1
- OFBQJSOFQDEBGM-UHFFFAOYSA-N n-pentane Natural products CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 1
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- FBUKVWPVBMHYJY-UHFFFAOYSA-N nonanoic acid Chemical compound CCCCCCCCC(O)=O FBUKVWPVBMHYJY-UHFFFAOYSA-N 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- HMMGMWAXVFQUOA-UHFFFAOYSA-N octamethylcyclotetrasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 HMMGMWAXVFQUOA-UHFFFAOYSA-N 0.000 description 1
- 229960002446 octanoic acid Drugs 0.000 description 1
- FMJSMJQBSVNSBF-UHFFFAOYSA-N octocrylene Chemical group C=1C=CC=CC=1C(=C(C#N)C(=O)OCC(CC)CCCC)C1=CC=CC=C1 FMJSMJQBSVNSBF-UHFFFAOYSA-N 0.000 description 1
- 229960000601 octocrylene Drugs 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- BARWIPMJPCRCTP-UHFFFAOYSA-N oleic acid oleyl ester Natural products CCCCCCCCC=CCCCCCCCCOC(=O)CCCCCCCC=CCCCCCCCC BARWIPMJPCRCTP-UHFFFAOYSA-N 0.000 description 1
- 229940120511 oleyl erucate Drugs 0.000 description 1
- 125000001117 oleyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])/C([H])=C([H])\C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- BARWIPMJPCRCTP-CLFAGFIQSA-N oleyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC BARWIPMJPCRCTP-CLFAGFIQSA-N 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000012186 ozocerite Substances 0.000 description 1
- 239000003346 palm kernel oil Substances 0.000 description 1
- 235000019865 palm kernel oil Nutrition 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- 229940098695 palmitic acid Drugs 0.000 description 1
- 125000001312 palmitoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 235000019809 paraffin wax Nutrition 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- 229940100460 peg-100 stearate Drugs 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 229940068041 phytic acid Drugs 0.000 description 1
- 239000000467 phytic acid Substances 0.000 description 1
- 235000002949 phytic acid Nutrition 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 238000009832 plasma treatment Methods 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920001993 poloxamer 188 Polymers 0.000 description 1
- 229940044519 poloxamer 188 Drugs 0.000 description 1
- 229920003216 poly(methylphenylsiloxane) Polymers 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 229920000223 polyglycerol Polymers 0.000 description 1
- 229920005862 polyol Polymers 0.000 description 1
- 150000003077 polyols Chemical class 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229940068977 polysorbate 20 Drugs 0.000 description 1
- 229940113171 polysorbate 85 Drugs 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- PZQSQRCNMZGWFT-QXMHVHEDSA-N propan-2-yl (z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC(C)C PZQSQRCNMZGWFT-QXMHVHEDSA-N 0.000 description 1
- ZPWFUIUNWDIYCJ-UHFFFAOYSA-N propan-2-yl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC(C)C ZPWFUIUNWDIYCJ-UHFFFAOYSA-N 0.000 description 1
- 239000001294 propane Substances 0.000 description 1
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 1
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
- 229960002662 propylthiouracil Drugs 0.000 description 1
- 239000003531 protein hydrolysate Substances 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000002207 retinal effect Effects 0.000 description 1
- 229930002330 retinoic acid Natural products 0.000 description 1
- 229960003471 retinol Drugs 0.000 description 1
- 235000020944 retinol Nutrition 0.000 description 1
- 239000011607 retinol Substances 0.000 description 1
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 1
- 229960004555 rutoside Drugs 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 229960002718 selenomethionine Drugs 0.000 description 1
- 239000002453 shampoo Substances 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- RPACBEVZENYWOL-XFULWGLBSA-M sodium;(2r)-2-[6-(4-chlorophenoxy)hexyl]oxirane-2-carboxylate Chemical compound [Na+].C=1C=C(Cl)C=CC=1OCCCCCC[C@]1(C(=O)[O-])CO1 RPACBEVZENYWOL-XFULWGLBSA-M 0.000 description 1
- BBHVQBQNEHFBIO-UHFFFAOYSA-M sodium;2-(3,4-dimethoxyphenyl)-2-oxoacetate Chemical compound [Na+].COC1=CC=C(C(=O)C([O-])=O)C=C1OC BBHVQBQNEHFBIO-UHFFFAOYSA-M 0.000 description 1
- 235000010199 sorbic acid Nutrition 0.000 description 1
- 239000004334 sorbic acid Substances 0.000 description 1
- 229940075582 sorbic acid Drugs 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 229940031439 squalene Drugs 0.000 description 1
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- PJANXHGTPQOBST-UHFFFAOYSA-N stilbene Chemical compound C=1C=CC=CC=1C=CC1=CC=CC=C1 PJANXHGTPQOBST-UHFFFAOYSA-N 0.000 description 1
- 235000021286 stilbenes Nutrition 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 1
- 125000005555 sulfoximide group Chemical group 0.000 description 1
- 229960000368 sulisobenzone Drugs 0.000 description 1
- 239000002600 sunflower oil Substances 0.000 description 1
- 235000019303 thiodipropionic acid Nutrition 0.000 description 1
- 150000003573 thiols Chemical class 0.000 description 1
- 229940094937 thioredoxin Drugs 0.000 description 1
- 108060008226 thioredoxin Proteins 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- 125000002640 tocopherol group Chemical class 0.000 description 1
- 235000019149 tocopherols Nutrition 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 239000012049 topical pharmaceutical composition Substances 0.000 description 1
- QURCVMIEKCOAJU-UHFFFAOYSA-N trans-isoferulic acid Natural products COC1=CC=C(C=CC(O)=O)C=C1O QURCVMIEKCOAJU-UHFFFAOYSA-N 0.000 description 1
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 description 1
- LOIYMIARKYCTBW-UHFFFAOYSA-N trans-urocanic acid Natural products OC(=O)C=CC1=CNC=N1 LOIYMIARKYCTBW-UHFFFAOYSA-N 0.000 description 1
- 238000011282 treatment Methods 0.000 description 1
- 229960001727 tretinoin Drugs 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 229940118594 trimethylolpropane triisostearate Drugs 0.000 description 1
- 125000000026 trimethylsilyl group Chemical group [H]C([H])([H])[Si]([*])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- UEVAMYPIMMOEFW-UHFFFAOYSA-N trolamine salicylate Chemical compound OCCN(CCO)CCO.OC(=O)C1=CC=CC=C1O UEVAMYPIMMOEFW-UHFFFAOYSA-N 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 229940040064 ubiquinol Drugs 0.000 description 1
- QNTNKSLOFHEFPK-UPTCCGCDSA-N ubiquinol-10 Chemical compound COC1=C(O)C(C)=C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)C(O)=C1OC QNTNKSLOFHEFPK-UPTCCGCDSA-N 0.000 description 1
- 229940035936 ubiquinone Drugs 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 229940116269 uric acid Drugs 0.000 description 1
- 238000009489 vacuum treatment Methods 0.000 description 1
- 239000012808 vapor phase Substances 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- XOOUIPVCVHRTMJ-UHFFFAOYSA-L zinc stearate Chemical class [Zn+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O XOOUIPVCVHRTMJ-UHFFFAOYSA-L 0.000 description 1
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 1
- 229910000368 zinc sulfate Inorganic materials 0.000 description 1
- 239000011686 zinc sulphate Substances 0.000 description 1
- 229910052726 zirconium Inorganic materials 0.000 description 1
Abstract
The present invention relates to the formation of surface treated zinc oxide and titania particles, and in particular zinc oxide and titania nanoparticles, with a siloxane star-graft copolymer coating, comprising a looped and/or linear polymeric structure on a star-graft copolymer coating, on a particle surface to control the interfacial surface interactions between the particle and the oil phase of the cosmetic skin formulation.
Description
Cosmetic Formulations Comprising Zn0 Nanoparticles Inventors:
Valerie Andre BASF Aktiengesellschaft Richard W. Brotzman, Jr.
Nanophase Technologies Corporation Cross-Reference to Related Patents Particulate surfaces, and in particular nanoparticle surfaces, may be surface treated by star-graft copolymers to form uniform coatings according to the methods disclosed in US
Patents 5,993,967 and 6,033,781, which are incorporated herein by reference.
Field of the Invention Modern skin care formulations must meet high standards of efficacy, skin compatibility and aesthetic appeal. It is commonly accepted that the performance of a cosmetic product is related to the entire formulation. Thus, an optimal galenic formulation that incorporated active ingredients is a necessary prerequisite to succeed in the market. The objective of topical formulations may be classified in two major areas: to modulate or assist the barrier function of the skin and to act as a delivery system for active ingredients. This patent focuses on the development of galenically interesting formulation concepts used in contemporary skin care products which combine, in particular, charged organic moieties, such as acrylate-based polymers, a- and (3-hydroxy acids, etc., and inorganic zinc oxide and titania.
The present invention relates in particular to problems encountered when particulate zinc oxide, and in particular nanoparticulate zinc oxide, is formulated with charged organic moieties, such as acrylate-based polymers, a- and ~i-hydroxy acids, etc.
Contemporary skin care formulations are dispersions. The charged organic moieties will reside in the aqueous phase of the dispersion and the inorganic ingredients, zinc oxide and titania, reside in the oil phase of the dispersion. In formulation the acrylate-based polymers, once neutralized with a cosmetically acceptable base such as triethanol amine or sodium hydroxide, extend to thicken the formulation by increasing the viscosity of the aqueous phase. Other charged organic moieties, such as a- and [3-hydroxy acids, may have other functions such as enhancing epithelial cell regeneration. However zinc ions from the particulate zinc oxide migrate from the oil phase to the aqueous phase and adversely interact with the charged organic moieties to either cause collapse of the acrylate-based polymers or the formation of organic salts with concomitant dissolution of the particulate inorganic.
Specifically excluded from the present invention are surface treatments for all inorganic, semi-metallic, and/or metallic oxide particles for all applications except (a) the products) per se, defined as surface treated Zn0 and/or Ti02 (titania), and (b) the use of the products) per' se in personal care formulations. Personal care formulations are defined as cosmetic or dermatological preparations for skin care, hair care, foot care, sun care, oral care, baby care, toiletries, color cosmetics, personal cleaning, and topical human sunscreens.
Invention The present invention relates to the formation of surface treated zinc oxide and titania particles, and in particular zinc oxide and titania nanoparticles, with a siloxane star-graft co-polymer coating, comprising a looped and/or linear polymeric structure on a star-graft copolymer coating, on a particle surface to control the interfacial surface interactions between the particle and the oil phase of the cosmetic skin formulation. The siloxane star-graft co-polymer, that may or may not contain topological loops, is formed in the "particle surface proximity" by a heterogeneous polymerization reaction. The resulting surface treatment will passivate the zinc oxide surface to prevent ion leakage and render the surface treated zinc oxide compatible with charged organic moieties, such as acrylate-based polymers and a- and (3-hydroxy acids, etc. In addition the surface treatment on zinc oxide and titania can be tailored to render the surface treated particle thermodynamically compatible with different oil phase components of a cosmetic skin formulation.
Background of the Invention The surface treatment of inorganic particles has been addressed over the years by many different techniques and chemical efforts. Some of the techniques are the application of coatings to the suxface of particles, using coupling agents on the surface of the particles, physically modifying the surface of the particles, chemically modifying the innate composition on the surface of the particles, and/or modifying the formulation to accommodate the particle - this latter is one of the least desirable methods of controlling particulate behavior in formulation as it limits formulation composition and ingredients and may alter essential formulation and product properties.
The surfaces of zinc oxide and titania have been conventionally coated by adsorption, ion exchange, and covalent bonding. Adsorption and ion exchange require the surface to have the appropriate chemical characteristics. Reactions that enable covalent bonding to particle surfaces generally involve reactions with a surface-bound hydroxyl group. These coatings are thin surface treatments which afford a degree of formulation and product compatibility and for the best available technology no particulate aggregation, but can not prevent ion migration from reactive particles or affect ultimate control of interfacial material properties.
Description of Invention The shortcomings of the existing art are overcome and additional advantages are provided through the provision of a surface treated zinc oxide and/or titania nanoparticle having a coating comprised of a star-graft siloxane copolymer to which are polymerized looped and/or linear polymer chains. Particulate surfaces, and in particular nanoparticulate surfaces, may be surface treated by siloxane star-graft copolymers to form uniform coatings according to the methods disclosed in US Patents 5,993,967 and 6,033,781 which are incorporated herein by reference. These uniform particulate surface treatments enable compatibility without particulate aggregation but they are subject to the limitations enumerated above. These star-graft copolymers may be formulated to have pendant groups that are reactive. It is to these reactive pendant groups that difunctional monomers are graft copolymerized to form looped and/or linear chains.
The star-graft copolymers may be applied to zinc oxide and/or titania particles, and in particular nanoparticles. The star-graft copolymer coatings are formed by reacting specific monomers to form a siloxane-based polymer. The surface treatment encapsulates the nanoparticulate zinc oxide and/or titania. In general, a plurality of nanoparticle zinc oxide and/or titania is surface treated with the star-graft copolymer and the surface treatment encapsulates at least a portion of the particles discretely, preferably all of the particles discretely. The star-graft copolymer, disclosed in US 5,993,967 and 6,033,781, comprises:
Si (w, x, y, z) where w, x, y, and z are the mole percent tetrafunctional, trifunctional, difunctional, and monofunctional monomeric units, respectively and wherein w, x, y, and z ranges of about 45-75, 5-25, 5-45, and 5-10, respectively.
As disclosed in US Patents 5,993,967 and 6,033,781, a star-graft copolymer, capable of coating and encapsulating nanoparticles, required a relatively large percentage of tetrafunctional monomers to yield a high degree of branching. In addition, the trifunctional monomers directed coating conformation, difunctional monomers were the linear polymer segments, and monofunctional monomers controlled the overall size Because difunctional monomers are polymerized to this star-graft polymer to form looped and/or linear polymer chains that extend from the particle surface into the solvating fluid or matrix structure, one skilled in the art would expect that a decrease the monofunctional monomer to enable the star-graft polymer surface treatment to retain functionality, and increase the difunctional monomers to form additional linear polymer segments would be yield the desired surface treatment. However to our surprise, not only was it necessary to decrease the monofunctional monomers to retain functionality on the star-graft polymer and to increase the difunctional monomers to form additional linear chains, but the present invention further requires the star-graft copolymer to have a significantly lower degree of branching, with respect to surface treatments taught in US Patents 5,993,967 and 6,033,781- this is an unexpected and surprising result.
It is these looped and/or linear polymer chains that enable surface treatments, what would otherwise be thin coatings, to extend into the application medium and control the interfacial properties of the zinc oxide and/or titanic particle.
The present invention relates to a surface treated particle comprising a plurality of zinc oxide and/or titanic particles and a star-graft copolymer with looped and/or linear polymeric structure on a star-graft copolymer encapsulating at least a portion of said particles, said surface treatment comprising:
Si (x, y) where x and y are the mole percent trifunctional and difunctional monomeric units, respectively.
In the preferred surface treated particle:
x is selected from the group of trifunctional monomers that have cosmetically acceptable non-reactive ligands comprising of methyltrimethoxysilane, n-propyltrimethoxysilane, isobutyltrimethoxysilane, n-hexyltrimethoxysilane, n-octyltrimethoxysilane, n-octadecyltrimethoxysilane, phenyltrimethoxysilane, and the triethoxy-containing counterparts of these monomers; and y is selected from the group of difunctional monomers that have cosmetically acceptable non-reactive ligands comprising of dicyclohexyldimethoxysilane, diethyldiethoxysilane, dimethyldichlorosilane, dimethyldiethoxysilane, dimethyldimethoxysilane, diphenyldiethoxysilane, diphenyldimethoxysilane, di-n-hexyldichlorosilane, n-hexylmethyldichlorosilane, methyldodecyldiethoxysilane, n-octylmethyldimethoxysilane, and the diethoxy-containing counterparts of these monomers.
In the most preferred surface treated particle:
x is selected from the group of n-octyltrimethoxysilane, n-octyltriethoxysilane, phenyltrimethoxysilane and phenyltriethoxysilane; and y is selected from the group of diphenyldiethoxysilane and diphenyldimethoxysilane.
The values of x and y in the above silicon-based polymers have ranged from 1-50 and 50-99, respectively. Preferably the values of x and y in the above silicon-based polymers have ranged from 1-40 and 60-99, respectively. Most preferably the values of x and y in the above silicon-based polymers have ranged from 10-30 and 70-90, respectively.
The surface treatment is applied to zinc oxide and/or titania particles, and in particular nanoparticles. The nanoparticle mean particle size range is from about 1 nm to about 900 nm. The preferred nanoparticle mean particle size range is from about 2 nm to about 500 nm.
The most preferred nanoparticle mean particle size range is from about 5 nm to about 100 nm.
As an alternative to processing methods disclosed in US Patents 5,993,967 and 6,033,71, the preferred method of preparing the surface treated zinc oxide and/or titania comprises mixing the particulate comprising substantially spherical nanocrystalline particles with surface treatment precursors. The siloxane star-graft copolymer, that contains loops and/or linear polymer chains, is formed in the "particle surface proximity" by a heterogeneous polymerization reaction. The mixture is carried out at a temperature, in an environment, and for a time that is effective for the star-graft copolymer to coat the nanocrystalline particle and the difunctional precursors to polymerize to form the looped and/or linear chain surface treatment morphology. Volatile by-products may be driven off as the surface treated powder is heated. The nanoparticles and the coating precursor are added in quantities effective to enable chemically passive surface treatments that prevent ion leakage and render the surface treated zinc oxide compatible with charged organic moieties, such as acrylate-based polymers, a- and (3-hydroxy acids. The amount of coating precursor used is directly related to the particle surface area or the particle size.
Detailed Description of the Invention In accordance with the principles of the present invention, a surface treatment of zinc oxide and/or titania particles, and in particular the surface treated nanoparticles, with looped and/or linear polymeric structure on a star-graft polymer coating on a particle surface and method for making the same are provided. To passivate the zinc oxide surface to prevent ion leakage and render the surface treated zinc oxide compatible with charged organic moieties, such as acrylate-based polymers, a- and (3-hydroxy acids, etc., the surface treatment contains predominantly phenyl chemistry. In addition the surface treatment on zinc oxide and titania can be tailored to render the surface treated particle thermodynamically compatible with different oil phase components of a cosmetic skin formulation, by judicious selection of non-phenyl containing precursors.
The surface treatment is applied to zinc oxide and/or titania particles, and in particular nanoparticles. The nanoparticle mean particle size range is from about 1 nm to about 900 nm. The preferred nanoparticle mean particle size range is from about 2 nm to about 500 nm.
The most preferred nanoparticle mean particle size range is from about 5 nm to about 100 nm.
The values of x and y in the above silicon-based polymers have ranged from 1-50 and 50-99, respectively. Preferably the values of x and y in the above silicon-based polymers have ranged from 1-40 and 60-99, respectively. Most preferably the values of x and y in the above silicon-based polymers have ranged from 10-30 and 70-90, respectively.
Various combinations are employed to control the branching of the siloxane backbone, the degree of looped and/or linear chains, and its chemical nature, that is, the degree of thermodynamic compatibility with specific oil phase components of a cosmetic skin formulation. Additionally the chemical nature of the difunctional monomers are selected to transform what would otherwise be thin coatings, into loops and/or linear chains that extend into the oil phase components of a cosmetic skin formulation medium.
The invention also relates to a method of protecting human skin or human hair from ultraviolet radiation comprising treating said skin or hair with an effective protecting concentration of a surface treated particle comprising a plurality of zinc oxide and/or titania particles and a star-graft copolymer with looped and/or linear polymeric structure on a star-graft copolymer encapsulating at least a portion of said particles, said surface treatment comprising:
Si (x, y) where x and y are mole percent trifunctional and difunctional monomeric units, respectively and wherein x and y are about 1-50 and 50 - 99, respectively, wherein:
x is selected from the group of trifunctional monomers that have cosmetically acceptable non-reactive ligands comprising of methyltrimethoxysilane, n-propyltrimethoxysilane, isobutyltrimethoxysilane, n-hexyltrimethoxysilane, n-octyltrimethoxysilane, n-octadecyltrimethoxysilane, phenyltrimethoxysilane, and the triethoxy-containing counterparts of these monomers;
y is selected from the group of difunctional monomers that have cosmetically acceptable non-reactive ligands comprising of dicyclohexyldimethoxysilane, diethyldiethoxysilane, dimethyldichlorosilane, dimethyldiethoxysilane, dimethyldimethoxysilane, diphenyldiethoxysilane, diphenyldimethoxysilane, di-n-hexyldichlorosilane, n-hexylmethyldichlorosilane, methyldodecyldiethoxysilane, n-octylmethyldimethoxysilane, and the diethoxy-containing counterparts of these monomers, where the products) per se, defined as surface treated Zn0 and/or Ti02, are used in personal care formulations.
In a preferred variant of the method the surface treatment comprising:
Si (x, y) wherein x and y are about 10-30 and 70-90, respectively, wherein:
x is selected from the group of n-octyltrimethoxysilane, n-octyltriethoxysilane, phenyltrimethoxysilane and phenyltriethoxysilane, and y ' is selected from the group of n-octyltrimethoxysilane, n-octyltriethoxysilane.
According to one variant of the method the said effective protecting concentration ranges between 0.1 % and 25% by weight, preferably between 0.1 % and 10%, particularly preferably between 1 % and 7%, based on the total weight of the personal care formulation.
In a preferred variant of the method the said personal care formulation comprises surface treated zinc oxide and/or titanium dioxide particles alone or together with compounds which absorb in the LTV region and are known for cosmetic and pharmaceutical preparations.
Accordingly, the present invention also relates to sunscreen-containing personal care formulations for protecting human skin or human hair from ultraviolet radiation, which comprises, in a cosmetically and pharmaceutically suitable carrier, an effective protecting concentration of a surface treated particle comprising a plurality of zinc oxide and/or titania particles and a star-graft copolymer with looped and/or linear polymeric structure on a star-graft copolymer encapsulating at least a portion of said particles, said coating polymer comprising:
Si (x,y) where x and y are the mole percent trifunctional and difunctional monomeric units, respectively, and wherein x is about 1-50 and y is about 50-99, respectively, wherein:
x is selected from the group of trifunctional monomers that have cosmetically acceptable non-reactive ligands comprising of methyltrimethoxysilane, n-propyltrimethoxysilane, isobutyltrimethoxysilane, n-hexyltrimethoxysilane, n-octyltrimethoxysilane, n-octadecyltrimethoxysilane, phenyltrimethoxysilane, and the triethoxy-containing counterparts of these monomers;
y is selected from the group of difunctional monomers that have cosmetically acceptable non-reactive ligands comprising of dicyclohexyldimethoxysilane, diethyldiethoxysilane, dimethyldichlorosilane, dimethyldiethoxysilane, dimethyldimethoxysilane, diphenyldiethoxysilane, diphenyldimethoxysilane, di-n-hexyldichlorosilane, n-hexylmethyldichlorosilane, methyldodecyldiethoxysilane, n-octylmethyldimethoxysilane, and the diethoxy-containing counterparts of these monomers.
Particular preference is given to personal care formulations wherein the said surface treatment comprising:
Si (x, y) wherein x and y are about 10-30 and 70-90, respectively, wherein:
x is selected from the group of n-octyltrimethoxysilane, n-octyltriethoxysilane, phenyltrimethoxysilane and phenyltriethoxysilane, and y is selected from the group of n-octyltrimethoxysilane, n-octyltriethoxysilane.
The cosmetic and dermatological preparations according to the invention can comprise cosmetic active ingredients, auxiliaries and/or additives, for example, coemulsifiers, fats and waxes, stabilizers, thickeners, biogenic active ingredients, film formers, fragrances, dyes, pearlizing agents, preservatives, pigments, electrolytes (e.g. magnesium sulfate) and pH
regulators.
Suitable coemulsifiers are, preferably, known W/O and also O/W emulsifiers, such as, for example, polyglycerol esters, sorbitan esters or partially esterified glycerides. Typical examples of fats are glycerides; waxes which may be mentioned are inter alia beeswax, paraffin wax or microcrystalline waxes, optionally in combination with hydrophilic waxes.
Stabilizers which may be used axe metal salts of fatty acids, such as, for example, magnesium, aluminum and/or zinc stearate. Examples of suitable thickeners are crosslinked polyacrylic acids and derivatives thereof, polysaccharides, in particular xanthan gum, guar guar, agar agar, alginates and tyloses, carboxymethylcellulose and hydroxyethylcellulose, and also fatty alcohols, monoglycerides and fatty acids, polycrylates, polyvinyl alcohol and polyvinylpyrrolidone. The term biogenic active ingredients means, for example, plant extracts, protein hydrolyzates and vitamin complexes. Customary film formers are, for example, hydrocolloids, such as chitosan, microcrystalline chitosan or quaternary chitosan, polyvinylpyrrolidone, vinylpyrrolidone/vinyl acetate copolymers, polymers of the acrylic acid series, quaternary cellulose derivatives and similar compounds. Examples of suitable preservatives are formaldehyde solution, p-hydroxybenzoate or sorbic acid.
Examples of suitable pearlizing agents are glycol distearic esters, such as ethylene glycol distearate, but also fatty acids and fatty acid monoglycol esters. Dyes which may be used are the substances suitable and approved for cosmetic purposes, as listed, for example, in the publication "I~osmetische Farbemittel" [Cosmetic Colorants] from the Farbstofflcommission der Deutschen Forschungsgemeinschaft [Dyes Commission of the German Research Council], published by Verlag Chemie, Weinheim, 1984. These dyes are usually used in a concentration of from 0.001 to 0.1 % by weight, based on the total mixture.
It is likewise advantageous to add customary antioxidants to the preparations for the purposes of the present invention. According to the invention, all antioxidants which are customary or suitable for cosmetic and dermatological applications may be used as favorable antioxidants.
The antioxidants are advantageously chosen from the group consisting of amino acids (e.g. glycine, histidine, tyrosine, tryptophan) and derivatives thereof, imidazoles (e.g.
urocanic acid) and derivatives thereof, peptides, such as D,L-carnosine, D-carnosine, L-carnosine and derivatives thereof (e.g. anserine), carotenoids, carotenes (e.g. a-carotene, f3-carotene, lycopene) and derivatives thereof, retinoids, such as, for example, retinol, retinal and/or retinoic acid and the respective esters, a-lipoic acid and derivatives thereof (e.g.
dihydrolipoic acid), aurothioglucose, propylthiouracil and other thiols (e.g.
thioredoxin, glutathione, cysteine, cystine, cystamine and the glycosyl, N-acetyl, methyl, ethyl, propyl, amyl, butyl and lauryl, palmitoyl, oleyl, y-linoleyl, cholesteryl and glyceryl esters thereof) and salts thereof, dilauryl thiodipropionate, distearyl thiodipropionate, thiodipropionic acid and derivatives thereof (esters, ethers, peptides, lipids, nucleotides, nucleosides and salts), and sulfoximine compounds (e.g. buthionine sulfoximines, homocysteine sulfoximine, buthionine sulfones, penta-, hexa-, heptathionine sulfoximine) in very low tolerated doses (e.g. pmol to ~.mol/kg), and also (metal) chelating agents (e.g. a-hydroxy fatty acids, palmitic acid, phytic acid, lactoferrin), a-hydroxy acids (e.g. citric acid, lactic acid, malefic acid), humic acid, bile acid, bile extracts, bilirubin, biliverdin, EDTA, EGTA and derivatives thereof, unsaturated fatty acids and derivatives thereof (e.g. y-linolenic acid, linoleic acid, oleic acid), folic acid and derivatives thereof, 2-aminopropionic acid diacetic acid, flavonoids, polyphenols, catechins, ubiquinone and ubiquinol and derivatives thereof, vitamin C and derivatives (e.g. ascorbyl palmitate, Mg ascorbyl phosphate, ascorbyl acetate), tocopherols and derivatives (e.g. vitamin E acetate), and coniferyl benzoate of benzoin resin, rutinic acid and derivatives thereof, ferulic acid and derivatives thereof, butylhydroxytoluene, butylhydroxyanisole, nordihydroguaiacic acid, nordihyrdoguaiaretic acid, trihydroxybutyrophenone, uric acid and derivatives thereof, mannose and derivatives thereof, zinc and derivatives thereof, (e.g. ZnO, ZnSO4), selenium and derivatives thereof (e.g.
selenomethionine), stilbene and derivatives thereof (e.g. silbene oxide, trans-stilbene oxide) and the derivatives (salts, esters, ethers, sugars, nucleotides, nucleosides, peptides and lipids) of said active ingredients which are suitable according to the invention.
The amount of antioxidants (one or more compounds) in the preparations is preferably 0.001 to 30% by weight, particularly preferably 0.05 to 20% by weight, in particular 0.1 to 10% by weight, based on the total weight of the preparation.
If vitamin E and/or derivatives thereof are the antioxidant or antioxidants, it is advantageous to choose their respective concentrations from the range 0.001 to 10% by weight, based on the total weight of the formulation.
If vitamin A and/or derivatives thereof or carotenoids are the antioxidant or antioxidants, it is advantageous to choose the respective concentration thereof from the range 0.001 to 10% by weight, based on the total weight of the formulation.
If the cosmetic or dermatological preparation for the purposes of the present invention is a solution or emulsion or dispersion, the solvents used may be:
water or aqueous solutions; oils, such as triglycerides of capric acid or of caprylic acid, but preferably castor oil; fats, waxes and other natural and synthetic fatty substances, preferably esters of fatty acids with alcohols of low carbon number, e.g. with isopropanol, propylene glycol or glycerol, or esters of fatty alcohols with alkanoic acids of low carbon number or with fatty acids; alcohols, diols or polyols of low carbon number, and ethers thereof, preferably ethanol, isopropanol, propylene glycol, glycerol, ethylene glycol, ethylene glycol monoethyl or monobutyl ether, propylene glycol monomethyl, monoethyl or monobutyl ether, diethylene glycol monomethyl or monethyl ether and analogous products.
In particular, mixtures of the above mentioned solvents are used. In the case of alcoholic solvents, water may be a further constituent.
The oil phase of the emulsions, oleogels or hydrodispersions or lipodispersions for the purposes of the present invention is advantageously chosen from the group of esters of saturated and/or unsaturated, branched and/or unbranched alkanecarboxylic acids with a chain length of from 3 to 30 carbon atoms and saturated and/or unsaturated, branched and/or unbranched alcohols with a chain length of from 3 to 30 carbon atoms, from the group of esters of aromatic carboxylic acids and saturated and/or unsaturated, branched and/or unbranched alcohols with a chain length of from 3 to 30 carbon atoms. Such ester oils can then advantageously be chosen from the group consisting of isopropyl myristate, isopropyl palmitate, isopropyl stearate, isopropyl oleate, n-butyl stearate, diisopropyl adipate, n-hexyl laurate, n-decyl oleate, glyceryl stearate, isooctyl steaxate, isononyl stearate, isononyl isononanoate, 2-ethylhexyl palmitate, 2-ethylhexyl laurate, 2-hexyldecyl stearate, 2-octyldodecyl palmitate, oleyl oleate, oleyl erucate, erucyl oleate, erucyl erucate, and synthetic, semisynthetic and natural mixtures of said esters, e.g. jojoba oil.
In addition, the oil phase can advantageously be chosen from the group of branched and unbranched hydrocarbons and hydrocarbon waxes, silicone oils, dialkyl ethers, the group of saturated or unsaturated, branched or unbranched alcohols, and fatty acid triglycerides, namely the triglycerol esters of saturated and/or unsaturated, branched and/or unbranched alkanecarboxylic acids with a chain length of from 8 to 24, in particular 12-18, carbon atoms.
The fatty acid triglycerides can, for example, be chosen advantageously from the group of synthetic, semisynthetic and natural oils, e.g. olive oil, sunflower oil, soybean oil, peanut oil, rapeseed oil, almond oil, palm oil, coconut oil, palm kernel oil and the like.
Any mixtures of such oil and wax components are also to be used advantageously for the purposes of the present invention. It may in some instances also be advantageous to use waxes, for example cetyl palmitate, as the sole lipid component of the oil phase.
The oil phase is advantageously chosen from the group consisting of 2-ethylhexyl isostearate, isohexadecane, octyldodecanol, isotridecyl isononanoate, isoeicosane, 2-ethylhexyl cocoate, C12-Cis-alkyl benzoate, caprylic/capric acid triglyceride, dicaprylyl ether.
Mixtures of C12-Cis-alkyl benzoate and 2-ethylhexyl isostearate, mixtures of C12-Cis-alkyll benzoate and isotridecyl isononanoate, and mixtures of C12-Cis-alkyl benzoate, 2-ethylhexyl isostearate and isotridecyl isononanoate are particularly advantageous.
Of the hydrocarbons, paraffin oils, squalane and squalene are to be used advantageously for the purposes of the present invention.
Advantageous oil components are also, for example, butyloctyl salicylate (for example that available under the trade name Hallbrite BHB from CP Hall), hexadecyl benzoate and butyloctyl benzoate and mixtures thereof (Hallstar AB) and/or diethylhexyl naphthalate (Hallbrite TQ).
The oil phase can also advantageously have a content of cyclic or lineax silicone oils, or consist entirely of such oils, although it is preferred to use an additional content of other oil phase components apart from the silicone oil or the silicone oils.
Advantageously, cyclomethicone (octamethylcyclotetrasiloxane) is used as silicone oil to be used according to the invention. However, other silicone oils can also be used advantageously for the purposes of the present invention, for example hexamethylcyclotrisiloxane, polydimethylsiloxane, poly(methylphenylsiloxane).
Mixtures of cyclomethicone and isotridecyl isononanoate, and of cyclomethicone and 2-ethylhexyl isostearate are also particularly advantageous.
Solid sticks comprise, for example, natural or synthetic waxes, fatty alcohols or fatty acid esters. Preference is given to using lip care sticks, and stick formulations for deodorizing the body.
Customary basic substances which are suitable for use as cosmetic sticks for the purposes of the present invention are liquid oils (e.g. paraffin oils, castor oil, isopropyl myristate), semisolid constituents (e.g. petroleum jelly, lanolin), solid constituents (e.g.
beeswax, ceresin and microcrystalline waxes and ozocerite), and high-melting waxes (e.g.
carnauba wax, candelilla wax).
Suitable propellants for cosmetic and/or dermatological preparations for the purposes of the present invention which can be sprayed from aerosol containers are the customary known readily volatile, liquefied propellants, for example hydrocarbons (propane, butane, isobutane), which can be used on their own or in a mixture with one another.
Compressed air can also be used advantageously.
The person skilled in the art is of course aware that there are propellant gases which are nontoxic per se which would in principle be suitable for realizing the present invention in the form of aerosol preparations, but which nevertheless have to be avoided due to a harmful effect on the environment or other accompanying phenomena, in particular fluorocarbons and chlorofluorocarbons (CFCs).
Cosmetic preparations for the purposes of the present invention may also be in the form of gels which, besides an effective content of active ingredient according to the invention and solvents customarily used therefore, preferably water, also comprise organic thickeners, e.g. gum arabic, xanthan gum, sodium alginate, cellulose derivatives, preferably methylcellulose, hydroxymethylcellulose, hydroxyethylcellulose, hydroxypropylcellulose, hydroxpropylmethylcellulose or inorganic thickeners, e.g. aluminum silicates, such as, for example, bentonites, or a mixture of polyethylene glycol and polyethylene glycol stearate or distearate. The thickener is present in the gel, for example, in an amount between 0.1 and 30% by weight, preferably between 0.5 and 15% by weight. The cosmetic and pharmaceutical preparations comprising light protection agents are generally based on a carrier which comprises at least one oil phase. Preparations based solely on aqueous components are, however, also possible. Accordingly, suitable preparations are oils, oil-in-water and water-in-oil emulsions, creams and pastes, lip-protection stick compositions or grease-free gels.
Gels used according to the invention usually comprise alcohols of low carbon number, e.g. ethanol, isopropanol, 1,2-propanediol, glycerol and water or an abovementioned oil in the presence of a thickener, which in the case of oily-alcoholic gels is preferably silicon dioxide or an aluminum silicate, and in the case of aqueous-alcoholic or alcoholic gels is preferably a polyacrylate.
The total proportion of auxiliaries and additives can be 1 to 80% by weight, preferably 6 to 40% by weight, and the nonaqueous proportion ("active substance") can be 20 to 80% by weight, preferably 30 to 70% by weight, based on the compositions. The compositions can be prepared in a manner known per se, i.e. for example by hot, cold, hot-hot/cold or PIT
emulsification. This is a purely mechanical process, and no chemical reaction takes place.
Such sunscreen preparations can accordingly be in liquid, paste or solid form, for example as water-in-oil creams, oil-in-water creams and lotions, aerosol foam creams, gels, oils, marking pencils, powders, sprays or alcohol-aqueous lotions.
According to the application technology requirements the surface treated particles (Zn0 and/or Ti02) can be added either to the Qil or to the aqueous phase of the cosmetic preparation.
Finally, it is possible additionally to use further substances known per se which absorb in the UV region, provided they axe stable in the overall system of the combination of UV
filters to be used according to the invention.
The majority of light protection agents in the cosmetic and pharmaceutical preparations used to protect the human epidermis consists of compounds which absorb UV
light in the UV-B region, i.e. in the range from 2~0 to 320 nm and UV-A
region, i.e. in the range from 320 to 400 nm. For example, the proportion of the UV-A absorbers to be used according to the invention is 10 to 90% by weight, preferably 20 to 50% by weight, based on the total amount of UV-B and LJV-A absorbing substances.
Suitable UV filter substances which are used in combination with the formulations to be used according to the invention are any UV-A and UV-B filter substances.
Examples which may be mentioned are:
No. Substance CAS No.
(=acid) 1 4-Aminobenzoic acid 150-13-0 2 3-(4'-Trimethylammonium)benzylidenebornan-2-one52793-97-2 methylsulfate 3 3,3,5-Trimethylcyclohexyl salicylate 11 ~-56-9 (homosalate) 4 2-Hydroxy-4~-methoxy-benzophenone 131-57-7 (oxybenzone) 2 Phenylbenzimidazole-5-sulfonic acid and 27503-81-7 its potassium, sodium and triethanolamine salts 6 3,3'-(1,4-Phenylenedimethine)-bis(7,7-dimethyl-2-90457-82-2 oxobicyclo[2.2.1]heptane-1-methanesulfonic acid) and its salts 7 Polyethoxyethyl4-bis(polyethoxy)aminobenzoate113010-52-9 8 2-Ethylhexyl4-dimethylaminobenzoate 21245-02-3 9 2-Ethylhexyl salicylate 118-60-5 2-Isoamyl4-methoxycinnamate 71617-10-2 11 2-Ethylhexyl 4-methoxycinnamate 5466-77-3 12 2-Hydroxy-4-methoxy-benzophenone-5-sulfonic 4065-45-6 acid (sulisobenzone) and the sodium salt 13 3-(4'-Sulfobenzylidene)bornan-2-one and salts58030-58-6 14 3-Benzylidenebornan-2-one 16087-24-8 1-(4'-Isopropylphenyl)-3 phenylpropane-1,3- 63260-25-9 dione 16 4-Isopropylbenzyl salicylate 94134-93-7 17 2,4,6-Trianiline(o-carbo-2'-ethylhexyl-1'-oxy)-1,3,588122-99-0 triazine 18 3-Imidazol-4-ylacrylic acid and its ethyl 104-98-3 ester 19 Ethyl2--cyano-3,3-diphenylacrylate 5232-99-5 2'-Ethylhexyl2-cyano-3,3-diphenylacrylate 6197-30~
21 Menthyl o-aminobenzoate or: 134-09-8 5-methyl-2-( 1-methylethyl)-2-aminobenzoate 22 Glyceryl p-aminobenzoate or: 136-44-7 1-glyceryl 4-aminobenzoate 23 2,2'-Dihydroxy~-methoxybenzophenone (dioxybenzone)131-53-3 24 2-Hydroxyl-methoxy-4-methylbenzophenone (mexenone)1641-17-4 Triethanolamine salicylate 2174-16-5 26 Dimethoxyphenylglyoxalic acid or: 4732-70-1 sodium 3,4-dimethoxyphenylglyoxalate 27 3-(4'Sulfobenzylidene)bornan-2-one and its 56039-58-8 salt 28 4-tert-Butyl-4'-methoxydibenzoylmethane 70356-09-1 29 2,2',4,4'-Tetrahydroxybenzophenone 131-SS-5 2,2'-Methylenebis[6(2H-benzotriazol-2 yl)-4-(1,1,3,3-103597-45-1 tetramethylbutyl)phenol]
31 2,2'-(1,4-Phenylene)-bis-1H-benzimidazole-4,6-180898-37-7 disulfonic acid, Na salt 32 2,4-bis[4-(2-Ethylhexyloxy)-2 hydroxy]phenyl-6-(4-187393-00-6 methoxyphenyl)-(1,3,5)-triazine 33 3-(4-Methylbenzylidene)camphor 36861-47-9 34 Polyethoxyethyl4-bis(polyethoxy)paraaminobenzoate113010-52-9 35 2,4-Dihydroxybenzophenone 131-56-6 36 2,2'-Dihydroxy-4,4'-dimethoxybenzophenone-5,5'-disodium3121-60-6 sulfonate 37 Benzoic acid, 2-[4-(diethylamino)-2-hydroxybenzoyl]-,302776-68-7 hexylester 38 2-(2H-Benzotriazol-2-yl)-4-methyl-6-[2-methyl-3-[1,3,3,3-155633-54-8 tetramethyl-1- [(trimethylsilyl)oxy] disiloxanyl]propyl]phenol 39 1,1-[(2,2'-Dimethylpropoxy)carbonyl]-4,4-diphenyl-1,3-363602-15-7 butadiene Polymeric or polymer-bonded filter substances can also be used according to the invention.
The cosmetic and dermatological preparations according to the invention can additionally advantageously comprise inorganic pigments based on metal oxides and/or other metal compounds which are insoluble or sparingly soluble in water, selected from the group consisting of the oxides of iron (e.g. Fe203), zirconium (Zr02), silicon (Si02), manganese (e.g. Mn0), aluminum (A1a03), cerium (e.g. Ce203), mixed oxides of the corresponding metals, and mixtures of such oxides.
For the purposes of the present invention, it is particularly advantageous, although not obligatory, for the inorganic pigments to be in coated form, i.e. to have been surface-treated.
This surface treatment may involve for example providing the pigments with a thin hydrophobic layer by a method known per se, as described in DE-A-33 14 742.
To protect human hair from UV rays, the light protection agent formulations according to the invention can be incorporated into shampoos, lotions, gels, hairsprays, aerosol foam creams or emulsions in concentrations of from 0.1 to 10% by weight, preferably to 7% by weight. The respective formulations can inter alia be used for washing, coloring and for styling hair.
The formulations to be used according to the invention are usually notable for a particularly high absorbance in the UV-A radiation region with a sharp band structure.
Moreover, they are readily soluble in cosmetic oils and can easily'be incorporated into cosmetic formulations. The emulsions prepared with the formulations are particularly notable for their high stability, the formulations I themselves are notable for their high photostability, and the preparations prepared therewith are notable for their pleasant feel on the skin.
The UV filter action of the formulations according to the invention can also be utilized for stabilizing active ingredients and auxiliaries in cosmetic and pharmaceutical formulations.
The preparations according to the invention are notable for particularly high absorbance in the UV-A radiation region with a sharp band structure and high light protection factors.
Example 1 General Batch Process for Surface Treating Zinc Oxide and/or Titania Particles The method comprises introducing zinc oxide and/or titania particles comprising a plurality of nanoparticles into a surface treatment vessel that is capable of mixing and heating its contents under a controlled environment. Example of suitable surface treatment vessels comprise a Buchi Rotovap (small scale available from Brinkrnann Instruments), V-blender (commercial scale available from Patterson-Kelley), ribbon-blender (commercial scale available from Jaygo), rotary oven (commercial scale available from Thermal Processing Solutions), and a fluidized bed (commercial scale available from Littleford Day).
a) The particles are introduced into the surface treatment vessel using methods known to those skilled in the art. Oxygen is removed from the vessel, typically by vacuum followed by inert gas flush, and the plurality of nanoparticles is mixed by methods such as, but not limited to, rotating the vessel or by rotating elements within the vessel. The particles are substantially spherical nanocrystalline nanoparticles and readily flow using standard unit operation methodologies. Particle mixing is carried out at a temperature, in an environment, and for a time that is effective at exposing particulate surface area to the environment of the surface treatment vessel enabling conditioning of the particle surface. Mixing may occur continuously, or at programmed intervals, and at a range of mixing rates. Mixing may occur at room temperature or at temperatures above or below room temperature depending on the chemistry of the surface treated particles. The degree of mixing may be used to control the bulk density of the final product - greater mixing yields a higher bulk density particulate product.
b) Particle surface conditioning comprises, but is not limited to, removing material sorbed to the particle surface, adding dopants to the particle surface, or a combination of conditioning steps. Particle surface conditioning may be accomplished by, but is not limited to, the following unit operations: vacuum treatment, plasma treatment, washing or flushing or fluidizing with a gas, fluid washing, reactive gas or fluid treatment, etc. In all instances reactive by-products and residues are removed prior to the application of surface treatment precursors.
c) Subsequent to particle surface conditioning, the particles are mixed with surface treatment precursors and heated in an environment, to a pre-determined temperature, and for a time effective for the star-graft copolymer to coat the nanocrystalline zinc oxide and/or titania particle and the difunctional precursors to polymerize to form the looped and/or linear chains on the star-graft copolymer. During surface treatment particulate mixing enables continuous surface exposure and promotes application of a uniform surface treatment to the plurality of particles. The nanoparticles and the coating precursor are added in relative quantities effective to enable a personal care application. The amount of coating precursor used is directly related to the particle surface area or the particle size.
d) Surface treatment sequences may include, but are not limited by, the followings process sequences: particle conditioning followed by surface treatment as in b) and c) above, multiple particle conditioning steps followed by surface treatment, particle conditioning followed by multiple surface treatment steps, sequential particle conditioning - surface treatment - particle conditioning - surface treatment steps, and others imagined by those skilled in the art.
e) The particles may comprise a single composition or multiple compositions.
f) Methods of introducing the surface treatment precursors may include, but are not limited by, fluid spray or vapor flow, employing any metered technique known to those skilled in the art.
g) The surface treatment precursors may be introduced as a precursor mixture, as a precursor mixture followed by a single precursor, or by sequential single precursor additions.
h) The surface treated particles are dried, if wet, cooled to room temperature, if reaction occurs at elevated temperature, and removed from the surface treatment vessel.
Example 2 Batch Process for Surface Treating Zinc Oxide The following process description is for preparing surface treated zinc oxide particles.
The surface treated zinc oxide is an active physical sunscreen ingredient for cosmetic formulations.
The product is prepared by the batch process detailed in Example 1.
a) 8-kg of zinc oxide nanoparticles, with a surface area of 14-m2/g, is weighed into a plastic bag and manually charged into a clean, 2-ft3 V-blender. Oxygen is removed by evacuating the V-blender to full vacuum level followed by vacuum relief of the V-blender with nitrogen. The evacuation and relieve cycle is repeated twice.
b) With the V-blender filled with inert gas, the V-blender is rotated at 5 RPM, and the V-blender is constantly flushed with nitrogen to condition the particles by removing sorbed materials.
c) Diphenyldimethoxysilane (168 g) and octyltriethoxysilane (42 g) monomers axe homogeneously mixed using a paddle mixer to form approximately a Si(0, 20, 80, and 0) surface treatment precursor mixture (210 g total weight).
d) Subsequent to particle surface conditioning, the surface treatment precursor mixture is introduced into the V-blender through a nozzle by inert pressure displacement and sprayed on the particles as the particles are mixing at room temperature. The temperature continues to ramp to 105 to.115°C. Particle mixing and vapor-phase transport enable surface treatment precursors to wet the particles and react to coat the nanocrystalline zinc oxide. The temperature is maintained at 105 to 115°C for 1-hour.
e) The surface treated zinc oxide is dried by pulling a vacuum, while purging the vessel with inert gas, N2, on the surface treatment vessel. Vacuum removes un-reacted surface treatment precursors and reaction by-products. At the same time the temperature of the vessel is cooled to room temperature. The surface treated zinc oxide is removed from the vessel at room temperature.
The surface treatment on the zinc oxide product, when added to cosmetic formulation, prevents ion leakage and renders the surface treated zinc oxide compatible with charged organic moieties, such as acrylate-based polymers, a- and (3-hydroxy acids. No other known commercial product or known surface treatment on zinc oxide particles enables the observed chemically passive behavior.
The above batch process may be scaled to surface treat larger amounts of particles or rendered continuous, as will be recognized by persons skilled in the art, by employing continuous mixing and heating equipment and appropriate process modifications.
.
Example 3 Specific Surface Treatment Examples 1) Physical sunscreen ingredients - Si(20, 80) / octyltriethoxysilane, diphenyldimethoxysilane; 4.3 wt% surface treatment precursor mixture applied to Zn0 (23 m2lg).
2) Physical sunscreen ingredients - Si(20, 80) / octyltriethoxysilane, diphenyldimethoxysilane; approximately 9.4 wt% surface treatment precursor mixture applied to Ti02 (50 ma/g).
Example 4 - Cosmetic Formulations Surface treated zinc oxide nanoparticles, produced by methods disclosed above, were incorporated into the oil in water formulations given in Tables 1-20 using the procedure following each respective table.
Table 1- Formulation 1 Weight INCI - Names %
Phase A
1,5 Steareth-2 0,5 Steareth-21 3,0 Cetearyl Alcohol 0,2 Bees wax 20,0 Cetearyl Ethylhexanoate 5,0 Surface Treated Zinc Oxide Phase B
0,3 Acrylates/Clo-C3o Alkyl Acrylate Crosspolymer ad 100 Deionized Water 0,04 Triethanolamine Procedure: Formulation 1 1. Heat Phase A ingredients to 80°C
2. Stir Phase A at 11000 rpm using a homogenizer for 3 minutes 3. Mix Phase B ingredients and heat them to 80°C.
4. Add Phase B to Phase A to form Mixture 1 5. Stir Mixture 1 at 11000 rpm using a homogenizer for 30sec-lmin 6. Cool Mixture 1 to room temperature under gentle planetary mixing 7. Stir Mixture 1 at 11000 rpm using a homogenizer for 30sec-lmin Table 2 - Formulation 2 Weight % 1NCI - Names Phase A
1,5 Steareth-2 0,5 Steareth-21 3,0 Cetearyl Alcohol 0,2 Bees wax 20,0 Cetearyl Ethylhexanoate 5,0 Surface Treated Zinc Oxide Phase B
0,2 Acrylates/C10-30 Alkyl Acrylate Cross olymer 45,77 Deionized Water 0,04 Triethanolamine Phase C
0,1 Acrylates/Acrylamide Copolymer, Mineral Oil, Polysorbate 85, Triethanolamine 22,88 ~ Deionized Water Procedure: Formulation 2 1. Heat Phase A ingredients to 80°C
2. Stir Phase A at 15000 rpm using a homogenizer for 3 minutes 3. Mix Phase B ingredient and heat them to 80°C
4. Mix Phase C ingredients and heat them to 80°C
5. Mix Phase B and Phase C to form Mixture 1 6. Add Mixture 1 to Phase A to form Mixture 2.
7. Stir Mixture 2 at 11000 rpm using a homogenizer for 30sec-lmin 8. Cool Mixtuxe 2 to room temperature under gentle planetary mixing 9. Stir Mixture 1 at 11000 rpm using a homogenizer for 30sec-lmin Table 3 - Formulation 3 Weight % INCI - Names Phase A
8,0 Dibutyl Adipate 8,0 Cla-C15 Alkyl Benzoate 12,0 Cocoglycerides 1,0 Sodium Cetearyl Sulfate 4,0 Lauryl Glucoside and Polyglyceryl-2 Dipolyhydroxystearate and Glycerin 2,0 Ceteraryl Alcohol 5,0 Surface Treated Zinc Oxide Phase B
3,0 Glycerin 0,05 pisodium EDTA
0,2 Allantoin 0,3 Carbomer ad 100 Demineralized Water 0,04 Triethanolamine Phase C
0,5 DMDM Hydantoin Procedure: Formulation 3 1. Heat Phase A ingredients to 80°C
2. Stir Phase A at 11000 rpm using a homogenizer for 3 minutes 3. Mix Phase B ingredients and heat them to 80°C
4. Mix Phase B and Phase A to form Mixture 1 5. Stir Mixture 1 at 11000 rpm using a homogenizer for 30sec-lmin 6. Cool Mixture 1 to room temperature under gentle planetary mixing.
7. Mix Phase C to Mixture 1 at 11000 rpm using a homogenizer for 30sec-1 min Table 4 - Formulation 4 INCI - Names Phase A
7,50 Ethylhexyl Methoxycinnamate 1,50 Polysorbate 20 3,00 Sodium Lauryl Lactylate 1,00 PEG - 40 Hydrogenated Castor Oil 1,00 Butyrospermum Parlcii (Shea Butter) 6,50 Cia-Cis Alkyl Benzoate Phase B
5,00 Surface Treated Zinc Oxide Phase C
4,00 Glycerin 1,00 Panthenol, Propylene Glycol 0,30 Xanthan gum . .
0,10 Disodium EDTA
2,00 Urea 2,00 Hydroxyethyl Acrylate/Sodium Acryloyldimethyl Taurate Copolymer, Squalane, Polysorbate 60 ad 100 l~emineralized Water Phase D
0,50 ~,actic acid 0,50 Phenoxyethanol, Methylparaben, Butylparaben, F~thylparaben, Pro ylparaben, Isobutylparaben Procedure: Formulation 4 1. Heat Phase A ingredients to 80°C
2. Add Phase B with Phase A and mix to form Mixture 1 using a homogenizer at 15000 rpm for 3 minutes 3. Mix Fhase C ingredients and heat them to 80°C
4. Mix Mixture 1 and Phase C to form Mixture 2 using a homogenizer at 11000 rpm for 3 minutes 5. Add Phase D ingredients to Mixture 2 to form Mixture 3 using a homogenizer at 11p00 rpm 30sec-lmin 6. Cool Mixture 3 to room temperature under gentle planetary mixing 7. Stir Mixture 1 at 11000 rpm using a homogenizer for 30sec-lmin Table 5 - Formulation 5 Weight % INCI - Names Phase A
1,00 ' Ceteareth - 25 2,00 Ceteareth - 6, Stearyl Alcohol 2,00 PEG -14 Dimethicone 3,60 Cetearyl Alcohol 6,00 Ethylhexyl Methoxycinnamate 2,00 Dibutyl Adipate 5,00 Surface Treated Zinc Oxide Phase B
1,00 Panthenol 5,00 Glycerin ad100 Demineralized Water Phase C
4,00 Caprylic/Capric Tri lyceride, Sodium Acrylates Copolymer Phase D
0,50 Phenoxyethanol, Methylparaben, Butylparaben, Ethylparaben, Propylparaben, Isobutylparaben Procedure: Formulation 5 1. Heat Phase A ingredients to 80°C
2. Stir Phase A at 11000 rpm using a homogenizes for 3 minutes 3. Heat Phase B ingredients to 80°C
4. Add Phase B with Phase A and mix to form Mixture 1 using a homogenizes at 11000 rpm for 30sec-lminute.
5. Mix Phase C to Mixture 1 to form Mixture 2 using a homogenizes at 11000rpm for 30 sec-lminute 6. Add Phase D ingredients to Mixture 2 while cooling to room temperature under gentle planetary mixing 7. Stir Mixture 1 at 11000 rpm using a homogenizes for 30sec-lmin Table 6 - Formulation 6 Weight % INCI - Names Phase A
3,0 Steareth-21 2,0 Cetearyl Alcohol 6,0 Ethylhexyl Methoxycinnamate 2,0 C12-Cis-Alkyl Benzoate 5,0 Surface Treated Zinc Oxide 3,0 VP/Eicosene Copolymer Phase B
5,0 Glycerin 2,0 Hydroxyethyl Acrylates/Sodium Acryloyl ad 100 Deionized Water 3,0 Potassium Cetyl Phos hate 0,1 Disodium EDTA
Phase C
0,5 Phenoxyethanol, Methylparaben, Ethylparaben, I Butylparaben, Pro ylparaben Procedure: Formulation 6 1. Heat Phase A and Phase B ingredients separately to 80°C
2. Homogenize Phase A and Phase B separately 3. Add Phase B to Phase A and homogenize for 3 minutes 4. Add Phase C to Phase A/B and homogenize S. Cool Mixture 4 to room temperature under gentle planetary mixing Table 7 - Formulation 7' Weight INCI - Names %
Phase A
3,0 Steareth-21 2,0 Cetearyl Alcohol 6,0 Ethylhexyl Methoxycinnamate 2,0 C12-Cis-Alkyl Benzoate 5,0 Surface Treated Zinc Oxide 3,0 VP/Eicosene Copolymer Phase B
5,0 Glycerin 2,0 Acrylates/Clo-C3o Alkylacrylate Crosspolymer ad 100 Deionized Water 0,04 Triethanolamine 3,0 Potassium Cetyl Phosphate 0,1 Disodium EDTA
Phase C
0,5 Phenoxyethanol, Methylparaben, Ethylparaben, Butylparaben, Propylparaben Procedure: Formulation 7 1. Heat Phase A and Phase B ingredients separately to 80°C
2. Homogenize Phase A and Phase B separately 3. Add Phase B to Phase A and homogenize for 3 minutes 4. Add Phase C to Phase A/B and homogenize 5. Cool Mixture 4 to room temperature under gentle planetary mixing Table 8 - Formulation 8 Weight INCI - Names %
Phase A
3,0 Steareth-21 2,0 Cetearyl Alcohol 6,0 Ethylhexyl Methoxycinnamate 2,0 Isohexadecane 3,0 Surface Treated Zinc Oxide 3,0 VP/Eicosene Copolymer Phase B
5,0 Glycerin 0.3 Acrylates/Clo-C3o Alkylacrylate Cross olymer ad 100 Deionized Water 0,06 Triethanolamine 3,0 Potassium Cetyl Phosphate 0,1 Disodium EDTA
Phase C
0,5 Phenoxyethanol, Methylparaben, Ethylparaben, Butylparaben, Propylparaben Procedure: Formulation 8 1. Heat Phase A and Phase B ingredients separately to 80°C
2. Homogenize Phase A and Phase B separately 3. Add Phase B to Phase A and homogenize for 3 minutes 4. Add Phase C to Phase A/B and homogenize S. Cool Mixture 4 to room temperature under gentle planetary mixing Table 9 - Formulation 9 Weight INCI - Names %
Phase A
8,0 Dibutyl Adipate 8,0 C12-Cls-Alkyl Benzoate 12,0 Cocoglycerides 1,0 Sodium Cetearyl Sulfate 4,0 Lauryl Glucoside, Polyglyceryl-2 Dipolyhydroxystearate 2,0 Cetearyl Sulfate 5,0 Surface Treated Zinc Oxide Phase B
3,0 Glycerin 0,05 Disodium EDTA
0,2 Allantoin 0,3 Carbomer ad 100 Deionized Water 0,04 Triethanolamine 3,0 Potassium Cetyl Phosphate Phase C
0,5 DMDM Hydantoin Procedure: Formulation 9 1. Heat Phase A and Phase B ingredients separately to 80°C
2. Homogenize Phase A and Phase B separately 3. Add Phase B to Phase A and homogenize for 3 minutes 4. Add Phase C to Phase A/B and homogenize 5. Cool Mixture 4 to room temperature under gentle planetary mixing Table 10 - Formulation 10 Weight INCI - Names %
Phase A
8,0 Dibutyl Adipate 8,0 C12 -Cls-Alkyl Benzoate 12,0 Cocoglycerides 1,0 Sodium Cetearyl Sulfate 4,p Lauryl Glucoside, Polyglyceryl-2 Dipolyhydroxystearate 2,0 Cetearyl Alcohol 5,0 Surface Treated Zinc Oxide 2,0 Ethylhexyl Triazone Phase B
3,0 Glycerin 0,05 Disodium EDTA
0,2 Allantoin 0,3 Carbomer ad 100 Deionized Water 0,04 Triethanolamine 3,4 Potassium Cetyl Phosphate Phase C
0,5 DMDM Hydantoin Procedure: Formulation 10 1. Heat Phase A and Phase B ingredients separately to 80°C
2. Homogenize Phase A and Phase B separately 3. Add Phase B to Phase A and homogenize for 3 minutes 4. Add Phase C to Phase A/B and homogenize 5. Cool Mixture 4 to room temperature under gentle planetary mixing Table 11- Formulation 11 Weight INCI - Names %
Phase A
3,0 Steareth-21 2,0 Cetearyl Alcohol 3,0 Ethylhexyl Methoxycinnamate 3,0 Octocrylene 2,0 C12-Cls-Alkyl Benzoate 5,0 Surface Treated Zinc Oxide 3,0 VP/Eicosene Copolymer Phase B
5,0 Glycerin 2,0 Acrylates/Clo-C3o Alkylacrylate Cross olymer ad 100 Deionized Water 0,04 Triethanolamine 3,0 Potassium Cetyl Phosphate 0,1 Disodium EDTA
Phase C
0,5 Phenoxyethanol, Methylparaben, Ethylparaben, Butyl araben, Propyl araben Procedure: Formulation 11 1. Heat Phase A and Phase B ingredients separately to 80°C
2. Homogenize Phase A and Phase B separately 3. Add Phase B to Phase A and homogenize for 3 minutes 4. Add Phase C to Phase AB and homogenize 5. Cool Mixture 4 to room temperature under gentle planetary mixing Table 12 - Formulation 12 Weight INCI - Names %
Phase A
3,0 Steareth-21 2,0 Cetearyl Alcohol 4,0 Ethylhexyl Methoxycinnamate 2,0 2-(4-Ethoxy-anilinomethylene)-propanedioic acid diethyl ester 2,0 Ci2-Cis-Alkyl Benzoate 5,0 Surface Treated Zinc Oxide 3,0 VPIEicosene Copolymer Phase B
5,0 Glycerin 2,0 AcrylateslClo-C3o Alkylacrylate Crosspolymer .
ad 100 Deionized Water 0,04 Triethanolamine 3,0 Potassium Cetyl Phosphate 0,1 Disodium EDTA
Phase C
0,5 Phenoxyethanol, Methylparaben, Ethylparaben, Butyl araben, Propylparaben Procedure: Formulation 12 1. Heat Phase A and Phase B ingredients separately to 80°C
2. Homogenize Phase A and Phase B separately 3. Add Phase B to Phase A and homogenize for 3 minutes 4.' Add Phase C to Phase A/B and homogenize 5. Cool Mixture 4 to room temperature under gentle planetary mixing Table 13 - Formulation 13 Weight % INCI - Names Phase A
3,0 Steareth-21 2,0 Cetearyl Alcohol 4,0 Ethylhexyl Methoxycinnamate 2,0 Drometrizole Trisiloxane 2,0 Cia -Cis-Alkyl Benzoate 5,0 Surface Treated Zinc Oxide 3,0 VP/Eicosene Co olymer Phase B
5,0 Glycerin 2,0 Acrylates/Clo-C3o Alkylacrylate Crosspolymer ad 1 Qp IDeionized Water O,Q4 Triethanolamine 3,0 Potassium Cetyl Phos hate 4,1 Disodium EDTA
Phase C
Q,5 Phenoxyethanol, Methylparaben, Ethylparaben, Butylparaben, Pro y1 araben _ Procedure: Formulation 13 1. Heat Phase A and Phase $ ingredients separately to SQ°C
2. Homogenize Phase A and Phase B separately 3. Add Phase B t9 Phase A and homogenize for 3 minutes 4. Add Phase C to Phase A/$ and homogenize 5. Cool Mixture 4 to room temperature under gentle planetary mixing Table 14 - Formulation 14 Weight INCI - Names %
Phase A
3,0 Ethylhexyl Methoxycinnamate 1,0 Diethylamino Hydroxybenzoyl Hexyl Benzoate 3,0 Cia-Cis-Alkyl Benzoate 0,5 Bees wax 3,0 Ceteareth-6, Stearyl Alcohol 1,0 Cetearyth-25 3,0 Cetearyl Alcohol 5,0 Caprylic/Capric Triglyceride 3,0 Surface Treated Zinc Oxide 2,0 Surface Treated Titanium Dioxide Phase B
2,0 Hydroxyethylacrylate l sodium acrylodimethyltaurate copolymer & Squalane& Polysorbate 60 ad 100 Deionized Water Phase C
0,5 Benzyl Alcohol, Methylchloroisothiazolinone, Methylisothiazolinone Procedure: Formulation 14 1. Heat Phase A and Phase B separately to about 80°C
2. Homogenize Phase A and Phase B at 11000 rpm using a homogenizer for 3 minutes 3. Stir Phase B into Phase A and homogenize 4. Cool Mixture 3 to room temperature under gentle planetary mixing 5. Stir in Phase C and homogenize Table 15 - Formulation 15 Weight INCI - Names %
Phase A
3,0 Ethylhexyl Methoxycinnamate 1,0 Diethylamino Hydroxybenzoyl Hexyl Benzoate 3,0 Cia -Cis-Alkyl Benzoate 0,5 Bees wax 3,0 Ceteareth-6, Stearyl Alcohol 1,0 Cetearyth-25 3,0 Cetearyl Alcohol 5,0 Isohexadecane 3,0 Surface Treated Zinc Oxide 2,0 Surface Treated Titanium Dioxide Phase B
0,3 Carbomer 0,04 Triethanolamine ad 100 Deionized Water Phase C
0,5 Benzyl Alcohol, Methylchloroisothiazolinone, Methylisothiazolinone Procedure: Formulation 15 1. Heat Phase A and Phase B separately to about 80°C
2. Homogenize Phase A and Phase B at 11000 rpm using a homogenizer for 3 minutes 3. Stir Phase B into Phase A and homogenize 4. Cool Mixture 3 to room temperature under gentle planetary mixing 5. Stir in Phase C and homogenize Table 16 - Formulation 16 Weight 1NCI - Names %
Phase A
4,0 Glyceryl Stearate, PEG-100 Stearate 3,0 Ethylhexyl Methoxycinnamate 1,0 Diethylamino Hydroxybenzoyl Hexyl Benzoate 0,5 Lecithin 0,5 Polyglyceryl Dimer Soyate Phase B
0,25 Iron Oxides Braun 70 E 172 2,25 Trimethylolpropane Triisostearate Phase C
5,5 Cyclopentasiloxane, Cyclohexasiloxane 4,0 Ethylhexyl Palmitate 1,5 Simmondsia Chinensis (Jojoba) Seed Oil 2,0 Propylene Glycol Dicaprylate/Dicaprate 1,5 Sweet Almond (Prunus Amygdalus Dulcis) Oil 5,0 Surface Treated Titanium Dioxide 0,5 Tocopheryl Acetate 1,0 Butyros ermum Parkii (Shea Butter) 0,5 Polyglyceryl-2 Dipolyhydroxystearate Phase D
5,0 Propylene Glicol 0,5 Poloxamer 188 0,1 Disodium EDTA
ad 100 Deionized Water Phase E
2,00 Hydroxyethylacrylate / sodium acrylodimethyltaurate copolymer & Squalane& Polysorbate 60 Phase F
1,0 Phenonip, Phenoxyethanol, Methylpaxaben, Ethylparaben, Butylparaben, Propylparaben, Isobutyl araben 0,2 Bisabolol Procedure: Formulation 16 1. Heat Phase A, B, C and Phase D separately to about 70°C
2. Homogenize Phase B over a roller mill 3. Mix Phase B into Phase A and homogenize 4. Homogenize Phase C and stir into Phase A and B and homogenize at 12000 rpm 5. Dissolve Phase D and stir into combined Phase A,B and C and homogenize 6. Stir in Phase E and homogenize smoothly 7. Cool down to 40°C under stirring 8. Add Phase F and homogenize Table 17 - Formulation 17 Weight INCI - Names %
Phase A
1,5 Steareth-2 0,5 Steareth-21 3,0 Cetearyl Alcohol 0,2 Bees wax 20,0 Cetearyl Ethylhexanoate Phase B
0,3 Acrylates/Clo-C3o Alkyl Acrylate Crosspolymer ad 100 Deionized Water 0,04 Triethanolamine Phase C
5,0 Surface Treated Zinc Oxide Procedure: Formulation 17 1. Heat Phase A ingredients to 80°C
2. Stir Phase A at 11000 rpm using a homogenizer for 3 minutes 3. Mix Phase B ingredients and heat them to 80°C.
4. Add Phase C to Phase B and homogenize 5. Add Phase B/C to Phase A and homogenize 6. Cool Mixture to room temperature under gentle planetary mixing Table 18 - Formulation 18 Weight 1NCI - Names %
Phase A
3,0 Diethylamino Hydroxybenzoyl Hexyl Benzoate 2,5 Di-C12-Ci3 Allcyl Malate p,5 Tocopherylacetate 1,0 Sodium Cetearyl Sulfate 4,0 Polyglyceryl-3 Methyl Glucose Distearate 1,0 VP/Eicosene Copolymer 1,0 Glycerin 5,0 CapryliclCapric Triglyceride 3,0 Surface Treated Zinc Oxide Phase B
2,0 Hydroxyethylacrylate / sodium acrylodimethyltaurate copolymer & Squalane& Polysorbate 60 ad 100 ~ Deionized Water Procedure: Formulation 18 1. Heat Phase A and Phase B ingredients separately to 80°C
2. Stir in Phase B into Phase A and homogenize 3. Cool Mixture to room temperature under gentle planetary mixing Table 19 - Formulation 19 Weight% INCI-Names Phase A
3,0 Avobenzone 2,5 Di-C12-Ci3 Alkyl Malate 0,5 Tocopherylacetate 1,0 Sodium Cetearyl Sulfate 4,0 Polyglyceryl-3 Methyl Glucose Distearate 1,0 VP/Eicosene Copolymer 1,0 Glycerin 5,0 Caprylic/Capric Triglyceride 3,0 Surface Treated Zinc Oxide Phase B
2,0 Hydroxyethylacrylate / sodium acrylodimethyltaurate copolymer & Squalane& Polysorbate 60 ad 100 ~ Deionized Water Procedure: Formulation 19 1. Heat Phase A and Phase B ingredients separately to 80°C
2. Stir in Phase B into Phase A and homogenize 3. Cool Mixture to room temperature under gentle planetary mixing Table 20 - Formulation 20 Weight 1NCI - Names %
Phase A
8,0 Dibutyl Adipate 8,0 C12 -Cls-Alkyl Benzoate 12,0 Cocoglycerides 1,0 Sodium Cetearyl Sulfate 4,0 Lauryl Glucoside, Polyglyceryl-2 Dipolyhydroxystearate 2,0 Cetearyl Alcohol 5,0 Surface Treated Zinc Oxide 2,0 l,1-[(2,2'-Dimethylpropoxy)carbonyl]-4,4-diphenyl-1,3-butadiene Phase B
3,0 Glycerin 0,05 Disodium EDTA
0,2 Allantoin 0,3 Carbomer ad 100 Deionized Water 0,04 Triethanolamine 3,0 Potassium Cetyl Phosphate Phase C
0,5 DMDM Hydantoin Procedure: Formulation 20 1. Heat Phase A and Phase B ingredients separately to 80°C
2. Homogenize Phase A and Phase B separately 3. Add Phase B to Phase A and homogenize for 3 minutes 4. Add Phase C to Phase AB and homogenize 5. Cool Mixture 4 to room temperature under gentle planetary mixing The above examples are O/W dispersions used as sun care formulations. However the disclosed invention is not limited by these examples, may be extended to other skin care formulations containing all acceptable cosmetic ingredients for all personal care formulations.
While particular elements, embodiment, and applications of the present invention have been shown and described, it will be understood, of course, that the invention is not limited thereto since modifications may be made by those skilled in the art, particularly in light of the forgoing teachings. It is therefore contemplated by the appended claims to cover such modifications as incorporate those features which come within the spirit an scope of the invention.
Valerie Andre BASF Aktiengesellschaft Richard W. Brotzman, Jr.
Nanophase Technologies Corporation Cross-Reference to Related Patents Particulate surfaces, and in particular nanoparticle surfaces, may be surface treated by star-graft copolymers to form uniform coatings according to the methods disclosed in US
Patents 5,993,967 and 6,033,781, which are incorporated herein by reference.
Field of the Invention Modern skin care formulations must meet high standards of efficacy, skin compatibility and aesthetic appeal. It is commonly accepted that the performance of a cosmetic product is related to the entire formulation. Thus, an optimal galenic formulation that incorporated active ingredients is a necessary prerequisite to succeed in the market. The objective of topical formulations may be classified in two major areas: to modulate or assist the barrier function of the skin and to act as a delivery system for active ingredients. This patent focuses on the development of galenically interesting formulation concepts used in contemporary skin care products which combine, in particular, charged organic moieties, such as acrylate-based polymers, a- and (3-hydroxy acids, etc., and inorganic zinc oxide and titania.
The present invention relates in particular to problems encountered when particulate zinc oxide, and in particular nanoparticulate zinc oxide, is formulated with charged organic moieties, such as acrylate-based polymers, a- and ~i-hydroxy acids, etc.
Contemporary skin care formulations are dispersions. The charged organic moieties will reside in the aqueous phase of the dispersion and the inorganic ingredients, zinc oxide and titania, reside in the oil phase of the dispersion. In formulation the acrylate-based polymers, once neutralized with a cosmetically acceptable base such as triethanol amine or sodium hydroxide, extend to thicken the formulation by increasing the viscosity of the aqueous phase. Other charged organic moieties, such as a- and [3-hydroxy acids, may have other functions such as enhancing epithelial cell regeneration. However zinc ions from the particulate zinc oxide migrate from the oil phase to the aqueous phase and adversely interact with the charged organic moieties to either cause collapse of the acrylate-based polymers or the formation of organic salts with concomitant dissolution of the particulate inorganic.
Specifically excluded from the present invention are surface treatments for all inorganic, semi-metallic, and/or metallic oxide particles for all applications except (a) the products) per se, defined as surface treated Zn0 and/or Ti02 (titania), and (b) the use of the products) per' se in personal care formulations. Personal care formulations are defined as cosmetic or dermatological preparations for skin care, hair care, foot care, sun care, oral care, baby care, toiletries, color cosmetics, personal cleaning, and topical human sunscreens.
Invention The present invention relates to the formation of surface treated zinc oxide and titania particles, and in particular zinc oxide and titania nanoparticles, with a siloxane star-graft co-polymer coating, comprising a looped and/or linear polymeric structure on a star-graft copolymer coating, on a particle surface to control the interfacial surface interactions between the particle and the oil phase of the cosmetic skin formulation. The siloxane star-graft co-polymer, that may or may not contain topological loops, is formed in the "particle surface proximity" by a heterogeneous polymerization reaction. The resulting surface treatment will passivate the zinc oxide surface to prevent ion leakage and render the surface treated zinc oxide compatible with charged organic moieties, such as acrylate-based polymers and a- and (3-hydroxy acids, etc. In addition the surface treatment on zinc oxide and titania can be tailored to render the surface treated particle thermodynamically compatible with different oil phase components of a cosmetic skin formulation.
Background of the Invention The surface treatment of inorganic particles has been addressed over the years by many different techniques and chemical efforts. Some of the techniques are the application of coatings to the suxface of particles, using coupling agents on the surface of the particles, physically modifying the surface of the particles, chemically modifying the innate composition on the surface of the particles, and/or modifying the formulation to accommodate the particle - this latter is one of the least desirable methods of controlling particulate behavior in formulation as it limits formulation composition and ingredients and may alter essential formulation and product properties.
The surfaces of zinc oxide and titania have been conventionally coated by adsorption, ion exchange, and covalent bonding. Adsorption and ion exchange require the surface to have the appropriate chemical characteristics. Reactions that enable covalent bonding to particle surfaces generally involve reactions with a surface-bound hydroxyl group. These coatings are thin surface treatments which afford a degree of formulation and product compatibility and for the best available technology no particulate aggregation, but can not prevent ion migration from reactive particles or affect ultimate control of interfacial material properties.
Description of Invention The shortcomings of the existing art are overcome and additional advantages are provided through the provision of a surface treated zinc oxide and/or titania nanoparticle having a coating comprised of a star-graft siloxane copolymer to which are polymerized looped and/or linear polymer chains. Particulate surfaces, and in particular nanoparticulate surfaces, may be surface treated by siloxane star-graft copolymers to form uniform coatings according to the methods disclosed in US Patents 5,993,967 and 6,033,781 which are incorporated herein by reference. These uniform particulate surface treatments enable compatibility without particulate aggregation but they are subject to the limitations enumerated above. These star-graft copolymers may be formulated to have pendant groups that are reactive. It is to these reactive pendant groups that difunctional monomers are graft copolymerized to form looped and/or linear chains.
The star-graft copolymers may be applied to zinc oxide and/or titania particles, and in particular nanoparticles. The star-graft copolymer coatings are formed by reacting specific monomers to form a siloxane-based polymer. The surface treatment encapsulates the nanoparticulate zinc oxide and/or titania. In general, a plurality of nanoparticle zinc oxide and/or titania is surface treated with the star-graft copolymer and the surface treatment encapsulates at least a portion of the particles discretely, preferably all of the particles discretely. The star-graft copolymer, disclosed in US 5,993,967 and 6,033,781, comprises:
Si (w, x, y, z) where w, x, y, and z are the mole percent tetrafunctional, trifunctional, difunctional, and monofunctional monomeric units, respectively and wherein w, x, y, and z ranges of about 45-75, 5-25, 5-45, and 5-10, respectively.
As disclosed in US Patents 5,993,967 and 6,033,781, a star-graft copolymer, capable of coating and encapsulating nanoparticles, required a relatively large percentage of tetrafunctional monomers to yield a high degree of branching. In addition, the trifunctional monomers directed coating conformation, difunctional monomers were the linear polymer segments, and monofunctional monomers controlled the overall size Because difunctional monomers are polymerized to this star-graft polymer to form looped and/or linear polymer chains that extend from the particle surface into the solvating fluid or matrix structure, one skilled in the art would expect that a decrease the monofunctional monomer to enable the star-graft polymer surface treatment to retain functionality, and increase the difunctional monomers to form additional linear polymer segments would be yield the desired surface treatment. However to our surprise, not only was it necessary to decrease the monofunctional monomers to retain functionality on the star-graft polymer and to increase the difunctional monomers to form additional linear chains, but the present invention further requires the star-graft copolymer to have a significantly lower degree of branching, with respect to surface treatments taught in US Patents 5,993,967 and 6,033,781- this is an unexpected and surprising result.
It is these looped and/or linear polymer chains that enable surface treatments, what would otherwise be thin coatings, to extend into the application medium and control the interfacial properties of the zinc oxide and/or titanic particle.
The present invention relates to a surface treated particle comprising a plurality of zinc oxide and/or titanic particles and a star-graft copolymer with looped and/or linear polymeric structure on a star-graft copolymer encapsulating at least a portion of said particles, said surface treatment comprising:
Si (x, y) where x and y are the mole percent trifunctional and difunctional monomeric units, respectively.
In the preferred surface treated particle:
x is selected from the group of trifunctional monomers that have cosmetically acceptable non-reactive ligands comprising of methyltrimethoxysilane, n-propyltrimethoxysilane, isobutyltrimethoxysilane, n-hexyltrimethoxysilane, n-octyltrimethoxysilane, n-octadecyltrimethoxysilane, phenyltrimethoxysilane, and the triethoxy-containing counterparts of these monomers; and y is selected from the group of difunctional monomers that have cosmetically acceptable non-reactive ligands comprising of dicyclohexyldimethoxysilane, diethyldiethoxysilane, dimethyldichlorosilane, dimethyldiethoxysilane, dimethyldimethoxysilane, diphenyldiethoxysilane, diphenyldimethoxysilane, di-n-hexyldichlorosilane, n-hexylmethyldichlorosilane, methyldodecyldiethoxysilane, n-octylmethyldimethoxysilane, and the diethoxy-containing counterparts of these monomers.
In the most preferred surface treated particle:
x is selected from the group of n-octyltrimethoxysilane, n-octyltriethoxysilane, phenyltrimethoxysilane and phenyltriethoxysilane; and y is selected from the group of diphenyldiethoxysilane and diphenyldimethoxysilane.
The values of x and y in the above silicon-based polymers have ranged from 1-50 and 50-99, respectively. Preferably the values of x and y in the above silicon-based polymers have ranged from 1-40 and 60-99, respectively. Most preferably the values of x and y in the above silicon-based polymers have ranged from 10-30 and 70-90, respectively.
The surface treatment is applied to zinc oxide and/or titania particles, and in particular nanoparticles. The nanoparticle mean particle size range is from about 1 nm to about 900 nm. The preferred nanoparticle mean particle size range is from about 2 nm to about 500 nm.
The most preferred nanoparticle mean particle size range is from about 5 nm to about 100 nm.
As an alternative to processing methods disclosed in US Patents 5,993,967 and 6,033,71, the preferred method of preparing the surface treated zinc oxide and/or titania comprises mixing the particulate comprising substantially spherical nanocrystalline particles with surface treatment precursors. The siloxane star-graft copolymer, that contains loops and/or linear polymer chains, is formed in the "particle surface proximity" by a heterogeneous polymerization reaction. The mixture is carried out at a temperature, in an environment, and for a time that is effective for the star-graft copolymer to coat the nanocrystalline particle and the difunctional precursors to polymerize to form the looped and/or linear chain surface treatment morphology. Volatile by-products may be driven off as the surface treated powder is heated. The nanoparticles and the coating precursor are added in quantities effective to enable chemically passive surface treatments that prevent ion leakage and render the surface treated zinc oxide compatible with charged organic moieties, such as acrylate-based polymers, a- and (3-hydroxy acids. The amount of coating precursor used is directly related to the particle surface area or the particle size.
Detailed Description of the Invention In accordance with the principles of the present invention, a surface treatment of zinc oxide and/or titania particles, and in particular the surface treated nanoparticles, with looped and/or linear polymeric structure on a star-graft polymer coating on a particle surface and method for making the same are provided. To passivate the zinc oxide surface to prevent ion leakage and render the surface treated zinc oxide compatible with charged organic moieties, such as acrylate-based polymers, a- and (3-hydroxy acids, etc., the surface treatment contains predominantly phenyl chemistry. In addition the surface treatment on zinc oxide and titania can be tailored to render the surface treated particle thermodynamically compatible with different oil phase components of a cosmetic skin formulation, by judicious selection of non-phenyl containing precursors.
The surface treatment is applied to zinc oxide and/or titania particles, and in particular nanoparticles. The nanoparticle mean particle size range is from about 1 nm to about 900 nm. The preferred nanoparticle mean particle size range is from about 2 nm to about 500 nm.
The most preferred nanoparticle mean particle size range is from about 5 nm to about 100 nm.
The values of x and y in the above silicon-based polymers have ranged from 1-50 and 50-99, respectively. Preferably the values of x and y in the above silicon-based polymers have ranged from 1-40 and 60-99, respectively. Most preferably the values of x and y in the above silicon-based polymers have ranged from 10-30 and 70-90, respectively.
Various combinations are employed to control the branching of the siloxane backbone, the degree of looped and/or linear chains, and its chemical nature, that is, the degree of thermodynamic compatibility with specific oil phase components of a cosmetic skin formulation. Additionally the chemical nature of the difunctional monomers are selected to transform what would otherwise be thin coatings, into loops and/or linear chains that extend into the oil phase components of a cosmetic skin formulation medium.
The invention also relates to a method of protecting human skin or human hair from ultraviolet radiation comprising treating said skin or hair with an effective protecting concentration of a surface treated particle comprising a plurality of zinc oxide and/or titania particles and a star-graft copolymer with looped and/or linear polymeric structure on a star-graft copolymer encapsulating at least a portion of said particles, said surface treatment comprising:
Si (x, y) where x and y are mole percent trifunctional and difunctional monomeric units, respectively and wherein x and y are about 1-50 and 50 - 99, respectively, wherein:
x is selected from the group of trifunctional monomers that have cosmetically acceptable non-reactive ligands comprising of methyltrimethoxysilane, n-propyltrimethoxysilane, isobutyltrimethoxysilane, n-hexyltrimethoxysilane, n-octyltrimethoxysilane, n-octadecyltrimethoxysilane, phenyltrimethoxysilane, and the triethoxy-containing counterparts of these monomers;
y is selected from the group of difunctional monomers that have cosmetically acceptable non-reactive ligands comprising of dicyclohexyldimethoxysilane, diethyldiethoxysilane, dimethyldichlorosilane, dimethyldiethoxysilane, dimethyldimethoxysilane, diphenyldiethoxysilane, diphenyldimethoxysilane, di-n-hexyldichlorosilane, n-hexylmethyldichlorosilane, methyldodecyldiethoxysilane, n-octylmethyldimethoxysilane, and the diethoxy-containing counterparts of these monomers, where the products) per se, defined as surface treated Zn0 and/or Ti02, are used in personal care formulations.
In a preferred variant of the method the surface treatment comprising:
Si (x, y) wherein x and y are about 10-30 and 70-90, respectively, wherein:
x is selected from the group of n-octyltrimethoxysilane, n-octyltriethoxysilane, phenyltrimethoxysilane and phenyltriethoxysilane, and y ' is selected from the group of n-octyltrimethoxysilane, n-octyltriethoxysilane.
According to one variant of the method the said effective protecting concentration ranges between 0.1 % and 25% by weight, preferably between 0.1 % and 10%, particularly preferably between 1 % and 7%, based on the total weight of the personal care formulation.
In a preferred variant of the method the said personal care formulation comprises surface treated zinc oxide and/or titanium dioxide particles alone or together with compounds which absorb in the LTV region and are known for cosmetic and pharmaceutical preparations.
Accordingly, the present invention also relates to sunscreen-containing personal care formulations for protecting human skin or human hair from ultraviolet radiation, which comprises, in a cosmetically and pharmaceutically suitable carrier, an effective protecting concentration of a surface treated particle comprising a plurality of zinc oxide and/or titania particles and a star-graft copolymer with looped and/or linear polymeric structure on a star-graft copolymer encapsulating at least a portion of said particles, said coating polymer comprising:
Si (x,y) where x and y are the mole percent trifunctional and difunctional monomeric units, respectively, and wherein x is about 1-50 and y is about 50-99, respectively, wherein:
x is selected from the group of trifunctional monomers that have cosmetically acceptable non-reactive ligands comprising of methyltrimethoxysilane, n-propyltrimethoxysilane, isobutyltrimethoxysilane, n-hexyltrimethoxysilane, n-octyltrimethoxysilane, n-octadecyltrimethoxysilane, phenyltrimethoxysilane, and the triethoxy-containing counterparts of these monomers;
y is selected from the group of difunctional monomers that have cosmetically acceptable non-reactive ligands comprising of dicyclohexyldimethoxysilane, diethyldiethoxysilane, dimethyldichlorosilane, dimethyldiethoxysilane, dimethyldimethoxysilane, diphenyldiethoxysilane, diphenyldimethoxysilane, di-n-hexyldichlorosilane, n-hexylmethyldichlorosilane, methyldodecyldiethoxysilane, n-octylmethyldimethoxysilane, and the diethoxy-containing counterparts of these monomers.
Particular preference is given to personal care formulations wherein the said surface treatment comprising:
Si (x, y) wherein x and y are about 10-30 and 70-90, respectively, wherein:
x is selected from the group of n-octyltrimethoxysilane, n-octyltriethoxysilane, phenyltrimethoxysilane and phenyltriethoxysilane, and y is selected from the group of n-octyltrimethoxysilane, n-octyltriethoxysilane.
The cosmetic and dermatological preparations according to the invention can comprise cosmetic active ingredients, auxiliaries and/or additives, for example, coemulsifiers, fats and waxes, stabilizers, thickeners, biogenic active ingredients, film formers, fragrances, dyes, pearlizing agents, preservatives, pigments, electrolytes (e.g. magnesium sulfate) and pH
regulators.
Suitable coemulsifiers are, preferably, known W/O and also O/W emulsifiers, such as, for example, polyglycerol esters, sorbitan esters or partially esterified glycerides. Typical examples of fats are glycerides; waxes which may be mentioned are inter alia beeswax, paraffin wax or microcrystalline waxes, optionally in combination with hydrophilic waxes.
Stabilizers which may be used axe metal salts of fatty acids, such as, for example, magnesium, aluminum and/or zinc stearate. Examples of suitable thickeners are crosslinked polyacrylic acids and derivatives thereof, polysaccharides, in particular xanthan gum, guar guar, agar agar, alginates and tyloses, carboxymethylcellulose and hydroxyethylcellulose, and also fatty alcohols, monoglycerides and fatty acids, polycrylates, polyvinyl alcohol and polyvinylpyrrolidone. The term biogenic active ingredients means, for example, plant extracts, protein hydrolyzates and vitamin complexes. Customary film formers are, for example, hydrocolloids, such as chitosan, microcrystalline chitosan or quaternary chitosan, polyvinylpyrrolidone, vinylpyrrolidone/vinyl acetate copolymers, polymers of the acrylic acid series, quaternary cellulose derivatives and similar compounds. Examples of suitable preservatives are formaldehyde solution, p-hydroxybenzoate or sorbic acid.
Examples of suitable pearlizing agents are glycol distearic esters, such as ethylene glycol distearate, but also fatty acids and fatty acid monoglycol esters. Dyes which may be used are the substances suitable and approved for cosmetic purposes, as listed, for example, in the publication "I~osmetische Farbemittel" [Cosmetic Colorants] from the Farbstofflcommission der Deutschen Forschungsgemeinschaft [Dyes Commission of the German Research Council], published by Verlag Chemie, Weinheim, 1984. These dyes are usually used in a concentration of from 0.001 to 0.1 % by weight, based on the total mixture.
It is likewise advantageous to add customary antioxidants to the preparations for the purposes of the present invention. According to the invention, all antioxidants which are customary or suitable for cosmetic and dermatological applications may be used as favorable antioxidants.
The antioxidants are advantageously chosen from the group consisting of amino acids (e.g. glycine, histidine, tyrosine, tryptophan) and derivatives thereof, imidazoles (e.g.
urocanic acid) and derivatives thereof, peptides, such as D,L-carnosine, D-carnosine, L-carnosine and derivatives thereof (e.g. anserine), carotenoids, carotenes (e.g. a-carotene, f3-carotene, lycopene) and derivatives thereof, retinoids, such as, for example, retinol, retinal and/or retinoic acid and the respective esters, a-lipoic acid and derivatives thereof (e.g.
dihydrolipoic acid), aurothioglucose, propylthiouracil and other thiols (e.g.
thioredoxin, glutathione, cysteine, cystine, cystamine and the glycosyl, N-acetyl, methyl, ethyl, propyl, amyl, butyl and lauryl, palmitoyl, oleyl, y-linoleyl, cholesteryl and glyceryl esters thereof) and salts thereof, dilauryl thiodipropionate, distearyl thiodipropionate, thiodipropionic acid and derivatives thereof (esters, ethers, peptides, lipids, nucleotides, nucleosides and salts), and sulfoximine compounds (e.g. buthionine sulfoximines, homocysteine sulfoximine, buthionine sulfones, penta-, hexa-, heptathionine sulfoximine) in very low tolerated doses (e.g. pmol to ~.mol/kg), and also (metal) chelating agents (e.g. a-hydroxy fatty acids, palmitic acid, phytic acid, lactoferrin), a-hydroxy acids (e.g. citric acid, lactic acid, malefic acid), humic acid, bile acid, bile extracts, bilirubin, biliverdin, EDTA, EGTA and derivatives thereof, unsaturated fatty acids and derivatives thereof (e.g. y-linolenic acid, linoleic acid, oleic acid), folic acid and derivatives thereof, 2-aminopropionic acid diacetic acid, flavonoids, polyphenols, catechins, ubiquinone and ubiquinol and derivatives thereof, vitamin C and derivatives (e.g. ascorbyl palmitate, Mg ascorbyl phosphate, ascorbyl acetate), tocopherols and derivatives (e.g. vitamin E acetate), and coniferyl benzoate of benzoin resin, rutinic acid and derivatives thereof, ferulic acid and derivatives thereof, butylhydroxytoluene, butylhydroxyanisole, nordihydroguaiacic acid, nordihyrdoguaiaretic acid, trihydroxybutyrophenone, uric acid and derivatives thereof, mannose and derivatives thereof, zinc and derivatives thereof, (e.g. ZnO, ZnSO4), selenium and derivatives thereof (e.g.
selenomethionine), stilbene and derivatives thereof (e.g. silbene oxide, trans-stilbene oxide) and the derivatives (salts, esters, ethers, sugars, nucleotides, nucleosides, peptides and lipids) of said active ingredients which are suitable according to the invention.
The amount of antioxidants (one or more compounds) in the preparations is preferably 0.001 to 30% by weight, particularly preferably 0.05 to 20% by weight, in particular 0.1 to 10% by weight, based on the total weight of the preparation.
If vitamin E and/or derivatives thereof are the antioxidant or antioxidants, it is advantageous to choose their respective concentrations from the range 0.001 to 10% by weight, based on the total weight of the formulation.
If vitamin A and/or derivatives thereof or carotenoids are the antioxidant or antioxidants, it is advantageous to choose the respective concentration thereof from the range 0.001 to 10% by weight, based on the total weight of the formulation.
If the cosmetic or dermatological preparation for the purposes of the present invention is a solution or emulsion or dispersion, the solvents used may be:
water or aqueous solutions; oils, such as triglycerides of capric acid or of caprylic acid, but preferably castor oil; fats, waxes and other natural and synthetic fatty substances, preferably esters of fatty acids with alcohols of low carbon number, e.g. with isopropanol, propylene glycol or glycerol, or esters of fatty alcohols with alkanoic acids of low carbon number or with fatty acids; alcohols, diols or polyols of low carbon number, and ethers thereof, preferably ethanol, isopropanol, propylene glycol, glycerol, ethylene glycol, ethylene glycol monoethyl or monobutyl ether, propylene glycol monomethyl, monoethyl or monobutyl ether, diethylene glycol monomethyl or monethyl ether and analogous products.
In particular, mixtures of the above mentioned solvents are used. In the case of alcoholic solvents, water may be a further constituent.
The oil phase of the emulsions, oleogels or hydrodispersions or lipodispersions for the purposes of the present invention is advantageously chosen from the group of esters of saturated and/or unsaturated, branched and/or unbranched alkanecarboxylic acids with a chain length of from 3 to 30 carbon atoms and saturated and/or unsaturated, branched and/or unbranched alcohols with a chain length of from 3 to 30 carbon atoms, from the group of esters of aromatic carboxylic acids and saturated and/or unsaturated, branched and/or unbranched alcohols with a chain length of from 3 to 30 carbon atoms. Such ester oils can then advantageously be chosen from the group consisting of isopropyl myristate, isopropyl palmitate, isopropyl stearate, isopropyl oleate, n-butyl stearate, diisopropyl adipate, n-hexyl laurate, n-decyl oleate, glyceryl stearate, isooctyl steaxate, isononyl stearate, isononyl isononanoate, 2-ethylhexyl palmitate, 2-ethylhexyl laurate, 2-hexyldecyl stearate, 2-octyldodecyl palmitate, oleyl oleate, oleyl erucate, erucyl oleate, erucyl erucate, and synthetic, semisynthetic and natural mixtures of said esters, e.g. jojoba oil.
In addition, the oil phase can advantageously be chosen from the group of branched and unbranched hydrocarbons and hydrocarbon waxes, silicone oils, dialkyl ethers, the group of saturated or unsaturated, branched or unbranched alcohols, and fatty acid triglycerides, namely the triglycerol esters of saturated and/or unsaturated, branched and/or unbranched alkanecarboxylic acids with a chain length of from 8 to 24, in particular 12-18, carbon atoms.
The fatty acid triglycerides can, for example, be chosen advantageously from the group of synthetic, semisynthetic and natural oils, e.g. olive oil, sunflower oil, soybean oil, peanut oil, rapeseed oil, almond oil, palm oil, coconut oil, palm kernel oil and the like.
Any mixtures of such oil and wax components are also to be used advantageously for the purposes of the present invention. It may in some instances also be advantageous to use waxes, for example cetyl palmitate, as the sole lipid component of the oil phase.
The oil phase is advantageously chosen from the group consisting of 2-ethylhexyl isostearate, isohexadecane, octyldodecanol, isotridecyl isononanoate, isoeicosane, 2-ethylhexyl cocoate, C12-Cis-alkyl benzoate, caprylic/capric acid triglyceride, dicaprylyl ether.
Mixtures of C12-Cis-alkyl benzoate and 2-ethylhexyl isostearate, mixtures of C12-Cis-alkyll benzoate and isotridecyl isononanoate, and mixtures of C12-Cis-alkyl benzoate, 2-ethylhexyl isostearate and isotridecyl isononanoate are particularly advantageous.
Of the hydrocarbons, paraffin oils, squalane and squalene are to be used advantageously for the purposes of the present invention.
Advantageous oil components are also, for example, butyloctyl salicylate (for example that available under the trade name Hallbrite BHB from CP Hall), hexadecyl benzoate and butyloctyl benzoate and mixtures thereof (Hallstar AB) and/or diethylhexyl naphthalate (Hallbrite TQ).
The oil phase can also advantageously have a content of cyclic or lineax silicone oils, or consist entirely of such oils, although it is preferred to use an additional content of other oil phase components apart from the silicone oil or the silicone oils.
Advantageously, cyclomethicone (octamethylcyclotetrasiloxane) is used as silicone oil to be used according to the invention. However, other silicone oils can also be used advantageously for the purposes of the present invention, for example hexamethylcyclotrisiloxane, polydimethylsiloxane, poly(methylphenylsiloxane).
Mixtures of cyclomethicone and isotridecyl isononanoate, and of cyclomethicone and 2-ethylhexyl isostearate are also particularly advantageous.
Solid sticks comprise, for example, natural or synthetic waxes, fatty alcohols or fatty acid esters. Preference is given to using lip care sticks, and stick formulations for deodorizing the body.
Customary basic substances which are suitable for use as cosmetic sticks for the purposes of the present invention are liquid oils (e.g. paraffin oils, castor oil, isopropyl myristate), semisolid constituents (e.g. petroleum jelly, lanolin), solid constituents (e.g.
beeswax, ceresin and microcrystalline waxes and ozocerite), and high-melting waxes (e.g.
carnauba wax, candelilla wax).
Suitable propellants for cosmetic and/or dermatological preparations for the purposes of the present invention which can be sprayed from aerosol containers are the customary known readily volatile, liquefied propellants, for example hydrocarbons (propane, butane, isobutane), which can be used on their own or in a mixture with one another.
Compressed air can also be used advantageously.
The person skilled in the art is of course aware that there are propellant gases which are nontoxic per se which would in principle be suitable for realizing the present invention in the form of aerosol preparations, but which nevertheless have to be avoided due to a harmful effect on the environment or other accompanying phenomena, in particular fluorocarbons and chlorofluorocarbons (CFCs).
Cosmetic preparations for the purposes of the present invention may also be in the form of gels which, besides an effective content of active ingredient according to the invention and solvents customarily used therefore, preferably water, also comprise organic thickeners, e.g. gum arabic, xanthan gum, sodium alginate, cellulose derivatives, preferably methylcellulose, hydroxymethylcellulose, hydroxyethylcellulose, hydroxypropylcellulose, hydroxpropylmethylcellulose or inorganic thickeners, e.g. aluminum silicates, such as, for example, bentonites, or a mixture of polyethylene glycol and polyethylene glycol stearate or distearate. The thickener is present in the gel, for example, in an amount between 0.1 and 30% by weight, preferably between 0.5 and 15% by weight. The cosmetic and pharmaceutical preparations comprising light protection agents are generally based on a carrier which comprises at least one oil phase. Preparations based solely on aqueous components are, however, also possible. Accordingly, suitable preparations are oils, oil-in-water and water-in-oil emulsions, creams and pastes, lip-protection stick compositions or grease-free gels.
Gels used according to the invention usually comprise alcohols of low carbon number, e.g. ethanol, isopropanol, 1,2-propanediol, glycerol and water or an abovementioned oil in the presence of a thickener, which in the case of oily-alcoholic gels is preferably silicon dioxide or an aluminum silicate, and in the case of aqueous-alcoholic or alcoholic gels is preferably a polyacrylate.
The total proportion of auxiliaries and additives can be 1 to 80% by weight, preferably 6 to 40% by weight, and the nonaqueous proportion ("active substance") can be 20 to 80% by weight, preferably 30 to 70% by weight, based on the compositions. The compositions can be prepared in a manner known per se, i.e. for example by hot, cold, hot-hot/cold or PIT
emulsification. This is a purely mechanical process, and no chemical reaction takes place.
Such sunscreen preparations can accordingly be in liquid, paste or solid form, for example as water-in-oil creams, oil-in-water creams and lotions, aerosol foam creams, gels, oils, marking pencils, powders, sprays or alcohol-aqueous lotions.
According to the application technology requirements the surface treated particles (Zn0 and/or Ti02) can be added either to the Qil or to the aqueous phase of the cosmetic preparation.
Finally, it is possible additionally to use further substances known per se which absorb in the UV region, provided they axe stable in the overall system of the combination of UV
filters to be used according to the invention.
The majority of light protection agents in the cosmetic and pharmaceutical preparations used to protect the human epidermis consists of compounds which absorb UV
light in the UV-B region, i.e. in the range from 2~0 to 320 nm and UV-A
region, i.e. in the range from 320 to 400 nm. For example, the proportion of the UV-A absorbers to be used according to the invention is 10 to 90% by weight, preferably 20 to 50% by weight, based on the total amount of UV-B and LJV-A absorbing substances.
Suitable UV filter substances which are used in combination with the formulations to be used according to the invention are any UV-A and UV-B filter substances.
Examples which may be mentioned are:
No. Substance CAS No.
(=acid) 1 4-Aminobenzoic acid 150-13-0 2 3-(4'-Trimethylammonium)benzylidenebornan-2-one52793-97-2 methylsulfate 3 3,3,5-Trimethylcyclohexyl salicylate 11 ~-56-9 (homosalate) 4 2-Hydroxy-4~-methoxy-benzophenone 131-57-7 (oxybenzone) 2 Phenylbenzimidazole-5-sulfonic acid and 27503-81-7 its potassium, sodium and triethanolamine salts 6 3,3'-(1,4-Phenylenedimethine)-bis(7,7-dimethyl-2-90457-82-2 oxobicyclo[2.2.1]heptane-1-methanesulfonic acid) and its salts 7 Polyethoxyethyl4-bis(polyethoxy)aminobenzoate113010-52-9 8 2-Ethylhexyl4-dimethylaminobenzoate 21245-02-3 9 2-Ethylhexyl salicylate 118-60-5 2-Isoamyl4-methoxycinnamate 71617-10-2 11 2-Ethylhexyl 4-methoxycinnamate 5466-77-3 12 2-Hydroxy-4-methoxy-benzophenone-5-sulfonic 4065-45-6 acid (sulisobenzone) and the sodium salt 13 3-(4'-Sulfobenzylidene)bornan-2-one and salts58030-58-6 14 3-Benzylidenebornan-2-one 16087-24-8 1-(4'-Isopropylphenyl)-3 phenylpropane-1,3- 63260-25-9 dione 16 4-Isopropylbenzyl salicylate 94134-93-7 17 2,4,6-Trianiline(o-carbo-2'-ethylhexyl-1'-oxy)-1,3,588122-99-0 triazine 18 3-Imidazol-4-ylacrylic acid and its ethyl 104-98-3 ester 19 Ethyl2--cyano-3,3-diphenylacrylate 5232-99-5 2'-Ethylhexyl2-cyano-3,3-diphenylacrylate 6197-30~
21 Menthyl o-aminobenzoate or: 134-09-8 5-methyl-2-( 1-methylethyl)-2-aminobenzoate 22 Glyceryl p-aminobenzoate or: 136-44-7 1-glyceryl 4-aminobenzoate 23 2,2'-Dihydroxy~-methoxybenzophenone (dioxybenzone)131-53-3 24 2-Hydroxyl-methoxy-4-methylbenzophenone (mexenone)1641-17-4 Triethanolamine salicylate 2174-16-5 26 Dimethoxyphenylglyoxalic acid or: 4732-70-1 sodium 3,4-dimethoxyphenylglyoxalate 27 3-(4'Sulfobenzylidene)bornan-2-one and its 56039-58-8 salt 28 4-tert-Butyl-4'-methoxydibenzoylmethane 70356-09-1 29 2,2',4,4'-Tetrahydroxybenzophenone 131-SS-5 2,2'-Methylenebis[6(2H-benzotriazol-2 yl)-4-(1,1,3,3-103597-45-1 tetramethylbutyl)phenol]
31 2,2'-(1,4-Phenylene)-bis-1H-benzimidazole-4,6-180898-37-7 disulfonic acid, Na salt 32 2,4-bis[4-(2-Ethylhexyloxy)-2 hydroxy]phenyl-6-(4-187393-00-6 methoxyphenyl)-(1,3,5)-triazine 33 3-(4-Methylbenzylidene)camphor 36861-47-9 34 Polyethoxyethyl4-bis(polyethoxy)paraaminobenzoate113010-52-9 35 2,4-Dihydroxybenzophenone 131-56-6 36 2,2'-Dihydroxy-4,4'-dimethoxybenzophenone-5,5'-disodium3121-60-6 sulfonate 37 Benzoic acid, 2-[4-(diethylamino)-2-hydroxybenzoyl]-,302776-68-7 hexylester 38 2-(2H-Benzotriazol-2-yl)-4-methyl-6-[2-methyl-3-[1,3,3,3-155633-54-8 tetramethyl-1- [(trimethylsilyl)oxy] disiloxanyl]propyl]phenol 39 1,1-[(2,2'-Dimethylpropoxy)carbonyl]-4,4-diphenyl-1,3-363602-15-7 butadiene Polymeric or polymer-bonded filter substances can also be used according to the invention.
The cosmetic and dermatological preparations according to the invention can additionally advantageously comprise inorganic pigments based on metal oxides and/or other metal compounds which are insoluble or sparingly soluble in water, selected from the group consisting of the oxides of iron (e.g. Fe203), zirconium (Zr02), silicon (Si02), manganese (e.g. Mn0), aluminum (A1a03), cerium (e.g. Ce203), mixed oxides of the corresponding metals, and mixtures of such oxides.
For the purposes of the present invention, it is particularly advantageous, although not obligatory, for the inorganic pigments to be in coated form, i.e. to have been surface-treated.
This surface treatment may involve for example providing the pigments with a thin hydrophobic layer by a method known per se, as described in DE-A-33 14 742.
To protect human hair from UV rays, the light protection agent formulations according to the invention can be incorporated into shampoos, lotions, gels, hairsprays, aerosol foam creams or emulsions in concentrations of from 0.1 to 10% by weight, preferably to 7% by weight. The respective formulations can inter alia be used for washing, coloring and for styling hair.
The formulations to be used according to the invention are usually notable for a particularly high absorbance in the UV-A radiation region with a sharp band structure.
Moreover, they are readily soluble in cosmetic oils and can easily'be incorporated into cosmetic formulations. The emulsions prepared with the formulations are particularly notable for their high stability, the formulations I themselves are notable for their high photostability, and the preparations prepared therewith are notable for their pleasant feel on the skin.
The UV filter action of the formulations according to the invention can also be utilized for stabilizing active ingredients and auxiliaries in cosmetic and pharmaceutical formulations.
The preparations according to the invention are notable for particularly high absorbance in the UV-A radiation region with a sharp band structure and high light protection factors.
Example 1 General Batch Process for Surface Treating Zinc Oxide and/or Titania Particles The method comprises introducing zinc oxide and/or titania particles comprising a plurality of nanoparticles into a surface treatment vessel that is capable of mixing and heating its contents under a controlled environment. Example of suitable surface treatment vessels comprise a Buchi Rotovap (small scale available from Brinkrnann Instruments), V-blender (commercial scale available from Patterson-Kelley), ribbon-blender (commercial scale available from Jaygo), rotary oven (commercial scale available from Thermal Processing Solutions), and a fluidized bed (commercial scale available from Littleford Day).
a) The particles are introduced into the surface treatment vessel using methods known to those skilled in the art. Oxygen is removed from the vessel, typically by vacuum followed by inert gas flush, and the plurality of nanoparticles is mixed by methods such as, but not limited to, rotating the vessel or by rotating elements within the vessel. The particles are substantially spherical nanocrystalline nanoparticles and readily flow using standard unit operation methodologies. Particle mixing is carried out at a temperature, in an environment, and for a time that is effective at exposing particulate surface area to the environment of the surface treatment vessel enabling conditioning of the particle surface. Mixing may occur continuously, or at programmed intervals, and at a range of mixing rates. Mixing may occur at room temperature or at temperatures above or below room temperature depending on the chemistry of the surface treated particles. The degree of mixing may be used to control the bulk density of the final product - greater mixing yields a higher bulk density particulate product.
b) Particle surface conditioning comprises, but is not limited to, removing material sorbed to the particle surface, adding dopants to the particle surface, or a combination of conditioning steps. Particle surface conditioning may be accomplished by, but is not limited to, the following unit operations: vacuum treatment, plasma treatment, washing or flushing or fluidizing with a gas, fluid washing, reactive gas or fluid treatment, etc. In all instances reactive by-products and residues are removed prior to the application of surface treatment precursors.
c) Subsequent to particle surface conditioning, the particles are mixed with surface treatment precursors and heated in an environment, to a pre-determined temperature, and for a time effective for the star-graft copolymer to coat the nanocrystalline zinc oxide and/or titania particle and the difunctional precursors to polymerize to form the looped and/or linear chains on the star-graft copolymer. During surface treatment particulate mixing enables continuous surface exposure and promotes application of a uniform surface treatment to the plurality of particles. The nanoparticles and the coating precursor are added in relative quantities effective to enable a personal care application. The amount of coating precursor used is directly related to the particle surface area or the particle size.
d) Surface treatment sequences may include, but are not limited by, the followings process sequences: particle conditioning followed by surface treatment as in b) and c) above, multiple particle conditioning steps followed by surface treatment, particle conditioning followed by multiple surface treatment steps, sequential particle conditioning - surface treatment - particle conditioning - surface treatment steps, and others imagined by those skilled in the art.
e) The particles may comprise a single composition or multiple compositions.
f) Methods of introducing the surface treatment precursors may include, but are not limited by, fluid spray or vapor flow, employing any metered technique known to those skilled in the art.
g) The surface treatment precursors may be introduced as a precursor mixture, as a precursor mixture followed by a single precursor, or by sequential single precursor additions.
h) The surface treated particles are dried, if wet, cooled to room temperature, if reaction occurs at elevated temperature, and removed from the surface treatment vessel.
Example 2 Batch Process for Surface Treating Zinc Oxide The following process description is for preparing surface treated zinc oxide particles.
The surface treated zinc oxide is an active physical sunscreen ingredient for cosmetic formulations.
The product is prepared by the batch process detailed in Example 1.
a) 8-kg of zinc oxide nanoparticles, with a surface area of 14-m2/g, is weighed into a plastic bag and manually charged into a clean, 2-ft3 V-blender. Oxygen is removed by evacuating the V-blender to full vacuum level followed by vacuum relief of the V-blender with nitrogen. The evacuation and relieve cycle is repeated twice.
b) With the V-blender filled with inert gas, the V-blender is rotated at 5 RPM, and the V-blender is constantly flushed with nitrogen to condition the particles by removing sorbed materials.
c) Diphenyldimethoxysilane (168 g) and octyltriethoxysilane (42 g) monomers axe homogeneously mixed using a paddle mixer to form approximately a Si(0, 20, 80, and 0) surface treatment precursor mixture (210 g total weight).
d) Subsequent to particle surface conditioning, the surface treatment precursor mixture is introduced into the V-blender through a nozzle by inert pressure displacement and sprayed on the particles as the particles are mixing at room temperature. The temperature continues to ramp to 105 to.115°C. Particle mixing and vapor-phase transport enable surface treatment precursors to wet the particles and react to coat the nanocrystalline zinc oxide. The temperature is maintained at 105 to 115°C for 1-hour.
e) The surface treated zinc oxide is dried by pulling a vacuum, while purging the vessel with inert gas, N2, on the surface treatment vessel. Vacuum removes un-reacted surface treatment precursors and reaction by-products. At the same time the temperature of the vessel is cooled to room temperature. The surface treated zinc oxide is removed from the vessel at room temperature.
The surface treatment on the zinc oxide product, when added to cosmetic formulation, prevents ion leakage and renders the surface treated zinc oxide compatible with charged organic moieties, such as acrylate-based polymers, a- and (3-hydroxy acids. No other known commercial product or known surface treatment on zinc oxide particles enables the observed chemically passive behavior.
The above batch process may be scaled to surface treat larger amounts of particles or rendered continuous, as will be recognized by persons skilled in the art, by employing continuous mixing and heating equipment and appropriate process modifications.
.
Example 3 Specific Surface Treatment Examples 1) Physical sunscreen ingredients - Si(20, 80) / octyltriethoxysilane, diphenyldimethoxysilane; 4.3 wt% surface treatment precursor mixture applied to Zn0 (23 m2lg).
2) Physical sunscreen ingredients - Si(20, 80) / octyltriethoxysilane, diphenyldimethoxysilane; approximately 9.4 wt% surface treatment precursor mixture applied to Ti02 (50 ma/g).
Example 4 - Cosmetic Formulations Surface treated zinc oxide nanoparticles, produced by methods disclosed above, were incorporated into the oil in water formulations given in Tables 1-20 using the procedure following each respective table.
Table 1- Formulation 1 Weight INCI - Names %
Phase A
1,5 Steareth-2 0,5 Steareth-21 3,0 Cetearyl Alcohol 0,2 Bees wax 20,0 Cetearyl Ethylhexanoate 5,0 Surface Treated Zinc Oxide Phase B
0,3 Acrylates/Clo-C3o Alkyl Acrylate Crosspolymer ad 100 Deionized Water 0,04 Triethanolamine Procedure: Formulation 1 1. Heat Phase A ingredients to 80°C
2. Stir Phase A at 11000 rpm using a homogenizer for 3 minutes 3. Mix Phase B ingredients and heat them to 80°C.
4. Add Phase B to Phase A to form Mixture 1 5. Stir Mixture 1 at 11000 rpm using a homogenizer for 30sec-lmin 6. Cool Mixture 1 to room temperature under gentle planetary mixing 7. Stir Mixture 1 at 11000 rpm using a homogenizer for 30sec-lmin Table 2 - Formulation 2 Weight % 1NCI - Names Phase A
1,5 Steareth-2 0,5 Steareth-21 3,0 Cetearyl Alcohol 0,2 Bees wax 20,0 Cetearyl Ethylhexanoate 5,0 Surface Treated Zinc Oxide Phase B
0,2 Acrylates/C10-30 Alkyl Acrylate Cross olymer 45,77 Deionized Water 0,04 Triethanolamine Phase C
0,1 Acrylates/Acrylamide Copolymer, Mineral Oil, Polysorbate 85, Triethanolamine 22,88 ~ Deionized Water Procedure: Formulation 2 1. Heat Phase A ingredients to 80°C
2. Stir Phase A at 15000 rpm using a homogenizer for 3 minutes 3. Mix Phase B ingredient and heat them to 80°C
4. Mix Phase C ingredients and heat them to 80°C
5. Mix Phase B and Phase C to form Mixture 1 6. Add Mixture 1 to Phase A to form Mixture 2.
7. Stir Mixture 2 at 11000 rpm using a homogenizer for 30sec-lmin 8. Cool Mixtuxe 2 to room temperature under gentle planetary mixing 9. Stir Mixture 1 at 11000 rpm using a homogenizer for 30sec-lmin Table 3 - Formulation 3 Weight % INCI - Names Phase A
8,0 Dibutyl Adipate 8,0 Cla-C15 Alkyl Benzoate 12,0 Cocoglycerides 1,0 Sodium Cetearyl Sulfate 4,0 Lauryl Glucoside and Polyglyceryl-2 Dipolyhydroxystearate and Glycerin 2,0 Ceteraryl Alcohol 5,0 Surface Treated Zinc Oxide Phase B
3,0 Glycerin 0,05 pisodium EDTA
0,2 Allantoin 0,3 Carbomer ad 100 Demineralized Water 0,04 Triethanolamine Phase C
0,5 DMDM Hydantoin Procedure: Formulation 3 1. Heat Phase A ingredients to 80°C
2. Stir Phase A at 11000 rpm using a homogenizer for 3 minutes 3. Mix Phase B ingredients and heat them to 80°C
4. Mix Phase B and Phase A to form Mixture 1 5. Stir Mixture 1 at 11000 rpm using a homogenizer for 30sec-lmin 6. Cool Mixture 1 to room temperature under gentle planetary mixing.
7. Mix Phase C to Mixture 1 at 11000 rpm using a homogenizer for 30sec-1 min Table 4 - Formulation 4 INCI - Names Phase A
7,50 Ethylhexyl Methoxycinnamate 1,50 Polysorbate 20 3,00 Sodium Lauryl Lactylate 1,00 PEG - 40 Hydrogenated Castor Oil 1,00 Butyrospermum Parlcii (Shea Butter) 6,50 Cia-Cis Alkyl Benzoate Phase B
5,00 Surface Treated Zinc Oxide Phase C
4,00 Glycerin 1,00 Panthenol, Propylene Glycol 0,30 Xanthan gum . .
0,10 Disodium EDTA
2,00 Urea 2,00 Hydroxyethyl Acrylate/Sodium Acryloyldimethyl Taurate Copolymer, Squalane, Polysorbate 60 ad 100 l~emineralized Water Phase D
0,50 ~,actic acid 0,50 Phenoxyethanol, Methylparaben, Butylparaben, F~thylparaben, Pro ylparaben, Isobutylparaben Procedure: Formulation 4 1. Heat Phase A ingredients to 80°C
2. Add Phase B with Phase A and mix to form Mixture 1 using a homogenizer at 15000 rpm for 3 minutes 3. Mix Fhase C ingredients and heat them to 80°C
4. Mix Mixture 1 and Phase C to form Mixture 2 using a homogenizer at 11000 rpm for 3 minutes 5. Add Phase D ingredients to Mixture 2 to form Mixture 3 using a homogenizer at 11p00 rpm 30sec-lmin 6. Cool Mixture 3 to room temperature under gentle planetary mixing 7. Stir Mixture 1 at 11000 rpm using a homogenizer for 30sec-lmin Table 5 - Formulation 5 Weight % INCI - Names Phase A
1,00 ' Ceteareth - 25 2,00 Ceteareth - 6, Stearyl Alcohol 2,00 PEG -14 Dimethicone 3,60 Cetearyl Alcohol 6,00 Ethylhexyl Methoxycinnamate 2,00 Dibutyl Adipate 5,00 Surface Treated Zinc Oxide Phase B
1,00 Panthenol 5,00 Glycerin ad100 Demineralized Water Phase C
4,00 Caprylic/Capric Tri lyceride, Sodium Acrylates Copolymer Phase D
0,50 Phenoxyethanol, Methylparaben, Butylparaben, Ethylparaben, Propylparaben, Isobutylparaben Procedure: Formulation 5 1. Heat Phase A ingredients to 80°C
2. Stir Phase A at 11000 rpm using a homogenizes for 3 minutes 3. Heat Phase B ingredients to 80°C
4. Add Phase B with Phase A and mix to form Mixture 1 using a homogenizes at 11000 rpm for 30sec-lminute.
5. Mix Phase C to Mixture 1 to form Mixture 2 using a homogenizes at 11000rpm for 30 sec-lminute 6. Add Phase D ingredients to Mixture 2 while cooling to room temperature under gentle planetary mixing 7. Stir Mixture 1 at 11000 rpm using a homogenizes for 30sec-lmin Table 6 - Formulation 6 Weight % INCI - Names Phase A
3,0 Steareth-21 2,0 Cetearyl Alcohol 6,0 Ethylhexyl Methoxycinnamate 2,0 C12-Cis-Alkyl Benzoate 5,0 Surface Treated Zinc Oxide 3,0 VP/Eicosene Copolymer Phase B
5,0 Glycerin 2,0 Hydroxyethyl Acrylates/Sodium Acryloyl ad 100 Deionized Water 3,0 Potassium Cetyl Phos hate 0,1 Disodium EDTA
Phase C
0,5 Phenoxyethanol, Methylparaben, Ethylparaben, I Butylparaben, Pro ylparaben Procedure: Formulation 6 1. Heat Phase A and Phase B ingredients separately to 80°C
2. Homogenize Phase A and Phase B separately 3. Add Phase B to Phase A and homogenize for 3 minutes 4. Add Phase C to Phase A/B and homogenize S. Cool Mixture 4 to room temperature under gentle planetary mixing Table 7 - Formulation 7' Weight INCI - Names %
Phase A
3,0 Steareth-21 2,0 Cetearyl Alcohol 6,0 Ethylhexyl Methoxycinnamate 2,0 C12-Cis-Alkyl Benzoate 5,0 Surface Treated Zinc Oxide 3,0 VP/Eicosene Copolymer Phase B
5,0 Glycerin 2,0 Acrylates/Clo-C3o Alkylacrylate Crosspolymer ad 100 Deionized Water 0,04 Triethanolamine 3,0 Potassium Cetyl Phosphate 0,1 Disodium EDTA
Phase C
0,5 Phenoxyethanol, Methylparaben, Ethylparaben, Butylparaben, Propylparaben Procedure: Formulation 7 1. Heat Phase A and Phase B ingredients separately to 80°C
2. Homogenize Phase A and Phase B separately 3. Add Phase B to Phase A and homogenize for 3 minutes 4. Add Phase C to Phase A/B and homogenize 5. Cool Mixture 4 to room temperature under gentle planetary mixing Table 8 - Formulation 8 Weight INCI - Names %
Phase A
3,0 Steareth-21 2,0 Cetearyl Alcohol 6,0 Ethylhexyl Methoxycinnamate 2,0 Isohexadecane 3,0 Surface Treated Zinc Oxide 3,0 VP/Eicosene Copolymer Phase B
5,0 Glycerin 0.3 Acrylates/Clo-C3o Alkylacrylate Cross olymer ad 100 Deionized Water 0,06 Triethanolamine 3,0 Potassium Cetyl Phosphate 0,1 Disodium EDTA
Phase C
0,5 Phenoxyethanol, Methylparaben, Ethylparaben, Butylparaben, Propylparaben Procedure: Formulation 8 1. Heat Phase A and Phase B ingredients separately to 80°C
2. Homogenize Phase A and Phase B separately 3. Add Phase B to Phase A and homogenize for 3 minutes 4. Add Phase C to Phase A/B and homogenize S. Cool Mixture 4 to room temperature under gentle planetary mixing Table 9 - Formulation 9 Weight INCI - Names %
Phase A
8,0 Dibutyl Adipate 8,0 C12-Cls-Alkyl Benzoate 12,0 Cocoglycerides 1,0 Sodium Cetearyl Sulfate 4,0 Lauryl Glucoside, Polyglyceryl-2 Dipolyhydroxystearate 2,0 Cetearyl Sulfate 5,0 Surface Treated Zinc Oxide Phase B
3,0 Glycerin 0,05 Disodium EDTA
0,2 Allantoin 0,3 Carbomer ad 100 Deionized Water 0,04 Triethanolamine 3,0 Potassium Cetyl Phosphate Phase C
0,5 DMDM Hydantoin Procedure: Formulation 9 1. Heat Phase A and Phase B ingredients separately to 80°C
2. Homogenize Phase A and Phase B separately 3. Add Phase B to Phase A and homogenize for 3 minutes 4. Add Phase C to Phase A/B and homogenize 5. Cool Mixture 4 to room temperature under gentle planetary mixing Table 10 - Formulation 10 Weight INCI - Names %
Phase A
8,0 Dibutyl Adipate 8,0 C12 -Cls-Alkyl Benzoate 12,0 Cocoglycerides 1,0 Sodium Cetearyl Sulfate 4,p Lauryl Glucoside, Polyglyceryl-2 Dipolyhydroxystearate 2,0 Cetearyl Alcohol 5,0 Surface Treated Zinc Oxide 2,0 Ethylhexyl Triazone Phase B
3,0 Glycerin 0,05 Disodium EDTA
0,2 Allantoin 0,3 Carbomer ad 100 Deionized Water 0,04 Triethanolamine 3,4 Potassium Cetyl Phosphate Phase C
0,5 DMDM Hydantoin Procedure: Formulation 10 1. Heat Phase A and Phase B ingredients separately to 80°C
2. Homogenize Phase A and Phase B separately 3. Add Phase B to Phase A and homogenize for 3 minutes 4. Add Phase C to Phase A/B and homogenize 5. Cool Mixture 4 to room temperature under gentle planetary mixing Table 11- Formulation 11 Weight INCI - Names %
Phase A
3,0 Steareth-21 2,0 Cetearyl Alcohol 3,0 Ethylhexyl Methoxycinnamate 3,0 Octocrylene 2,0 C12-Cls-Alkyl Benzoate 5,0 Surface Treated Zinc Oxide 3,0 VP/Eicosene Copolymer Phase B
5,0 Glycerin 2,0 Acrylates/Clo-C3o Alkylacrylate Cross olymer ad 100 Deionized Water 0,04 Triethanolamine 3,0 Potassium Cetyl Phosphate 0,1 Disodium EDTA
Phase C
0,5 Phenoxyethanol, Methylparaben, Ethylparaben, Butyl araben, Propyl araben Procedure: Formulation 11 1. Heat Phase A and Phase B ingredients separately to 80°C
2. Homogenize Phase A and Phase B separately 3. Add Phase B to Phase A and homogenize for 3 minutes 4. Add Phase C to Phase AB and homogenize 5. Cool Mixture 4 to room temperature under gentle planetary mixing Table 12 - Formulation 12 Weight INCI - Names %
Phase A
3,0 Steareth-21 2,0 Cetearyl Alcohol 4,0 Ethylhexyl Methoxycinnamate 2,0 2-(4-Ethoxy-anilinomethylene)-propanedioic acid diethyl ester 2,0 Ci2-Cis-Alkyl Benzoate 5,0 Surface Treated Zinc Oxide 3,0 VPIEicosene Copolymer Phase B
5,0 Glycerin 2,0 AcrylateslClo-C3o Alkylacrylate Crosspolymer .
ad 100 Deionized Water 0,04 Triethanolamine 3,0 Potassium Cetyl Phosphate 0,1 Disodium EDTA
Phase C
0,5 Phenoxyethanol, Methylparaben, Ethylparaben, Butyl araben, Propylparaben Procedure: Formulation 12 1. Heat Phase A and Phase B ingredients separately to 80°C
2. Homogenize Phase A and Phase B separately 3. Add Phase B to Phase A and homogenize for 3 minutes 4.' Add Phase C to Phase A/B and homogenize 5. Cool Mixture 4 to room temperature under gentle planetary mixing Table 13 - Formulation 13 Weight % INCI - Names Phase A
3,0 Steareth-21 2,0 Cetearyl Alcohol 4,0 Ethylhexyl Methoxycinnamate 2,0 Drometrizole Trisiloxane 2,0 Cia -Cis-Alkyl Benzoate 5,0 Surface Treated Zinc Oxide 3,0 VP/Eicosene Co olymer Phase B
5,0 Glycerin 2,0 Acrylates/Clo-C3o Alkylacrylate Crosspolymer ad 1 Qp IDeionized Water O,Q4 Triethanolamine 3,0 Potassium Cetyl Phos hate 4,1 Disodium EDTA
Phase C
Q,5 Phenoxyethanol, Methylparaben, Ethylparaben, Butylparaben, Pro y1 araben _ Procedure: Formulation 13 1. Heat Phase A and Phase $ ingredients separately to SQ°C
2. Homogenize Phase A and Phase B separately 3. Add Phase B t9 Phase A and homogenize for 3 minutes 4. Add Phase C to Phase A/$ and homogenize 5. Cool Mixture 4 to room temperature under gentle planetary mixing Table 14 - Formulation 14 Weight INCI - Names %
Phase A
3,0 Ethylhexyl Methoxycinnamate 1,0 Diethylamino Hydroxybenzoyl Hexyl Benzoate 3,0 Cia-Cis-Alkyl Benzoate 0,5 Bees wax 3,0 Ceteareth-6, Stearyl Alcohol 1,0 Cetearyth-25 3,0 Cetearyl Alcohol 5,0 Caprylic/Capric Triglyceride 3,0 Surface Treated Zinc Oxide 2,0 Surface Treated Titanium Dioxide Phase B
2,0 Hydroxyethylacrylate l sodium acrylodimethyltaurate copolymer & Squalane& Polysorbate 60 ad 100 Deionized Water Phase C
0,5 Benzyl Alcohol, Methylchloroisothiazolinone, Methylisothiazolinone Procedure: Formulation 14 1. Heat Phase A and Phase B separately to about 80°C
2. Homogenize Phase A and Phase B at 11000 rpm using a homogenizer for 3 minutes 3. Stir Phase B into Phase A and homogenize 4. Cool Mixture 3 to room temperature under gentle planetary mixing 5. Stir in Phase C and homogenize Table 15 - Formulation 15 Weight INCI - Names %
Phase A
3,0 Ethylhexyl Methoxycinnamate 1,0 Diethylamino Hydroxybenzoyl Hexyl Benzoate 3,0 Cia -Cis-Alkyl Benzoate 0,5 Bees wax 3,0 Ceteareth-6, Stearyl Alcohol 1,0 Cetearyth-25 3,0 Cetearyl Alcohol 5,0 Isohexadecane 3,0 Surface Treated Zinc Oxide 2,0 Surface Treated Titanium Dioxide Phase B
0,3 Carbomer 0,04 Triethanolamine ad 100 Deionized Water Phase C
0,5 Benzyl Alcohol, Methylchloroisothiazolinone, Methylisothiazolinone Procedure: Formulation 15 1. Heat Phase A and Phase B separately to about 80°C
2. Homogenize Phase A and Phase B at 11000 rpm using a homogenizer for 3 minutes 3. Stir Phase B into Phase A and homogenize 4. Cool Mixture 3 to room temperature under gentle planetary mixing 5. Stir in Phase C and homogenize Table 16 - Formulation 16 Weight 1NCI - Names %
Phase A
4,0 Glyceryl Stearate, PEG-100 Stearate 3,0 Ethylhexyl Methoxycinnamate 1,0 Diethylamino Hydroxybenzoyl Hexyl Benzoate 0,5 Lecithin 0,5 Polyglyceryl Dimer Soyate Phase B
0,25 Iron Oxides Braun 70 E 172 2,25 Trimethylolpropane Triisostearate Phase C
5,5 Cyclopentasiloxane, Cyclohexasiloxane 4,0 Ethylhexyl Palmitate 1,5 Simmondsia Chinensis (Jojoba) Seed Oil 2,0 Propylene Glycol Dicaprylate/Dicaprate 1,5 Sweet Almond (Prunus Amygdalus Dulcis) Oil 5,0 Surface Treated Titanium Dioxide 0,5 Tocopheryl Acetate 1,0 Butyros ermum Parkii (Shea Butter) 0,5 Polyglyceryl-2 Dipolyhydroxystearate Phase D
5,0 Propylene Glicol 0,5 Poloxamer 188 0,1 Disodium EDTA
ad 100 Deionized Water Phase E
2,00 Hydroxyethylacrylate / sodium acrylodimethyltaurate copolymer & Squalane& Polysorbate 60 Phase F
1,0 Phenonip, Phenoxyethanol, Methylpaxaben, Ethylparaben, Butylparaben, Propylparaben, Isobutyl araben 0,2 Bisabolol Procedure: Formulation 16 1. Heat Phase A, B, C and Phase D separately to about 70°C
2. Homogenize Phase B over a roller mill 3. Mix Phase B into Phase A and homogenize 4. Homogenize Phase C and stir into Phase A and B and homogenize at 12000 rpm 5. Dissolve Phase D and stir into combined Phase A,B and C and homogenize 6. Stir in Phase E and homogenize smoothly 7. Cool down to 40°C under stirring 8. Add Phase F and homogenize Table 17 - Formulation 17 Weight INCI - Names %
Phase A
1,5 Steareth-2 0,5 Steareth-21 3,0 Cetearyl Alcohol 0,2 Bees wax 20,0 Cetearyl Ethylhexanoate Phase B
0,3 Acrylates/Clo-C3o Alkyl Acrylate Crosspolymer ad 100 Deionized Water 0,04 Triethanolamine Phase C
5,0 Surface Treated Zinc Oxide Procedure: Formulation 17 1. Heat Phase A ingredients to 80°C
2. Stir Phase A at 11000 rpm using a homogenizer for 3 minutes 3. Mix Phase B ingredients and heat them to 80°C.
4. Add Phase C to Phase B and homogenize 5. Add Phase B/C to Phase A and homogenize 6. Cool Mixture to room temperature under gentle planetary mixing Table 18 - Formulation 18 Weight 1NCI - Names %
Phase A
3,0 Diethylamino Hydroxybenzoyl Hexyl Benzoate 2,5 Di-C12-Ci3 Allcyl Malate p,5 Tocopherylacetate 1,0 Sodium Cetearyl Sulfate 4,0 Polyglyceryl-3 Methyl Glucose Distearate 1,0 VP/Eicosene Copolymer 1,0 Glycerin 5,0 CapryliclCapric Triglyceride 3,0 Surface Treated Zinc Oxide Phase B
2,0 Hydroxyethylacrylate / sodium acrylodimethyltaurate copolymer & Squalane& Polysorbate 60 ad 100 ~ Deionized Water Procedure: Formulation 18 1. Heat Phase A and Phase B ingredients separately to 80°C
2. Stir in Phase B into Phase A and homogenize 3. Cool Mixture to room temperature under gentle planetary mixing Table 19 - Formulation 19 Weight% INCI-Names Phase A
3,0 Avobenzone 2,5 Di-C12-Ci3 Alkyl Malate 0,5 Tocopherylacetate 1,0 Sodium Cetearyl Sulfate 4,0 Polyglyceryl-3 Methyl Glucose Distearate 1,0 VP/Eicosene Copolymer 1,0 Glycerin 5,0 Caprylic/Capric Triglyceride 3,0 Surface Treated Zinc Oxide Phase B
2,0 Hydroxyethylacrylate / sodium acrylodimethyltaurate copolymer & Squalane& Polysorbate 60 ad 100 ~ Deionized Water Procedure: Formulation 19 1. Heat Phase A and Phase B ingredients separately to 80°C
2. Stir in Phase B into Phase A and homogenize 3. Cool Mixture to room temperature under gentle planetary mixing Table 20 - Formulation 20 Weight 1NCI - Names %
Phase A
8,0 Dibutyl Adipate 8,0 C12 -Cls-Alkyl Benzoate 12,0 Cocoglycerides 1,0 Sodium Cetearyl Sulfate 4,0 Lauryl Glucoside, Polyglyceryl-2 Dipolyhydroxystearate 2,0 Cetearyl Alcohol 5,0 Surface Treated Zinc Oxide 2,0 l,1-[(2,2'-Dimethylpropoxy)carbonyl]-4,4-diphenyl-1,3-butadiene Phase B
3,0 Glycerin 0,05 Disodium EDTA
0,2 Allantoin 0,3 Carbomer ad 100 Deionized Water 0,04 Triethanolamine 3,0 Potassium Cetyl Phosphate Phase C
0,5 DMDM Hydantoin Procedure: Formulation 20 1. Heat Phase A and Phase B ingredients separately to 80°C
2. Homogenize Phase A and Phase B separately 3. Add Phase B to Phase A and homogenize for 3 minutes 4. Add Phase C to Phase AB and homogenize 5. Cool Mixture 4 to room temperature under gentle planetary mixing The above examples are O/W dispersions used as sun care formulations. However the disclosed invention is not limited by these examples, may be extended to other skin care formulations containing all acceptable cosmetic ingredients for all personal care formulations.
While particular elements, embodiment, and applications of the present invention have been shown and described, it will be understood, of course, that the invention is not limited thereto since modifications may be made by those skilled in the art, particularly in light of the forgoing teachings. It is therefore contemplated by the appended claims to cover such modifications as incorporate those features which come within the spirit an scope of the invention.
Claims (14)
1. A method of protecting human skin or human hair from ultraviolet radiation comprising treating said skin or hair with an effective protecting concentration of a surface treated particle comprising a plurality of zinc oxide and/or titania particles and a star-graft copolymer with looped and/or linear polymeric structure on a star-graft copolymer encapsulating at least a portion of said particles, said surface treatment comprising:
Si (x, y) where x and y are mole percent trifunctional and difunctional monomeric units, respectively and wherein x and y are about 1-50 and 50-99, respectively, wherein:
x is selected from the group of trifunctional monomers that have cosmetically acceptable non-reactive ligands comprising of methyltrimethoxysilane, n-propyltrimethoxysilane, isobutyltrimethoxysilane, n-hexyltrimethoxysilane, n-octyltrimethoxysilane, n-octadecyltrimethoxysilane, phenyltrimethoxysilane, and the triethoxy-containing counterparts of these monomers;
y is selected from the group of difunctional monomers that have cosmetically acceptable non-reactive ligands comprising of dicyclohexyldimethoxysilane, diethyldiethoxysilane, dimethyldichlorosilane, dimethyldiethoxysilane, dimethyldimethoxysilane, diphenyldiethoxysilane, diphenyldimethoxysilane, di-n-hexyldichlorosilane, n-hexylmethyldichlorosilane, methyldodecyldiethoxysilane, n-octylmethyldimethoxysilane, and the diethoxy-containing counterparts of these monomers, where the product(s) per se, defined as surface treated ZnO and/or TiO2, are used in personal care formulations.
Si (x, y) where x and y are mole percent trifunctional and difunctional monomeric units, respectively and wherein x and y are about 1-50 and 50-99, respectively, wherein:
x is selected from the group of trifunctional monomers that have cosmetically acceptable non-reactive ligands comprising of methyltrimethoxysilane, n-propyltrimethoxysilane, isobutyltrimethoxysilane, n-hexyltrimethoxysilane, n-octyltrimethoxysilane, n-octadecyltrimethoxysilane, phenyltrimethoxysilane, and the triethoxy-containing counterparts of these monomers;
y is selected from the group of difunctional monomers that have cosmetically acceptable non-reactive ligands comprising of dicyclohexyldimethoxysilane, diethyldiethoxysilane, dimethyldichlorosilane, dimethyldiethoxysilane, dimethyldimethoxysilane, diphenyldiethoxysilane, diphenyldimethoxysilane, di-n-hexyldichlorosilane, n-hexylmethyldichlorosilane, methyldodecyldiethoxysilane, n-octylmethyldimethoxysilane, and the diethoxy-containing counterparts of these monomers, where the product(s) per se, defined as surface treated ZnO and/or TiO2, are used in personal care formulations.
2. The method according to claim 1, wherein said surface treatment comprising:
Si (x, y) wherein x and y are about 10-30 and 70-90, respectively, wherein:
x is selected from the group of n-octyltrimethoxysilane, n-octyltriethoxysilane, phenyltrimethoxysilane and phenyltriethoxysilane, and y is selected from the group of n-octyltrimethoxysilane, n-octyltriethoxysilane.
Si (x, y) wherein x and y are about 10-30 and 70-90, respectively, wherein:
x is selected from the group of n-octyltrimethoxysilane, n-octyltriethoxysilane, phenyltrimethoxysilane and phenyltriethoxysilane, and y is selected from the group of n-octyltrimethoxysilane, n-octyltriethoxysilane.
3. The method according to claims 1, wherein said effective protecting concentration ranges between 0.1% and 25% by weight, based on the total weight of the personal care formulation.
4. The method according to claim 1, wherein said personal care formulation comprises surface treated zinc oxide and/or titanium dioxide particles alone or together with compounds which absorb in the UV region and are known for cosmetic and pharmaceutical preparations.
5. A sunscreen-containing personal care formulation for protecting human skin or human hair from ultraviolet radiation, which comprises, in a cosmetically and pharmaceutically suitable carrier, an effective protecting concentration of a surface treated particle comprising a plurality of zinc oxide and/or titania particles and a star-graft copolymer with looped and/or linear polymeric structure on a star-graft copolymer encapsulating at least a portion of said particles, said coating polymer comprising:
Si (x,y) where x and y are the mole percent trifunctional and difunctional monomeric units, respectively, and wherein x is about 1-50 and y is about 50-99, respectively, wherein:
x is selected from the group of trifunctional monomers that have cosmetically acceptable non-reactive ligands comprising of methyltrimethoxysilane, n-propyltrimethoxysilane, isobutyltrimethoxysilane, n-hexyltrimethoxysilane, n-octyltrimethoxysilane, n-octadecyltrimethoxysilane, phenyltrimethoxysilane, and the triethoxy-containing counterparts of these monomers;
y is selected from the group of difunctional monomers that have cosmetically acceptable non-reactive ligands comprising of dicyclohexyldimethoxysilane, diethyldiethoxysilane, dimethyldichlorosilane, dimethyldiethoxysilane, dimethyldimethoxysilane, diphenyldiethoxysilane, diphenyldimethoxysilane, di-n-hexyldichlorosilane, n-hexylmethyldichlorosilane, methyldodecyldiethoxysilane, n-octylmethyldimethoxysilane, and the diethoxy-containing counterparts of these monomers.
Si (x,y) where x and y are the mole percent trifunctional and difunctional monomeric units, respectively, and wherein x is about 1-50 and y is about 50-99, respectively, wherein:
x is selected from the group of trifunctional monomers that have cosmetically acceptable non-reactive ligands comprising of methyltrimethoxysilane, n-propyltrimethoxysilane, isobutyltrimethoxysilane, n-hexyltrimethoxysilane, n-octyltrimethoxysilane, n-octadecyltrimethoxysilane, phenyltrimethoxysilane, and the triethoxy-containing counterparts of these monomers;
y is selected from the group of difunctional monomers that have cosmetically acceptable non-reactive ligands comprising of dicyclohexyldimethoxysilane, diethyldiethoxysilane, dimethyldichlorosilane, dimethyldiethoxysilane, dimethyldimethoxysilane, diphenyldiethoxysilane, diphenyldimethoxysilane, di-n-hexyldichlorosilane, n-hexylmethyldichlorosilane, methyldodecyldiethoxysilane, n-octylmethyldimethoxysilane, and the diethoxy-containing counterparts of these monomers.
6. The personal care formulation according to claim 5, wherein said surface treatment comprising:
Si (x, y) wherein x and y are about 10-30 and 70-90, respectively, wherein:
x is selected from the group of n-octyltrimethoxysilane, n-octyltriethoxysilane, phenyltrimethoxysilane and phenyltriethoxysilane, and y is selected from the group of n-octyltrimethoxysilane, n-octyltriethoxysilane.
Si (x, y) wherein x and y are about 10-30 and 70-90, respectively, wherein:
x is selected from the group of n-octyltrimethoxysilane, n-octyltriethoxysilane, phenyltrimethoxysilane and phenyltriethoxysilane, and y is selected from the group of n-octyltrimethoxysilane, n-octyltriethoxysilane.
7. A surface treated particle comprising a plurality of zinc oxide and/or titania particles and a star-graft copolymer with looped and/or linear polymeric structure on a star-graft copolymer encapsulating at least a portion of said particles, said surface treatment comprising:
Si (x, y) where x and y are mole percent trifunctional and difunctional monomeric units, respectively and wherein x and y are about 1-50 and 50-99, respectively, wherein:
x is selected from the group of trifunctional monomers that have cosmetically acceptable non-reactive ligands comprising of methyltrimethoxysilane, n-propyltrimethoxysilane, isobutyltrimethoxysilane, n-hexyltrimethoxysilane, n-octyltrimethoxysilane, n-octadecyltrimethoxysilane, phenyltrimethoxysilane, and the triethoxy-containing counterparts of these monomers;
y is selected from the group of difunctional monomers that have cosmetically acceptable non-reactive ligands comprising of dicyclohexyldimethoxysilane, diethyldiethoxysilane, dimethyldichlorosilane, dimethyldiethoxysilane, dimethyldimethoxysilane, diphenyldiethoxysilane, diphenyldimethoxysilane, di-n-hexyldichlorosilane, n-hexylmethyldichlorosilane, methyldodecyldiethoxysilane, n-octylmethyldimethoxysilane, and the diethoxy-containing counterparts of these monomers.
Si (x, y) where x and y are mole percent trifunctional and difunctional monomeric units, respectively and wherein x and y are about 1-50 and 50-99, respectively, wherein:
x is selected from the group of trifunctional monomers that have cosmetically acceptable non-reactive ligands comprising of methyltrimethoxysilane, n-propyltrimethoxysilane, isobutyltrimethoxysilane, n-hexyltrimethoxysilane, n-octyltrimethoxysilane, n-octadecyltrimethoxysilane, phenyltrimethoxysilane, and the triethoxy-containing counterparts of these monomers;
y is selected from the group of difunctional monomers that have cosmetically acceptable non-reactive ligands comprising of dicyclohexyldimethoxysilane, diethyldiethoxysilane, dimethyldichlorosilane, dimethyldiethoxysilane, dimethyldimethoxysilane, diphenyldiethoxysilane, diphenyldimethoxysilane, di-n-hexyldichlorosilane, n-hexylmethyldichlorosilane, methyldodecyldiethoxysilane, n-octylmethyldimethoxysilane, and the diethoxy-containing counterparts of these monomers.
8. The surface treated zinc oxide and/or titania particle according to claim 7, wherein said surface treatment comprising:
Si (x, y) wherein x and y are about 10-30 and 70-90, respectively, wherein:
x is selected from the group of n-octyltrimethoxysilane, n-octyltriethoxysilane, phenyltrimethoxysilane and phenyltriethoxysilane, and y is selected from the group of n-octyltrimethoxysilane, n-octyltriethoxysilane.
Si (x, y) wherein x and y are about 10-30 and 70-90, respectively, wherein:
x is selected from the group of n-octyltrimethoxysilane, n-octyltriethoxysilane, phenyltrimethoxysilane and phenyltriethoxysilane, and y is selected from the group of n-octyltrimethoxysilane, n-octyltriethoxysilane.
9. The surface treated zinc oxide and/or titania particle according to claim 7, wherein the particles are nanocrystalline particles.
10. The surface treated zinc oxide and/or titania particle according to claim 7, wherein the particles are nanoparticles with a mean particle size range from about 1 nm to about 900 nm.
11. The surface treated zinc oxide and/or titania particle according to claim 7, where in the particles are nanoparticles with a mean particle size range from about 2 nm to about 500 nm.
12. The surface treated zinc oxide and/or titania particle according to claim 7, wherein the particles are nanoparticles with a mean particle size range from about 5 nm to about 100 nm.
13. The surface treated zinc oxide and/or titanic particle according to claim 7, where x and y are about 1-40 and 60-99, respectively.
14. The surface treated zinc oxide and/or titanic particle according to claim 7, where x and y are about 10-30 and 70-90, respectively.
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US55985104P | 2004-04-06 | 2004-04-06 | |
US60/559,851 | 2004-04-06 | ||
US59213304P | 2004-07-30 | 2004-07-30 | |
US60/592,133 | 2004-07-30 | ||
PCT/US2005/007779 WO2005104213A2 (en) | 2004-04-06 | 2005-03-09 | COSMETIC FORMULATIONS COMPRISING ZnO NANOPARTICLES |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2562047A1 true CA2562047A1 (en) | 2005-11-03 |
Family
ID=37545714
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002562047A Abandoned CA2562047A1 (en) | 2004-04-06 | 2005-03-09 | Cosmetic formulations comprising zno nanoparticles |
Country Status (2)
Country | Link |
---|---|
JP (1) | JP2007532541A (en) |
CA (1) | CA2562047A1 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5965619B2 (en) * | 2011-11-18 | 2016-08-10 | 株式会社ミルボン | spray |
KR102167111B1 (en) * | 2017-07-28 | 2020-10-20 | 경희대학교 산학협력단 | A composition for producing zinc nanocomposites comprising Dendropanax Morbifera extracts and the use thereof |
JP7005308B2 (en) * | 2017-11-20 | 2022-02-10 | エア・ウォーター・ゾル株式会社 | Aerosol foam sunscreen cosmetics |
JP7052317B2 (en) * | 2017-11-27 | 2022-04-12 | 堺化学工業株式会社 | Underwater oil type sunscreen cosmetics and their manufacturing methods |
-
2005
- 2005-03-09 JP JP2007507318A patent/JP2007532541A/en not_active Withdrawn
- 2005-03-09 CA CA002562047A patent/CA2562047A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
JP2007532541A (en) | 2007-11-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2005236840B2 (en) | Cosmetic formulations comprising ZnO nanoparticles | |
US6531117B2 (en) | Aqueous dispersion of water-insoluble organic UV filter substances | |
JP5015132B2 (en) | Metal oxide particles coated with polysiloxane | |
US20050276763A1 (en) | Emulsion concentrate containing water-soluble and oil-soluble polymers | |
JP4966667B2 (en) | Microcapsules having UV filter activity and method for producing the same | |
US20130085186A1 (en) | Cosmetic preparations based on molecularly imprinted polymers | |
US20020004034A1 (en) | Use of sunscreen combinations comprising, as essential constituent, 4,4'-diarylbutadienes as photostable UV filters in cosmetic and pharmaceutical preparations | |
US20080020054A1 (en) | Cosmetic and Dermatological Preparations Containing Transparent Surface-Coated Titanium Dioxide Particles | |
US6488915B1 (en) | Use of sunscreen combinations which comprise, as essential constituent, 2-(4-alkoxyanilinomethylene) malonic dialkyl esters as photostable UV filters in cosmetic and pharmaceutical preparations | |
US6458342B1 (en) | Use of sunscreen combinations comprising, as essential constituent, 2,2′-p-phenylenebis (3,1-benzoxazin-4-one) as photostable UV filters in cosmetic and pharmaceutical preparations | |
US20030215405A1 (en) | Cosmetic or dermatological light protection agent preparations | |
CA2562047A1 (en) | Cosmetic formulations comprising zno nanoparticles | |
KR100765035B1 (en) | Powdery preparations containing diethylamino-hydroxybenzoyl-hexyl-benzoate | |
AU784135B2 (en) | Cosmetic or dermatological sunscreen preparations | |
US20070028401A1 (en) | Powdered preparations containing a mixture of 2,4,6-trianilino-p-(carbo-2'-ethylhexyl-1'-oxi)-1,3,5-triazine and diethylamino-hydroxybenzoyl-hexyl-benzoate | |
CA2528311C (en) | Mixture consisting of uv-a and uv-b filters | |
US20070025931A1 (en) | Powdery preparations containing 2.4.6-trianilino-p-(carbo-2'-ethylhexyl-1'-oxi)-1.3.5-triazine | |
CN117679316A (en) | Fluid photoprotective compositions |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Discontinued |